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Abstract		Development	and	Application	of	a	Synthetic	Near	Infrared	Fluorescent	Probe	for	Imaging	Modulatory	Neurotransmitters		by		Abraham	G.	Beyene		 Doctor	of	Philosophy	in	Chemical	Engineering		University	of	California,	Berkeley		Professor	Markita	Landry,	Chair	
	
	 Dopamine	neurotransmission	plays	critical	roles	in	brain	function	in	both	health	and	disease	 and	 aberrations	 in	 dopamine	 neurotransmission	 are	 implicated	 in	 several	psychiatric	 and	 neurological	 disorders,	 including	 schizophrenia,	 depression,	 anxiety,	 and	Parkinson’s	 disease.	 Until	 recently,	 measuring	 the	 dynamics	 of	 dopamine	 and	 other	neurotransmitters	 of	 this	 class	 could	 not	 be	 achieved	 at	 spatiotemporal	 resolutions	necessary	to	study	how	dopamine	regulates	the	plasticity	and	function	of	neurons	and	neural	circuits,	and	how	dysfunctions	in	this	regulation	lead	to	disease.	Probes	that	satisfy	critical	attributes	 in	 spatiotemporal	 resolution	 and	 chemical	 selectivity	 are	 needed	 to	 facilitate	investigations	of	dopamine	neurochemistry.	To	address	this	need,	this	dissertation	describes	the	synthesis	and	implementation	of	an	 ultrasensitive	 near-infrared	 “turn-on”	 nanosensor	 (nIRCat)	 for	 the	 catecholamine	neuromodulators	dopamine	and	norepinephrine.	To	guide	probe	development,	we	present	results	from	a	computational	model	that	offers	insight	into	the	spatiotemporal	dynamics	of	dopamine	 in	 the	striatum,	a	subcortical	structure	 that	 is	enriched	 in	dopamine.	With	 this	model,	we	elucidated	the	kinetic	requirements	for	a	prototypical	optical	indicator	as	well	as	optimal	 imaging	 framerates	 needed	 for	 measuring	 dopamine	 neurochemical	 dynamics.	Stochastic	 modeling	 of	 dopamine	 dynamics,	 driven	 by	 kinetic	 phenomena	 of	 vesicular	release,	 diffusion	 and	 clearance,	 provide	 a	 platform	 to	 evaluate	 dopaminergic	 volume	transmission	arising	from	a	single	terminal	or	ensemble	terminal	activity.	With	this	work,	we	illustrate	that	only	probes	with	kinetic	parameters	in	a	particular	range	are	feasible	for	dopamine	imaging	at	spatiotemporal	scales	likely	to	be	encountered	in	brain	tissue.		In	 two	 subsequent	 chapters,	 we	 describe	 the	 development	 and	 in	 vitro	characterization	of	nIRCats,	synthesized	from	functionalized	single	wall	carbon	nanotubes	(SWCNT)	that	fluoresce	in	the	near	infrared	range	of	the	spectrum.	We	show	that	nIRCats	exhibit	 maximal	 relative	 change	 in	 fluorescence	 intensity	 (ΔF/F0)	 of	 up	 to	 35-fold	 in	response	 to	 catecholamines	 and	 have	 optimal	 dynamic	 range	 that	 span	 physiological	concentrations	of	their	target	brain	analytes.	Through	a	combination	of	experimental	and	molecular	 dynamics	 approaches,	 we	 elucidate	 the	 photophysical	 principles	 and	
2 
intermolecular	 interactions	 that	 govern	 the	 molecular	 recognition	 and	 fluorescence	modulation	of	nIRCats	by	dopamine.		Finally,	 we	 demonstrate	 that	 nIRCat	 can	 be	 used	 to	 measure	 electrically	 and	optogenetically	 evoked	 release	 of	 dopamine	 in	 striatal	 brain	 slices,	 revealing	 hotspots	 of	activity	with	a	median	size	of	2	µm,	and	exhibiting	a	log-normal	size	distribution	that	extends	up	to	10	µm.	Moreover,	nIRCats	are	shown	to	be	compatible	with	dopamine	pharmacology	and	permit	studies	of	how	receptor-targeting	drugs	modulate	evoked	dopamine	release.	Our	results	suggest	nIRCats	may	uniquely	support	similar	explorations	of	processes	that	regulate	dopamine	neuromodulation	at	the	level	of	individual	synapses,	and	exploration	of	the	effects	of	 receptor	 agonists	 and	 antagonists	 that	 are	 commonly	 used	 as	 psychiatric	 drugs	 and	psychoactive	molecules	that	modulate	the	release	and	clearance	profiles	of	dopamine.	We	conclude	that	nIRCats	and	other	nanosensors	of	this	class	can	serve	as	versatile	synthetic	optical	tools	to	monitor	interneuronal	chemical	signaling	in	the	brain	extracellular	space	at	spatial	and	temporal	scales	pertinent	to	the	encoded	information.
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Chapter	1	
1.1	Introduction	
Portions	of	this	chapter	are	reproduced	with	permission	from	Ref	1.1		Copyright	2018.	American	
Chemical	Society.		 Communication	between	neurons	is	mediated	by	a	series	of	electrical	and	chemical	signaling	modalities	 that	 occur	 in	 highly	 specialized	 structures	 called	 chemical	 synapses.	When	 a	 neuron	 fires	 an	 action	 potential,	 a	 fast,	 depolarizing	 burst	 of	 electrical	 impulse	propagates	 through	 its	 plasma	membrane	 and	 travels	 down	 an	 axonal	 process	where	 it	invades	 presynaptic	 terminals	 and	 gates	 Ca2+-permeable	 ion	 channels.	 The	 influx	 of	 Ca2+	triggers	a	biochemical	machinery	that	induces	exocytotic	vesicle	fusion	and	the	release	of	neurotransmitters	 into	 the	synaptic	 cleft,	which	diffuse	across	gap	 junctions	and	activate	receptors	 on	 the	 recipient	 target	 neurons	 to	 produce	 postsynaptic	 signals.	 Chemical	synapses	constitute	the	fundamental	processing	units	of	the	brain	and	enable	 interneural	communications	that	underpin	normal	brain	function.		A	 wide	 range	 of	 investigative	 methods	 have	 been	 developed	 to	 investigate	 the	electrical	 activity	 of	 neurons	 and	 neuronal	 networks,	 spanning	 the	 realms	 of	 molecular	biology,	genetics,	chemistry,	optics,	and	engineering,	and	forming	a	nexus	of	discovery	that	has	accelerated	our	understanding	of	how	certain	facets	of	brain	function,	such	as	memory	and	 learning,	 are	 encoded	 by	 neuronal	 electrical	 activity.	 Whereas	 neuronal	 electrical	excitability	is	a	hallmark	property	of	neurons	and	justifiably	draws	much	attention,	chemical	signaling	between	neurons	–	mediated	by	hundreds	of	neurotransmitters,	neuromodulators,	hormones,	 and	 other	 signaling	molecules	 –	 is	 equally	 important,	 but	more	 elusive	 in	 its	regulation	of	brain	function	for	motor	control,	learning,	and	behavior.	Tools	that	can	monitor	dynamic	brain	chemistry	at	pertinent	spatial	and	temporal	scales	are	necessary	to	advance	our	understanding	of	brain	 function	but	have	been	 lagging	tools	 for	monitoring	electrical	activity	in	their	robustness	and	sophistication.		In	addition	to	the	diversity	of	chemicals	that	neurons	use	to	communicate,	the	modes	of	chemical	signaling	between	neurons	may	also	be	different,	which	further	complicates	tool	development.	In	a	canonical	fast	synaptic	neurotransmission,	signaling	is	mediated	by	amino	acids	such	as	glutamate	and	γ-amino	butyric	acid	(GABA),	and	occurs	on	millisecond	time	scales	and	over	highly	specialized	nanoscale	spatial	domains,	and	results	in	the	influx	of	ions	through	 ligand-gated	 ion	 channels	 on	 postsynaptic	 neurons.	 On	 the	 other	 hand,	 unlike	classical	neurotransmitters,	neuromodulators	do	not	produce	 immediate	electrical	effects	that	excite	or	inhibit	target	neurons.	Instead,	neuromodulators	tune	the	intrinsic	or	synaptic	properties	 of	 neurons,	 most	 commonly	 through	 interaction	 with	 G-protein	 coupled	receptors	(GPCRs).	Neuromodulators	can	escape	the	synaptic	cleft	and	diffuse	broadly,	over	micrometer	length	and	second	time	scales,	allowing	them	to	influence	the	activity	of	many	neurons	 in	 a	 state-dependent	 manner.	 	 Consequently,	 the	 spatial	 component	 of	neuromodulatory	signaling	between	neurons	becomes	important.	The	diversity	of	chemical	species	as	well	as	the	range	of	the	relevant	spatiotemporal	dynamics	adds	to	the	challenges	of	developing	effective	methodologies	for	monitoring	and	manipulating	neurochemistry.	
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1.2	Fluorescent	Indicators	of	Neuronal	Electrical	and	Chemical	Activity	Advances	in	neuroscience	are	inextricably	linked	to	the	emergence	of	new	tools	and	techniques	 that	 facilitate	 new	 discoveries	 by	 unraveling	 phenomena	 that	 elude	 inquiry	through	conventional	methods.	One	of	 the	earliest	explorations	 in	neuroanatomy	utilized	Golgi’s	 silver	 staining	method	 to	 visualize	 neuronal	 connectivity,	 which	 gave	 rise	 to	 the	neuronal	 doctrine	 of	 modern	 neuroscience.	 In	 subsequent	 decades,	 developments	 in	electrophysiology,	driven	by	the	invention	of	electrode	or	patch	clamp	recording	techniques,	facilitated	recording	of	the	electrical	activity	from	small	group	of	neurons	at	a	time,	enabling	the	 first	 measurements	 of	 neuronal	 electrical	 activity	 in	 reduced	 preparations,	 and	subsequently	 in	 awake	 behaving	 animals.	 In	 parallel,	 early	 investigations	 of	 dynamical	neurochemical	 processes	 primarily	 relied	 on	 highly	 invasive	 techniques	 such	 as	microdialysis,	in	which	chemical	analytes	are	recovered	from	the	interstitial	space	of	brain	tissue	by	dialysis	and	characterized	downstream	using	various	analytical	approaches	such	as	liquid	chromatography,	capillary	electrophoresis,	and	mass	spectrometry.	Amperometry	and	 cyclic	 voltammetry	 enabled	 quantifying	 the	 neurochemistry	 of	 certain	 redox-active	molecules	 in	the	brain	with	high	temporal	resolution.	While	these	classical	methods	have	contributed	 significantly	 to	 quantitative	measurements	 of	 important	 brain	 analytes,	 they	have	low	throughput,	are	highly	invasive	and	do	not	operate	at	pertinent	spatial	resolutions.		In	recent	decades,	rapid	advances	in	molecular	biology,	genetics,	chemistry	and	microscopy	have	 formed	 a	 synergistic	 nexus	 and	 provided	 a	 library	 of	 light-activated	 reporters	 and	actuators	of	brain	activity	that	are	minimally	invasive,	highly	targetable	and	operate	with	improved	throughput,	enabling	recording	of	neuronal	electrical	and	chemical	activity	over	significant	spatial	scales.	Fluorescent	activity	indicators	in	particular	have	addressed	the	need	for	monitoring	dynamical	 electrical	 and	 chemical	 activity	 of	 neurons	 at	 pertinent	 spatial	 and	 temporal	scales.	Such	fluorescent	indicators	can	be	categorized	into	two	broad	families:	genetically-encoded	 fluorescent	 proteins	 and	 synthetic	 fluorescent	 molecules.	 Genetically-encoded	fluorescent	 indicators	 take	 a	 “nature	 knows	 best”	 strategy,	 in	 which	 naturally	 existing	protein	recognition	motifs	are	conjugated	to	 fluorescent	proteins	(FP).	The	conjugate	 is	a	chimeric	construct	capable	of	translating	ligand-binding	induced	conformational	changes	to	fluorescence	 intensity	 or	 Förster	 Resonance	 Energy	 Transfer	 (FRET)	 changes	 in	 the	 FP.	These	 chimeric	 constructs	 can	 be	 expressed	 in	 the	 cytoplasm	 or	 plasma	 membrane	 of	specific	cellular	populations	via	genetic	engineering	strategies.	Genetically-encoded	probes	were	 initially	 developed	 for	 measuring	 calcium	 (Ca2+)	 activity	 in	 neurons	 by	 coupling	 a	calcium	sensing	protein	(for	example,	calmodulin)	to	an	FP	(for	example,	GFP)	via	a	short	peptide	 linker.	 Alternative	 strategies	 use	 FRET	 as	 a	 read-out	 of	 protein	 conformational	changes.	In	both	approaches,	iterative	improvements	over	the	course	of	nearly	two	decades	have	produced	a	diverse	library	of	Ca2+	activity	indicators	with	spectral	properties,	kinetics,	sensitivity	and	targetability	suited	for	a	broad	range	of	applications.	Although	not	as	mature	as	 Ca2+	 indicators,	 genetically-encoded	 voltage	 indicators	 (GEVI)	 have	 made	 impressive	advances	 in	 the	 recent	 past	 and	 are	 rapidly	 becoming	 an	 indispensable	 part	 of	 the	
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neuroscience	 investigative	 toolkit.	 Most	 recently,	 genetic	 and	 protein	 engineering	approaches	 have	 been	 expanded	 to	 generate	 fluorescent	 indicators	 for	 interneuronal	chemical	signaling	molecules,	including	neurotransmitters	and	neuromodulators.	2–4	Genetically-encoded	probes	demonstrate	how	advances	in	fluorescence	microscopy,	transgene	 delivery	 and	 protein	 engineering	 intersect	 to	 accelerate	 tool	 development	 for	neuroscience	research.	Despite	their	success,	protein-based	probes	have	certain	drawbacks	that	motivate	the	need	for	alternative	platforms	for	sensor	development.	First,	the	spectrum	of	available	colors	in	the	fluorescent	protein	library	is	primarily	limited	to	the	visible	range	of	 the	 electromagnetic	 spectrum	 and	 there	 has	 so	 far	 been	 limited	 success	 in	 producing	stable	and	bright	far	red	and	near	infrared	emissive	FPs.	Spectral	overlap	between	optical	indicators	 or	 actuators	 of	 neuronal	 activity	 in	 the	 visible	 range	 of	 the	 spectrum	 limit	multiplexed	 usage.	 Additionally,	 scattering	 of	 visible-range	 photons	 by	 brain	 tissue	adversely	affects	imaging	depth	and	resolution.		Moreover,	genetically	encoded	probes	rely	on	 genetically	 tractable	 model	 organisms	 and	 require	 robust	 protein	 expression	 for	successful	 implementation,	which	 further	motivates	 the	need	 for	 approaches	 that	 do	not	require	gene	delivery	and	protein	expression	and	can	be	rolled	out	seamlessly	across	many	species	and	experimental	preparations.	The	 second	 family	 of	 fluorescent	 indicators	 exploits	 synthetic	 small	 molecules	 to	generate	useful	neural	activity	indicators.	Before	being	supplanted	by	genetically	encoded	probes,	the	earliest	Ca2+	activity	indicators	were	generated	from	synthetic	calcium	chelating	moieties	(for	example,	BAPTA)	that	are	covalently	fused	to	organic	fluorescent	scaffolds	(for	example,	 fluorescein).	Despite	 their	 lack	of	 cellular	 specificity	 and	 challenges	 in	delivery,	small	molecule	organic	fluorophores	offer	certain	advantages	over	FPs:	they	tend	to	have	superior	photostability	and	brightness,	which	can	be	advantageous	 for	capturing	photon-limited	fast	transients	at	video	rate	temporal	resolutions.	Here	too	however,	the	spectrum	of	available	colors	is	mostly	confined	within	the	visible-range	(400	–	700	nm).	Near-infrared	emissive	synthetic	dyes	are	the	subject	of	active	research	but	still	suffer	from	challenges	of	low	quantum	yield	and	poor	photostability.	Furthermore,	whereas	full	and	semi-synthetic	Ca2+	and	voltage	activity	reporters	have	been	demonstrated,	neurochemical	sensing	using	synthetic	constructs	are	yet	to	be	demonstrated	at	any	useful	scale.		An	 alternative	 class	 of	 synthetic	 fluorescent	 species,	 including	 semiconducting	fluorescent	 nanostructures	 such	 as	 transition	 metal	 quantum	 dots	 and	 graphitic	nanomaterials,	 possess	 attributes	 that	 have	 recently	 drawn	 considerable	 interest	 from	biological	researchers.	These	nanocrystalline	materials	exhibit	superior	photostability,	have	large	extinction	coefficients,	and	a	tunable	emission	spectrum	that	can	be	extended	into	the	near	 infrared	 region	 of	 the	 spectrum.	 Fluorescent	 nanoparticles	 allow	 surface	 chemical	modifications	that	can	optimize	their	photophysical	and	chemical	properties	and	they	can	be	conjugated	to	motifs	for	molecular	recognition	and	single	particle	tracking.	Therefore,	this	class	of	synthetic	fluorescent	materials	offer	attributes	that	can	be	exploited	to	continue	to	address	some	of	the	outstanding	needs	in	optical	tool	development,	particularly	within	the	context	of	neuroscience	research.	This	dissertation	describes	the	use	of	a	class	of	carbon	nanostructures	called	single	wall	 carbon	 nanotubes	 (SWCNT)	 as	 scaffolds	 for	 the	 synthesis	 and	 implementation	 of	fluorescent	indicators	of	neurochemical	activity.	SWCNT	are	semiconducting	nanocrystals	composed	 of	 sp2-hybridized	 graphitic	 carbon	 atoms	 that	 are	 rolled	 seamlessly	 into	cylindrical	tubes	of	approximately	1	nm	in	diameter	and	length	scales	that	can	be	up	to	four	
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orders	 of	 magnitude	 larger.	 In	 SWCNTs,	 quantum	 confinement	 effects	 in	 the	 radial	dimension	give	rise	to	fascinating	photophysical	and	electrical	properties	that	draw	interest	from	a	myriad	of	fields.	Within	the	context	of	biological	imaging,	SWCNTs	exhibit	superior	photostability	 and	 fluorescence	 intrinsically	 in	 the	 relatively	 tissue-penetrating	 near	infrared	(NIR)	range	of	the	spectrum	(1000	–	1300	nm),	a	window	that	has	heretofore	been	largely	 inaccessible	 with	 organic	 synthetic	 molecules	 and	 FPs.	 Biological	 tissue	 exhibits	remarkably	 diminished	 scattering	 and	 autofluorescence	 in	 this	window	 of	 the	 spectrum,	which	 in	 principle	 should	 allow	 imaging	 in	 deeper	 brain	 structures	 than	 may	 not	 be	accessible	with	 visible-photon	 emitting	 dyes.	Moreover,	 the	 1000	 –	 1300	 nm	window	 is	sufficiently	far	removed	from	and	possesses	little	spectral	overlap	with	the	existing	suite	of	optical	 activity	 indicators	 and	 actuators.	 This	 suggests	 that	 SWCNT-based	 tools	 can	 be	seamlessly	 implemented	 in	 conjunction	 with	 existing	 tools.	 Finally,	 chiral	 diversity	 of	SWCNTs	offers	a	palette	of	colors	within	the	NIR	region	that	offers	tantalizing	opportunities	for	ratiometric	sensing	and	multiplexing	within	the	NIR	window	of	the	spectrum.	Covalent	 and	 non-covalent	 strategies	 can	 be	 employed	 to	 conjugate	 recognition	motifs	 to	 SWCNTs	 for	 the	 development	 of	 NIR-emissive	 fluorescent	 indicators.	 In	 this	dissertation,	we	use	non-covalent	conjugation	of	SWCNT	with	amphiphilic	biopolymers	as	recognition	moieties	to	develop	fluorescent	indicators	for	catecholamine	neuromodulators,	a	class	of	biogenic	amines	that	play	critical	roles	in	a	wide	range	of	brain	functions	and	are	implicated	in	several	neurological	and	psychiatric	diseases.	With	this	tool,	we	demonstrated	optical	detection	of	extracellular	dopamine	dynamics	in	ex	vivo	brain	slices	at	micron	spatial	and	sub-second	temporal	scales,	which	are	resolutions	pertinent	to	applications	in	molecular	and	circuit	neuroscience.	We	conclude	that	SWCNT-based	optical	probes	can	offer	a	suite	of	NIR	fluorescent	activity	 indicators	within	a	window	of	the	electromagnetic	spectrum	that	has	considerable	favorable	attributes	for	biological	research.	
1.3	Outline	of	Dissertation	The	 contents	 of	 this	 dissertation	 are	 organized	 into	 the	 following	 chapters.	 We	provide	synopses	and	highlight	conclusions	from	each	chapter	below.		Chapter	2			 Here,	 we	 present	 a	 stochastic	 model	 of	 dopamine	 neuromodulation,	 which	 we	developed	 from	 a	 first	 principles	 mathematical	 framework	 and	 with	 model	 parameters	obtained	from	an	extensive	review	of	the	neuroanatomical	and	physiological	literature.	We	outline	 the	 temporal	 and	 spatial	 scales	 of	 dopamine	neuromodulation	within	 the	 striatal	region	of	the	basal	ganglia	as	predicted	by	our	model,	arising	from	three	competing	dynamic	processes:	quantal	dopamine	release,	diffusion	and	transporter-mediated	clearance.	Using	this	model,	we	asked	what	the	kinetic	requirements	are	for	such	an	optical	probe	and	what	the	optimal	imaging	parameters	are	for	measuring	the	dynamics	of	dopamine	in	brain	tissue	at	 video	 frame	 rates.	 	 This	 model	 afforded	 identification	 a	 dopamine-to-probe	 binding	affinity	 window	 and	 imaging	 frame	 rate	 that	 is	 optimal	 for	 recording	 dynamics	 in	 the	striatum.	This	work	provided	valuable	insights	that	contributed	to	sensor	development	and	
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guided	subsequent	endogenous	dopamine	imaging	experiments	in	brain	tissue,	which	are	topics	of	subsequent	chapters	of	this	dissertation.		Chapter	3		 Here,	 we	 discuss	 the	 development	 of	 a	 SWCNT-based	 “turn-on”	 sensor	 for	 the	catecholamines	dopamine	and	norepinephrine.	The	sensor	is	synthesized	from	noncovalent	functionalizations	of	SWCNTs	with	single	strand	DNA	(ssDNA)	oligonucleotides.	We	present	methodologies	for	sensor	synthesis,	experimental	work	that	characterizes	the	spectroscopic	properties	 of	 the	 probe	 and	 its	 performance	 in	 in	 vitro	 conditions.	 We	 show	 that	 non-covalent	associations	between	ssDNA	and	SWCNTs	form	colloidal	suspensions	that	exhibit	exquisite	 “turn-on”	 sensitivity	 to	 and	 selectivity	 for	 dopamine	 and	 norepinephrine.	 We	uncover	 experimentally	 accessible	 tuning	 parameters,	 including	 nucleobase	 chemistry,	ssDNA	 oligonucleotide	 length,	 SWCNT	 bandgap	 and	 polymer	 surface	 density	 that	 play	critical	roles	in	setting	the	sensitivity	and	dynamic	range	of	the	probe.		Chapter	4		 In	 this	 chapter,	 we	 introduce	molecular	 dynamics	 simulation	 strategies	 to	 bridge	macroscale	experimental	observations	with	molecular	processes	that	underpin	them.	First,	we	 will	 present	 results	 from	 molecular	 dynamics	 simulation	 studies	 that	 elucidate	 the	organization	of	ssDNA	oligonucleotide	surface	corona	on	SWCNTs.	We	explore	the	molecular	processes	that	drive	target	recognition	and	the	mechanisms	of	optical	signal	transduction	within	the	underlying	SWCNT-oligonucleotide	scaffold	for	the	dopamine	sensor	presented	in	Chapter	3.	Our	findings	in	this	chapter	rationalize	key	experimental	observations	and	offer	mechanistic	insights	into	the	influence	of	ssDNA	oligonucleotide	surface	moieties	on	SWCNT	photophysics	 and	 how	 interactions	 with	 dopamine	 molecules	 induce	 perturbations	 that	engender	SWCNT	fluorescence	modulation.			Chapter	5		 In	 this	 chapter,	 we	 demonstrate	 that	 optical	 probes	 based	 on	 ssDNA-SWCNT	technology	 can	 measure	 endogenous	 dopamine	 dynamics	 in	 ex	 vivo	 acute	 brain	 slices	prepared	 from	 mice.	 We	 have	 named	 this	 nanosensor	 platform	 nIRCat,	 short	 for	 near	infrared	catecholamine	nanosensor.	Using	nIRCats,	we	show	hotspots	of	putative	dopamine	release	in	the	dorsomedial	striatum	that	are	vary	in	size	from	2	to	10	µm.	We	demonstrate	the	compatibility	of	nIRCats	with	pharmacological	agents	that	modulate	dopamine	release	and	clearance	from	tissue.	We	show	that	nIRCats	have	the	temporal	and	spatial	resolution	that	 enable	 investigations	 into	 presynaptic	 control	 of	 dopamine	 release,	 including	 how	presynaptic	 control	 is	 modulated	 by	 dopamine	 receptor	 agonists	 and	 antagonists.	 We	conclude	that	nIRCats	and	other	similar	probes	of	its	class	offer	a	valuable	category	of	tools	with	unique	photophysical	attributes	that	can	facilitate	new	discoveries	in	neuroscience.		Chapter	6	
	
	 We	summarize	our	work	and	offer	concluding	remarks	for	the	dissertation.	
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Chapter	2	
Simulations	of	Striatal	Dopamine	Neuromodulation	for	Design	
and	Implementation	of	Optical	Probes	in	Extracellular	Space	
	
Portions	of	this	chapter	are	reproduced	with	permission	from	Ref	5.5	Copyright	2017.	American	
Chemical	Society.		 Imaging	 the	 dynamic	 behavior	 of	 neuromodulatory	 neurotransmitters	 in	 the	extracellular	space	arising	from	individual	quantal	releases	would	constitute	an	important	addition	 to	 the	 neuroscience	 toolkit.	 The	 spatial	 and	 temporal	 scales	 of	 these	 highly	stochastic	events	necessitate	concurrent	advances	 in	the	chemical	development	of	optical	probes	selective	for	neuromodulators,	in	concert	with	advances	in	imaging	methodologies	to	 capture	 millisecond-scale	 neurotransmitter	 release.	 Here,	 we	 developed	 a	 stochastic	model	 to	 describe	 the	 dynamics	 of	 the	 neuromodulator	 dopamine	 in	 extracellular	 space	(ECS)	of	the	brain	dorsal	striatum,	which	can	be	used	to	guide	the	design	and	implementation	of	optical	probes	that	can	record	dynamical	neurochemical	processes	in	the	ECS.	Our	model	is	developed	from	first	principles	and	simulates	release,	diffusion,	and	reuptake	of	dopamine	in	 a	 3D	 simulation	 volume	 of	 striatal	 tissue.	 We	 find	 that	 imaging	 endogenous	neuromodulatory	dynamics	requires	simultaneous	optimization	of	the	probe’s	reversibility	and	 sensitivity.	 Our	 work	 shows	 that	 dopamine	 imaging	 in	 the	 dorsal	 striatum	 is	 best	accomplished	 with	 probes	 that	 have	 dissociation	 constant	 (Kd)	 on	 the	 order	 of	 1	 µM.	Furthermore,	as	a	result	of	the	probabilistic	nature	of	vesicular	fusions	that	lead	to	quantal	release,	 our	 model	 suggests	 that	 video	 frame	 rates	 of	 20	 Hz	 are	 optimal	 for	 recording	temporally	resolved	release	events.	Our	work	provides	a	modeling	platform	to	probe	how	neuromodulatory	 processes	 can	 be	 studied	 with	 optical	 indicators	 and	 enables	 facile	assessment	 of	 probe	 kinetic	 properties	 and	 imaging	 framerates.	 Our	 stochastic	model	 is	generic	 for	 evaluating	 and	 optimizing	 fluorescent	 chemical	 activity	 indicators	 for	 brain	systems	 whose	 neuroanatomical	 and	 neurophysiological	 properties	 are	 sufficiently	understood.	
2.1	Introduction	Diffuse	volume	transmission	constitutes	an	important	element	of	neuronal	signaling	for	 certain	 neurotransmitters	 such	 as	 acetylcholine,	 dopamine,	 norepinephrine,	 and	serotonin.	While	classical	neurotransmission	is	confined	to	communication	between	the	pre-	and	 postsynaptic	 neuron,	 and	 is	 mediated	 by	 fast	 acting	 ligand-gated	 ion	 channels,	neuromodulation	employs	slower	acting	metabotropic	receptors	that	exhibit	a	high	level	of	extrasynaptic	expression.	6	Thus,	modulatory	neurotransmitter	activity	extends	well	beyond	the	synapse.	As	a	consequence,	neuromodulators	such	as	dopamine	influence	a	population	of	neurons	beyond	the	synapse,	enabling	a	single	neuron	to	modulate	the	activity	of	a	larger	network	 of	 connections.	 It	 is	 therefore	 of	 great	 interest	 to	 develop	 tools	 to	 observe	 and	quantify	the	release,	diffusion,	and	reuptake	of	neuromodulatory	neurotransmitters	such	as	
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dopamine,	where	 the	 spatial	 and	 temporal	 dynamics	 observed	 in	 the	 brain	 extracellular	space	(ECS)	can	be	directly	linked	to	receptor	activation,	neuronal	activity	modulation,	and	ultimately,	behavior.	Among	the	most	prominent	dopaminergic	systems	are	the	nigrostriatal,	mesocortical,	and	mesolimbic	projections.	Small	clusters	of	dopamine	neuron	cell	bodies	 located	 in	 the	substantia	nigra	pars	compacta	(SNc)	make	extensive	connections	with	the	medium	spiny	neurons	(MSN)	of	the	dorsal	striatum,	forming	the	nigrostriatal	pathway.	7,8	This	pathway	is	responsible	 for	 controlling	 fine	 motor	 movements	 and	 its	 dysfunction	 underlies	 the	pathology	 of	 Parkinson’s	 disease.9	 	 Axons	 of	 dopaminergic	 cell	 bodies	 in	 the	 ventral	tegmental	area	project	into	the	nucleus	accumbens	and	the	prefrontal	cortex,	forming	the	mesolimbic	and	mesocortical	pathways,	respectively.7,8		These	systems	play	significant	roles	in	cognitive	control	of	behavior	and	reward	processing,	and	their	dysfunction	contributes	to	the	 pathology	 of	 depression,	 addiction,	 schizophrenia	 and	 attention	 deficit	 hyperactivity	disorder	(ADHD),	among	others.10–14	In	all	of	these	systems,	neuromodulation,	as	opposed	to	neurotransmission,	is	the	primary	mode	of	influence.	The	diffusion-mediated	transport	of	dopamine	in	the	ECS	is	also	known	as	volume	transmission.15	One	of	 the	most	ambitious	pursuits	 in	neuroscience	 is	elucidating	 the	relationship	between	neurons,	neural	circuits,	behavior,	and	disease.16	Successful	chronic	and	real-time	recording	of	neurotransmitter	mediated	chemical	signaling	would	be	a	decisive	step	in	that	direction.17	Current	methods	to	measure	the	dynamics	of	dopamine	volume	transmission	in	ECS	 lack	 the	 spatial	 and/or	 temporal	 resolution	 of	 relevance	 to	 study	 neuromodulation.	Voltammetry	and	amperometry	are	electrode-based	methods	used	to	record	the	presence	of	neuromodulators	via	redox	chemistries	yet	require	penetration	of	the	brain	tissue	and	only	assay	 neurotransmitter	 concentration	 at	 one	 point	 in	 space.	 Optical	 probes	 include	 cell-based	 neurotransmitter	 fluorescent-engineered	 reporters	 (CNiFERs)	 that	 have	 been	engineered	 to	 express	 a	 chimeric	 dopamine	 receptor	 and	 a	 genetically	 encoded	 calcium	indicator.18	CNiFERs	utilize	slow	G-protein	coupled	receptor	(GPCR)	responses	and	thus	do	not	 report	 millisecond	 or	 micron-scale	 neurotransmitter	 activity.	 Fluorescent	 false	neurotransmitters	(FFNs)	fluorescently	label	dopaminergic	vesicles	to	provide	single	release	site	resolution	but	do	not	report	the	evolution	of	neurotransmitter	concentrations	in	ECS.19–21	Calcium	imaging	can	show	bouton	activity	in	dopamine	axons	preceding	release	but	tell	us	little	about	extracellular	dopamine	concentration.	In	sum,	existing	methods	are	insufficient	to	enable	reliable	measurements	of	dopamine	and	other	modulatory	neurotransmitters	in	the	 ECS	 with	 the	 necessary	 spatial	 and	 temporal	 resolutions	 pertinent	 to	 their	neurophysiological	function.		Over	the	last	two	decades,	tremendous	advances	have	been	made	in	the	development	of	 optical	 activity	 indicators	 for	 two	 important	 facets	 of	 neuronal	 activity:	 cytoplasmic	calcium	dynamics	and	membrane	voltage.	These	technologies	provide	excellent	spatial	and	temporal	resolutions	at	reasonably	high	throughput	and	with	remarkable	targetability.22,23	However,	development	of	probes	for	chemical	signaling	molecules	have	only	made	modest	advances.	 One	 contributing	 factor	 in	 this	 lag	 is	 the	 lack	 of	 knowledge	 about	 the	 native	spatiotemporal	dynamics	of	neurochemicals,	which	hinders	probe	development.	To	address	this	need,	we	developed	a	mathematical	model	that	estimates	dopamine	dynamics	in	striatal	tissue	and	can	therefore	be	used	to	guide	probe	development	for	implementation	under	ex	
vivo	and	in	vivo	imaging	conditions.	We	coupled	our	model-derived	dopamine	dynamics	with	probe	kinetic	properties	and	found	that	only	probes	with	kinetic	properties	in	a	small	critical	
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window	(Kd	~	1	µM)	are	optimal	 for	measuring	dopamine	dynamics.	Probes	with	higher	affinity	(Kd	<	10	nM)	were	found	to	be	prone	to	saturation	by	tonic	dopamine	levels,	which	leads	 to	 diminished	 response	 to	 transient	 phasic	 dopamine	 signals.	 Probes	 with	 lower	affinity	(Kd	>	10	µM)	are	likely	to	have	a	diminished	overlap	between	their	dynamic	range	and	dopamine	concentration	ranges	estimated	by	our	model.	
2.2	Results	and	Discussion											We	model	the	diffusion	driven	dynamics	of	dopamine	in	the	ECS	of	striatal	tissue	by	numerically	solving	the	diffusion	equation	with	dopamine	source	and	sink	terms.	Dopamine	sources	are	the	quantal	releases	from	dopaminergic	terminals	within	a	defined	simulation	volume,	while	the	reuptake	of	dopamine	from	the	ECS	acts	as	a	sink.	Reuptake	parameters	are	assumed	to	be	uniform	throughout	the	simulation	volume.	We	set	the	simulation	volume	as	a	cubic	block	of	striatal	 tissue	comprised	of	evenly	 interspaced	dopamine	terminals.	A	schematic	of	striatal	 tissue	model	with	dopamine	terminals	depicted	as	yellow	spheres	 is	shown	 in	Figure	2.1a.	We	use	 the	nigrostriatal	projection	as	a	model	system	owing	 to	 its	critical	 role	 in	 reward	 and	 reinforcement,	 addictive	 behavior,	 habit	 formation,	 and	 its	implications	for	motor	disorders,	such	as	Parkinson’s	disease.	Furthermore,	the	nigrostriatal	system	 is	 well	 described	 in	 the	 literature,	 providing	 requisite	 physiological	 parameters	relevant	to	dopaminergic	neurotransmission	with	which	to	implement	our	model.	
	
Simulation	Volume			 Dopamine	 terminals	 are	 the	 source	of	dopamine	 in	our	 simulation,	 and	dopamine	transporters	(DATs)	drive	dopamine	reuptake.	To	elucidate	the	spatiotemporal	dynamics	of	dopamine	concentration	in	the	ECS,	we	define	our	simulation	space	as	a	1000	μm3	(10	μm	x	10	μm	x	10	μm)	volume	of	 striatal	neural	 tissue	 containing	100	dopaminergic	 terminals.	Terminals	 are	 arranged	 in	 a	 periodic	 lattice	 structure	 filling	 the	 simulation	 volume.	 The	structural	and	functional	parameters	of	our	simulation	volume	are	summarized	thus:	(i)	the	density	of	dopaminergic	terminals	in	the	striatum,	(ii)	probability	of	dopamine	release	upon	membrane	depolarization,	(iii)	amount	of	dopamine	released	per	quanta	(per	vesicle	fusion),	(iv)	effective	diffusivity	of	dopamine	in	tissue	and	(v)	dopamine	reuptake	kinetics	by	DATs.	A	summary	of	parameter	values	and	literature	sources	is	provided	in	Table	1.		
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Figure	 2.1	 Schematic	 of	 dopamine	model.	 (a)	 Dorsal	 striatum	with	medium	 spiny	 neurons	 (MSN	 -	 red	contours/gray	body),	dopamine	terminals	(yellow),	and	projection	axons	(tan)	from	SNc.	(b)	A	magnified	view	of	an	individual	dopamine	terminal	forming	a	synapse	onto	a	dendritic	shaft	of	MSN.	Dopamine	release:	An	action	potential	causes	a	dopamine-containing	vesicle	to	release	dopamine	into	the	synaptic	cleft.	Dopamine	encounters	 post-synaptic	 receptor	 proteins,	 triggering	 further	 downstream	 neuronal	 processes.	 Dopamine	reuptake:	DATs	clear	dopamine	from	the	ECS	to	be	recycled.	(c)	Space	discretization	around	a	dopaminergic	terminal	representing	tortuous	morphology	of	brain	tissue.	Black	represents	tissue	surrounded	by	void	ECS.	Concentric	circles	depict	simulation	volume	elements.	Inset	graph:	Dopamine	concentration	fluctuates	in	space	and	time	as	a	result	of	release,	diffusion	and	reuptake.		
	
Model	Representation	of	Dopamine	Terminals			 We	define	dopamine	terminals	as	the	boutons	of	axonal	projections	from	the	SNc	into	the	dorsal	striatum	(Figure	2.1a).	Cell	bodies	of	dopaminergic	neurons	of	the	nigrostriatal	pathway	are	located	in	the	SNc	and	their	axonal	projections	ascend	into	the	dorsal	striatum	and	 make	 connections	 with	 dendritic	 spines	 or	 dendritic	 shafts	 of	 MSNs.8,24,25	 These	ascending	 axonal	 tracts	 are	 notable	 for	 their	 high	 terminal	 density,	 where	 each	 axon	 is	estimated	to	make	on	the	order	of	400,000	connections	in	the	striatum.26–28	A	dopaminergic	terminal	contains	a	cluster	of	vesicles	in	close	proximity	to	symmetric	membrane	densities,	forming	 dopaminergic	 synapses	 with	 MSNs	 (Figure	 2.1b).	 Asymmetric	 synapses	 also	constitute	 a	minority	of	 synaptic	 configurations.8	Our	 simulation	 considers	 these	 sites	 as	
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point	release	sources	in	a	three	dimensional	space.	We	recreate	the	neuroanatomy	within	the	simulation	volume	as	described	in	previous	computational	studies.29–32			
Table	2.1	Values	of	Simulation	Parameters	and	Literature	Sources		
		
Dopamine	Release	Sites	and	Probability	of	Release		
	 Neurotransmitter	 release	 occurs	 at	 release	 sites	within	 synapses.	We	 execute	 our	model	 for	which	each	dopamine	 terminal	possesses	a	 single	 release	 site33	 	 (Figure	2.1b),	where	dopamine	release	probability	per	action	potential	per	 terminal	 is	 set	 to	6%.30	The	probability	of	quantal	release	is	a	function	of	the	size	of	the	readily	releasable	pool	(RRP)	in	proportion	 to	 the	 total	 pool	 size	which	 encompasses	 the	RRP,	 the	 recycling,	 and	 reserve	pools.34	 For	 dopaminergic	 activity	 in	 striatum,	 the	 low	 dopamine	 release	 probability	 is	further	 supported	 by	 experimental	 results,	 which	 reveal	 that	 many	 dopamine	 terminals	remain	 “silent”	 during	 stimulation.19,20	We	 assume	 a	 constant	 probability	 of	 release	 and	quantity	of	release	in	our	simulation.	Furthermore,	membrane	depolarization,	which	drives	neurotransmitter	 release,	 is	 mediated	 by	 voltage-gated	 sodium	 channel	 activity	 which	remain	inactive	for	~10	ms	following	an	action	potential.	Thus,	we	impose	a	constraint	in	our	simulation	to	limit	sequential	dopamine	release	events	to	occur	at	intervals	greater	than	10	ms	per	terminal,	for	a	100	Hz	maximum	release	rate	for	any	given	terminal.	Despite	this	maximum	release	rate,	the	low	probability	of	release	makes	it	such	that	the	100	Hz	boundary	condition	is	rarely	encountered	in	our	simulations.	
	
Simulation	of	Release,	Diffusion	and	Reuptake			 Our	simulation	of	dopamine	concentration	in	the	ECS	invokes	the	equation	of	change	for	species	conservation	surrounding	a	dopaminergic	terminal31			
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	 		 	 	 											1		where	c(r,t)	represents	spatial	(r)	and	temporal	(t)	variation	in	dopamine	concentration,	and	
Q(r,t)	and	U(r,t)	represent	quantal	release	of	dopamine	into	the	ECS	and	reuptake	by	DATs,	respectively.	D	is	the	effective	diffusivity	of	dopamine	in	tissue	after	accounting	for	tortuosity	of	brain	 tissue.35,36	 	We	solve	 this	governing	equation	at	 each	dopamine	 release	 terminal	using	finite	difference	method,	and	obtain	the	solution	for	temporal	and	spatial	dopamine	dynamics	resulting	from	release	from	one	dopamine	terminal.	Striatal	tissue	is	composed	of	approximately	 1	 terminal	 per	 10	 μm3.26,28	With	 this	 terminal	 density,	 we	 determine	 the	temporal	 profile	 of	 dopamine	 concentration	 resulting	 from	 the	 activity	 of	 all	 terminals	included	in	the	simulation	volume	of	interest	as	described	in	Methods	in	Appendix	I.	Lastly,	we	 discretize	 the	 governing	 equation	 to	 solve	 it	 numerically,	 since	 no	 known	 analytical	solutions	exist	for	this	equation.	The	difference	equation	is	written	in	spherical	coordinates	as	forward	difference	in	time	and	central	difference	in	space.			
Quantal	Release			 In	equation	1,	Q(r,t)	 represents	quantal	dopamine	release	 following	 	vesicle	 fusion		and	is	represented	by:		 																																						2		where	Q0	represents	the	number	of	dopamine	molecules	released	per	exocytosis	event	and	
NA	represents	Avogadro’s	number.	The	parameter	𝜓	assumes	a	value	of	1	or	0	based	on	a	release	probability	p.	A	release	event	increases	the	concentration	of	the	first	spatial	element	of	the	simulation	volume	(Figure	2.1c)	by	an	amount	represented	by:		 						 						 	 	 	 											3		This	is	the	volume	element	immediately	surrounding	the	location	of	the	dopamine	release	site	 (Figure	 2.1b,	 c).	 The	 parameter	 α	 accounts	 for	 porosity	 of	 brain	 tissue.31	We	 use	 a	Gaussian	 probability	 density	 function	 to	 determine	 the	 spatial	 distribution	 of	 dopamine	immediately	after	release,	normalized	to	ensure	that	only	5000	(Q0)	molecules	of	dopamine	are	 released	 per	 quanta	 (Table	 1).	 Dopamine	 spillover	 after	 quantal	 release	 is	instantaneous.29	Thus,	a	quantal	release	event	affects	the	concentration	of	volume	elements	away	from	the	center	of	the	release	site	by	an	amount	equal	to	the	increase	in	the	center	of	the	release	site	(eqn.	3)	scaled	by	an	exponential	decay	term,	 𝑒#(%#&)( .	This	exponential	term	is	a	function	of	the	distance	of	the	volume	element	from	the	center	of	the	release	site	r	
=	(n-1)dr,	where	n	represents	the	spatial	index,	n	=	1,	2…N,	representing	each	volume	element	in	the	simulation.	The	sum	of	this	exponential	scaling	term	over	the	spatial	indices	gives	rise	to	 the	 normalization	 constant,	 1.386.	 Firing	 frequency	 (F)	 sets	 the	 number	 of	 action	
∂c(r, t)
∂t = D∇
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potentials	over	a	given	simulation	period.	The	temporal	distribution	of	action	potentials	over	the	simulation	time	period,	tf,	is	modeled	as	a	Poisson	distribution	with	mean	a	firing	rate	of	
F.	 	is	a	delta	function	in	time	and	ensures	that	release	can	only	occur	during	an	action	potential	firing	event	with	a	binary	probability	𝜓.			
Dopamine	Reuptake	(U)			 Reuptake	of	 dopamine	 from	 the	ECS	occurs	 via	DATs.	 In	 our	model,	we	 assume	a	uniform	distribution	of	DATs	in	the	simulation	volume	and	model	dopamine	reuptake	with	a	Michaelis-Menten	rate	equation	with	parameters	rmax	and	Km	and	in	a	medium	of	porosity	𝛼.	31,37		 																 																																																											4		Dopamine	saturation	must	be	taken	into	account	especially	for	simulation	regions	in	close	proximity	to	a	terminal,	where	dopamine	concentration	immediately	following	a	release	can	be	 very	high.	This	 non-linear	 expression	 allows	 for	 saturation	of	 the	dopamine	 reuptake	process	 at	 high	 physiological	 dopamine	 concentrations,	 corresponding	 to	 the	 case	 of	transporter	saturation.		
	
Single	Terminal	Behavior		 The	spatiotemporal	dynamics	of	dopamine	in	the	ECS	following	release	from	a	single	terminal	 influences	 dopamine	 receptors	 within	 the	 diffusion	 volume	 prior	 to	 dopamine	reuptake.	 Dopamine	 is	 the	 primary	 endogenous	 ligand	 for	 two	 dopamine	 receptor	 sub-classes:	 D1-type	 and	 D2-type	 receptors,	 with	 EC50	 binding	 affinities	 of	 1	 μM	 and	 10	 nM	respectively.29,38	We	define	the	sphere	of	 influence	of	a	quantal	release	of	dopamine	after	release	from	a	terminal	based	on	these	activation	EC50	values.29	Our	simulation	shows	that	for	a	single	quantal	release	from	a	terminal,	the	sphere	of	influence	on	low	affinity	D1-type	receptors	and	high	affinity	D2-type	receptors	is	7	μm	and	17	μm,	respectively	(Figure	2.3a).	The	spatiotemporal	dynamics	of	a	quantal	release	from	a	single	terminal	over	a	20	µm	radial	distance	shown	in	Figures	2.2a,b,	Figure	2.3a	and	Figure	2.S1,	is	consistent	with	prior	studies	that	 show	 that	 dopamine	 diffuses	 from	 synaptic	 termini	 in	 quantities	 that	 overflow	 the	synaptic	cleft,	giving	rise	to	dopamine	volume	transmission.29,32			
δ(t − t f )
U(r, t) = rmaxc(r, t)
α(c(r, t)+Km )
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Figure	 2.2	 Spatiotemporal	 dopamine	 dynamics	 following	 a	 single	 action	 potential	 driven	 quantal	
release	of	dopamine.	 (a)	Dopamine	concentration	profile	evolution	following	a	single	quantal	release	as	a	function	 of	 distance	 and	 time.	 Red	 wedge	 indicates	 quantal	 dopamine	 release.	 (b)	 Dopamine	 spatial	concentration	profile	at	varying	distances	 from	release	site.	 (c)	Front	 (instance	where	EC50	 is	exceeded)	of	dopamine	 receptor	 activation	 following	 dopamine	 release	 for	 D1	 (pink)	 and	 D2	 (blue)	 type	 receptors.	 (d)	Propagation	speed	of	D1	and	D2-type	receptor	activation	after	a	quantal	release	obtained	from	first	derivative	of	 (c)	 (solid	 trace)	 compared	 with	 propagation	 speed	 obtained	 with	 porosity	 and	 tortuosity	 of	 ECS	 in	Parkinson’s	 disease.	 (e)	 Nominal	 propagation	 speeds	 compared	 with	 speeds	 computed	 with	 DAT	 density	increased	by	a	factor	of	2.	(f)	Nominal	propagation	speeds	compared	with	speeds	in	which	dopamine	clearance	is	competitively	inhibited.	
14 
Dopamine	 propagation	 from	 the	 center	 of	 the	 synaptic	 cleft	 occurs	 on	 short	 time	scales	relative	to	dopamine	diffusive	effects.	Our	simulation	shows	that	the	activation	EC50	for	both	D2	and	D1-type	receptors	within	the	sphere	of	influence	of	a	terminal	are	exceeded	within	50	ms	and	20	ms	of	dopamine	release,	respectively	(Figure	2.2c).	Furthermore,	we	compute	the	speed	of	propagation	of	receptor	activation	as	a	function	of	distance	from	the	release	 site	 (Figure	 2.2d,	 solid).	 The	D2-type	 receptor	 activation	EC50	wave	 front	 (10	nM	dopamine)	moves	forward	at	peak	speeds	approaching	1.5	µm/ms	and	slows	to	0	µm/ms	as	a	function	of	distance	from	the	release	site.	Similarly,	we	observe	peak	propagation	speeds	of	1	µm/ms	for	D1-type	receptor	activation	(1	µM	of	dopamine).	Our	simulations	provide	estimates	 for	 speeds	 of	 dopamine	 volume	 transmission,	 and	 the	 time	 dependence	 of	dopamine’s	 activity	 on	 distal	 receptors	 from	 the	 release	 point.	 As	 expected,	 dopamine	volume	propagation	speeds	we	compute	for	D1-	and	D2-type	receptors	is	four	to	five	orders	of	magnitude	slower	than	reported	speeds	of	electrical	signal	propagation	in	nerve	fibers.	To	our	 knowledge,	 this	 is	 the	 first	 quantitative	 report	 on	 the	 speed	of	 chemical	 signaling	 of	dopamine	in	the	dorsal	striatum.		We	 studied	 the	 effect	 of	 varying	 simulation	 parameters	 on	 the	 speed	 of	 signal	propagation	in	the	striatum.	Changes	in	morphology	of	the	ECS	in	disease	states	and	under	hypoxic	 conditions	 could	 affect	 dopamine	 volume	 transmission.	 Brain	 tissue	 afflicted	 by	Parkinson’s	disease	shows	changes	 in	the	tortuosity	and	porosity	of	the	ECS	morphology,	where	 porosity	 and	 tortuosity	 decrease	 by	 33%	 and	 5%	 respectively.39	 When	 such	parameters	 are	 varied	 in	 our	 simulation,	 we	 observe	 modest	 increases	 in	 the	 speed	 of	propagation	for	both	D1	and	D2	receptor	types,	with	the	effect	being	slightly	higher	for	D1-type	receptors	(Figure	2.2d).	We	next	explored	the	anisotropy	of	volume	transmission	that	could	arise	from	heterogeneous	DAT	expression.	When	we	double	the	density	of	DATs,	we	observe	enhanced	transmission	speeds	for	D2-type	receptors	for	proximal	regions	that	are	co-localized	with	high	DAT	expressions,	and	slower	transmission	speeds	for	distal	sites	and	a	 correspondingly	 reduced	 overall	 sphere	 of	 influence	 (Figure	 2.2e).	 On	 the	 other	 hand,	competitive	inhibition	of	DATs	by	cocaine	slows	the	speed	of	D2-type	receptor	activation	but	increases	 the	 activation	 sphere	 of	 influence	 (Figure	 2.2f,	 Figure	 2.3c).	 Combined,	 these	results	 suggest	 that	anisotropy	 in	dopamine	neuromodulation	could	 in	part	be	driven	by	heterogeneities	in	capacity	for	dopamine	clearance	in	the	striatum.	In	regions	close	to	the	release	site	(<	5	µm),	high	DAT	expression	creates	a	concentration	gradient	driving	force	that	speeds	 up	 the	 activation	 of	 colocalized	 receptors,	whereas	 reuptake	 inhibition	 slows	 the	speed	of	volume	transmission.	Non-linear	reuptake	kinetics	we	defined	in	equation	4	is	sometimes	approximated	by	a	linear	expression	of	the	form	(rmax/Km)c(r,t).31	While	a	linear	approximation	of	dopamine	reuptake	facilitates	an	analytical	solution	for	the	governing	equation,	linearization	creates	significant	deviation	from	dopamine	dynamic	behavior	obtained	with	non-linear	reuptake	kinetics	 (Figure	 2.3a).	 The	 impact	 of	 the	 linear	 approximation	 on	 dopamine	 reuptake	kinetics	arises	from	neglecting	the	fact	that	DATs	in	close	proximity	to	the	releasing	terminal	are	saturated	(c(r,t)	>>	Km)	and	can	only	clear	dopamine	at	a	maximum	rate	of	rmax..	The	linear	approximation	overestimates	uptake	in	regions	proximal	to	the	point	of	dopamine	release,	resulting	in	different	linear	versus	non-linear	reuptake	kinetics.	Our	model	implements	non-linear	reuptake	kinetics	with	a	Michaelis-Menten	rate	equation,	and	enables	us	to	calculate	the	 spatial	 sphere	 of	 influence	 with	 the	 biologically-relevant	 influence	 of	 saturating	dopamine	reuptake	proximal	to	the	release	site.	Indeed,	our	results	show	the	spatial	sphere	
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of	influence	with	linear	uptake	is	only	half	of	that	obtained	with	non-linear	kinetics	for	D1-type	 receptors	 (Figure	 2.3a).	 To	 demonstrate	 the	 importance	 of	 treating	 the	 reuptake	kinetics	as	a	non-linear	saturable	process,	we	compared	the	linear	model	at	nominal	rmax	and	
Km	values	(Table	1)	with	a	non-linear	model	in	which	rmax	was	increased	by	a	factor	of	10	(equivalent	to	increasing	the	density	of	DATs	by	an	order	of	magnitude)	and	found	the	two	dynamic	behaviors	to	be	comparable	(Figure	2.S2).		Our	results	exemplify	the	importance	of	treating	dopamine	clearance	from	ECS	as	a	non-linear	process,	especially	when	spatial	and	temporal	domains	are	simultaneously	considered,	and	provide	a	quantitative	comparison	between	linear	and	non-linear	reuptake	on	the	dynamics	of	dopamine	in	ECS.		
	
	
Figure	2.3	Non-linear	computation	of	receptor	activation	by	dopamine	diffusion.	(a)	Sphere	of	influence	of	a	single	dopaminergic	terminal	over	D1-	and	D2-type	receptors.	Time	over	which	the	EC50	of	each	receptor	type	is	exceeded	is	plotted	as	a	function	of	distance	from	the	terminal.	D1-	type	receptors	are	insensitive	to	quantal	release	at	7	μm	radial	distance	beyond	the	release	site,	whereas	D2-type	receptors	can	be	influenced	by	a	single	quantal	release	through	a	radial	distance	of	17	μm.	The	duration	during	which	the	EC50	of	each	receptor	type	is	exceeded	decreases	monotonically	with	distance.		Broken	lines	represent	spheres	of	influence	of	linear	uptake	kinetics	with	the	nominal	rmax	and	Km	values	listed	in	Table	1.	(b)	Effect	of	dopamine	reuptake	blocker,	 cocaine,	 on	 sphere	 of	 influence	 of	 D1-type	 receptors,	 plotted	 as	 receptor	 activation	 duration	 as	 a	function	of	distance	from	release	site.	(c)	The	same	competitive	inhibition	effect	on	D2-type	receptor	activation.	Cocaine	increases	the	sphere	of	influence	on	D2-type	receptors	dramatically.		 Certain	 psychostimulants	 act	 by	 competitively	 binding	 to	 DATs	 and	 modulating	dopamine	clearance	rate	 from	the	ECS.	We	demonstrate	 the	applicability	of	our	model	 to	probe	 the	 neurophysiology	 of	 dopaminergic	 systems	 by	 testing	 the	 effect	 of	 dopamine	reuptake	inhibition	by	cocaine.	Cocaine	has	been	shown	to	increase	the	affinity	parameter	in	equation	4,	Km,	from	0.21	µM	to	8	µM.40	Our	simulation	shows	that	inhibition	of	dopamine	reuptake	by	cocaine	increases	the	duration	of	D1-type	receptor	activation	by	up	to	two	fold	and	 that	 of	 D2-type	 receptors	 by	 up	 to	 six	 fold	 (Figure	 2.3b,	 c).	 	 The	 spatial	 spheres	 of	influence	from	a	quantal	release	increase	from	7	µm	to	9	µm,	and	from	17	µm	to	47	µm,	for	D1	 and	 D2-type	 receptors,	 respectively.	 Our	 results	 suggest	 that	 competitive	 inhibitors	 –	
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whether	therapeutic	or	abusive	–	have	drastic	effects	on	the	dopamine	sphere	of	influence	for	a	singular	dopamine	terminal,	the	extent	of	which	is	best	demonstrated	when	we	model	dopamine	reuptake	as	a	non-linear	process.		
Many-Terminal	Behavior		
	 Dynamic	 dopamine	 behavior	 at	 a	 point	 in	 the	 striatal	 ECS	 is	 influenced	 by	 the	behavior	of	all	active	terminals	in	the	vicinity.	Dopaminergic	neurons	exhibit	slow	tonic	and	fast	burst	firing	activity.41,42	A	burst	in	firing	activity	correlates	with	reward	reinforcement	as	a	response	to	salient	events,	whereby	striatal	dopamine	neurons	burst	in	spike	trains	of	4	to	7	spikes	per	burst	event	at	a	spiking	frequency	of	20	Hz.42–44		Conversely,	a	pause	in	firing	is	correlated	with	response	to	adverse	events	or	withdrawal	of	an	expected	reward.	Tonic	activity	underlies	dopaminergic	activity	at	rest.41–44	We	implement	our	model	to	calculate	dopamine	concentrations	in	a	volume	of	striatal	brain	tissue	for	a	simulated	spike	train	of	physiological	relevance.	To	account	for	the	neurologically	relevant	case	of	collective	multi-terminal	activity,	we	extend	our	model	to	employ	spatiotemporal	summation	of	solutions	from	each	terminal	surrounding	of	a	point	of	interest	in	the	ECS	(Methods	in	Appendix	I).	To	this	end,	we	evaluate	spatiotemporal	dopamine	dynamics	at	a	point	of	interest	surrounded	by	 100	 dopamine	 terminals	 (Figure	 2.4a)	 and,	 separately,	 at	 a	 point	 surrounded	 by	 25	terminals	(Figure	2.4b)	arranged	at	uniformly	spaced	cubic	lattice	points,	with	no	terminal	located	closer	than	2	µm	to	the	point	of	interest.	The	terminal	spacing	of	each	cluster	is	based	on	density	parameter	defined	in	Table	1.	We	chose	an	extrasynaptic	point	located	at	least	2	µm	from	the	closest	terminal	to	avoid	capturing	the	dominant	behavior	of	synaptic	dopamine	hot	spots	in	which	behavior	is	dominated	by	the	firing	activity	of	the	closest	terminal.	We	simulate	a	2-second	spike	train	representative	of	phasic	firing	behavior	by	implementing	our	model	over	four	distinct	firing	regimes	(Figure	2.4a,	b).	The	simulated	firing	frequency	and	duration	is	chosen	based	on	experimentally	observed	in	vivo	spiking	activity	of	dopaminergic	neurons42,43:	we	simulate	an	ensemble	of	dopaminergic	neurons	undergoing	a	4	Hz	 tonic	firing	rate	for	t	=	0	to	t	=	0.4	s,	followed	by	a	20	Hz	burst	firing	regime	for	t=	0.4	s	to	t	=	0.7	s,	followed	by	a	0.5	s	pause	(0	Hz)	until	t		=	1.2	s.	For	the	last	0.8	s	of	the	simulation,	we	return	to	a	4	Hz	tonic	firing	regime.	Note	that	each	firing	rate	is	the	mean	of	a	Poisson	distribution	of	firing	rates	among	the	ensemble,	as	we	described	in	preceding	sections	and	in	Methods	in	Appendix	 I.	 The	 simulation	 ensemble	 size	 is	 commensurate	with	 experimental	 fast	 scan	cyclic	 voltammetry	 (FSCV)	 assays	 where	 the	 carbon	 fiber	 electrode	 samples	 dopamine	overflow	from	a	region	encompassing	~100	dopaminergic	terminals.21		
	
17 
	
	
Figure	2.4	Dopamine	concentration	evolution	profile	for	a	simulated	volume.	Dopamine	dynamics	at	an	extrasynaptic	 point	 surrounded	 by	 (a)	 100	 and	 (b)	 25	 phasically	 firing	 dopaminergic	 neurons	 with	asynchronous	 firing	 (blue	 trace,	 solid)	 and	 synchronous	 firing	 (red	 trace,	 dash).	 Each	 trace	 represents	 the	average	of	N=20	independent	simulation	runs.		 We	 present	 results	 from	 a	 cluster	 of	 100	 dopaminergic	 terminals	 and	 25	dopaminergic	terminals	firing	phasically	with	the	above-described	spike	train	to	highlight	how	 the	 underlying	 functional	 connectivity	 of	 terminals	 can	 result	 in	 different	spatiotemporal	 dopamine	behavior.	While	 the	 firing	 activity	 of	 an	 individual	 or	 a	 pair	 of	dopaminergic	 neurons	 is	 well	 studied,	 the	 number	 of	 terminals	 in	 a	 phasically	 firing	ensemble	 is	 not	 well	 understood.43,45	 It	 is	 predicted	 that	 functional	 or	 sub-functional	connectivity	 influences	 the	 size	 of	 phasically	 firing	 ensembles	 and	 their	 synchrony.43	 	As	such,	we	simulate	a	spike	train	from	a	phasically	firing	cluster	of	100	dopaminergic	terminals	(Figure	 2.4a)	 compared	 to	 a	 cluster	 of	 25	 dopaminergic	 terminals	 (Figure	 2.4b)	 firing	synchronously	or	asynchronously.	Dopamine	release	is	a	highly	stochastic	process	and	the	results	presented	here	are	average	behavior	from	N	=	20	separate	runs	of	our	simulation.	We	present	individual	simulation	runs	and	run	average	for	the	100	terminal	asynchronous	firing	case	in	Figure	2.S3.	In	both	terminal	clusters,	asynchronous	firing	results	in	a	more	temporally	 homogenous	 concentration	 profile.	 Synchronous	 firing	 concentration	 profiles	exhibit	sharp	dopamine	concentration	transience	in	all	firing	regimes	(Figure	2.4a,	b).	Peak	dopamine	concentration	during	burst	phase	is	modestly	higher	for	the	100-terminal	cluster,	and	 its	scale	and	diffusion	also	has	a	 larger	spatial	extent.	Tonic	dopamine	concentration	levels,	however,	are	roughly	the	same	for	both	the	100	and	25	terminal	clusters.	For	both	simulated	 terminal	 cluster	 sizes,	 tonic	 asynchronous	 firing	 gives	 rise	 to	 a	 steady	 basal	dopamine	 level	whereas	synchronous	 firing	does	not.	The	pause	 in	 firing	 following	burst	firing	activity	clears	dopamine	from	the	ECS	in	both	cases;	complete	clearance	is	achieved	within	 150	 ms	 of	 the	 onset	 of	 pause	 in	 firing.	 The	 observation	 that	 tonic	 dopamine	concentrations	are	mediated	by	uncorrelated,	asynchronous	firing	is	in	agreement	with	prior	studies,	which	show	that	tonic	activity	gives	rise	to	the	basal	dopamine	level	measured	in	ECS.8	It	is	worth	noting	the	concentration	profile	depicted	in	Figure	2.4	measures	dopamine	
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for	a	singular	point	in	ECS.	Of	relevance	to	the	spatial	and	temporal	limitations	of	existing	experimental	 tools	to	probe	brain	neurotransmission,	we	 implement	our	model	 for	space	averaged	dopamine	dynamics,	as	detailed	below.		
Dopamine	Optical	Probes	in	the	Striatal	ECS		 Of	relevance	to	fluorescent	probes	for	measuring	neurotransmitter	concentrations	in	the	ECS,	 our	model	 captures	 spatial	 evolution	of	dopamine	 in	 the	ECS,	 in	 addition	 to	 the	temporally-relevant	information	obtained	from	FSCV.	Fluorescent	optical	probes	hold	great	promise	for	probing	volume	transmission	dynamics	in	the	ECS	in	a	space	and	time	resolved	manner.	First,	optical	probes	can	fit	into	the	intricate	porous	and	tortuous	morphology	of	the	ECS,	 allowing	 them	 proximate	 access	 to	 synaptic	 and	 extrasynaptic	 locations	 to	 record	dynamic	 concentration	 behavior.	 Second,	 optical	 probes	 can	 be	 distributed	 over	 large	volumes	of	the	ECS	to	provides	much	needed	spatial	information.	Here,	we	develop	a	model	of	a	prototypical	optical	probe’s	 fluorescence	modulation	 in	response	 to	dynamic	analyte	behavior.	 Denoting	 the	 total	 number	 of	 dopamine	 binding	 probe	 sites	 as	 L,	 the	 free	(dopamine	 unbound)	 sites	 as	 *,	 the	 dopamine-bound	 sites	 as	 DA*	 and	 free	 dopamine	molecules	as	DA,	we	establish	equilibrium	conditions	for	reversible	dopamine	binding	to	an	ensemble	of	optical	probe	sites	in	the	ECS:										 	 	 	 													 	 	 	 																								5		The	 first	 expression	 represents	 the	 dopamine	 active	 site	 balance	 and	 the	 second	approximates	 that	 the	dopamine	adsorption	process	equilibrates	on	relatively	short	 time	scales	compared	to	dopamine	diffusion	timescales	in	tissue.	We	define	equilibrium	constant,	
Keq	for	the	dopamine-sensor	binding	process	as:			 	 	 	 	 	 	 	 	 											6		We	 next	 substitute	 the	 equilibrium	 constant	 into	 the	 site	 balance	 equation	 to	 derive	 an	expression	for	the	dopamine	probe	fluorescent	response	as	follows:																		 	 	 									 	 	 	 																								7								 	 	 																			 	 	 																								8		We	note	that	the	increase	in	probe	fluorescence	intensity	is	directly	proportional	to	bound	active	 sites	 	 [+,∗]/ 	 .	 Thus,	 the	 expression	 for	 change	 in	 intensity	normalized	against	 initial	sensor	fluorescence,		 ,	can	be	represented	as:	
[L]= [*]+[DA*]
DA+*⇔DA*
Keq =
[DA*]
[DA][*]
L = [*]+Keq[DA][*]
[DA*]
L =1−
[*]
L =
[DA]Keq
1+[DA]Keq
ΔF
F0
19 
								 	 	 	 						 	 	 	 	 											9			The	 additional	 fitting	 parameter,	 n,	 is	 introduced	 to	 account	 for	 dopamine	 binding	cooperativity.			
Temporal	Resolution	Is	Determined	by	Probe	Kinetics	and	Imaging	Frame	Rate			 Optical	technologies	to	measure	neurotransmitters	in	the	ECS	must	capture	hundred	millisecond-scale	dopamine	release	and	clearance,	as	shown	by	our	simulations.	Temporally	resolved	 neurotransmitter	 measurements	 with	 FSCV	 need	 only	 account	 for	 temporal	sampling	 rates,	which	are	achieved	with	a	high	scan	rate	voltammogram.	Conversely,	 for	probes	with	fluorescence	readouts,	both	temporal	and	spatial	sampling	rates	will	influence	the	measurement	signal-to-noise,	due	 to	hardware	 limitations	 in	 fast	 sampling	rates.	Our	simulations	above	set	the	physiologically	relevant	dopamine	spatiotemporal	dynamics	in	the	striatum.	Henceforth,	we	consider	optical	probe	performance	limitations	that	are	imposed	by	 imaging	 hardware	 and	 binding	 kinetics.	 During	 video-rate	 fluorescence	 imaging,	substantive	deviations	from	theoretical	probe	response	profiles	are	likely	to	be	encountered	owing	to	the	short	time	scales	over	which	dopamine	is	released	into	and	cleared	from	the	ECS.	Specifically,	our	model	results	show	that	dopamine	dynamic	behavior	occurs	on	similar	timescales	 as	 the	 exposure	 time	 used	 in	 conventional	 fluorescence	 microscopy	 (tens	 to	hundreds	 of	 milliseconds).	 We	 must	 therefore	 account	 for	 possible	 temporal	 distortion	imposed	on	probe	response	by	imaging	hardware.	The	probe	ΔF/F0	observed	using	a	video-rate	fluorescence	imaging	is	evaluated	as:																																																	 		 	 																				10			where	 	is	the	observed	probe	response	when	imaging	by	fluorescence	microscopy,	
and	 	is	the	theoretical	probe	response	function	given	by	eqn.	9.	Texp	is	the	camera	exposure	time	and	is	inversely	related	to	the	nominal	frame	rate	of	imaging.		 To	optimize	probe	performance,	we	tuned	several	parameters	in	eqn.	9.	Our	goal	is	to	determine	 which	 probe	 parameters	 will	 enable	 us	 to	 resolve	 dopamine	 dynamics	 of	physiological	relevance	in	the	striatum.	The	equilibrium	constant	(Keq),	the	proportionality	factor	(α),	and	the	cooperativity	parameter	(n),	are	intrinsic	to	the	probe	and	can	be	tuned	to	 optimize	 probe	 performance.	 The	 parameter	 α	weighs	 the	 fluorescent	 quantum	 yield	
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increase	 toward	 the	 imaging	 SNR.	 Higher	 α	 corresponds	 to	 stronger	 turn-on	 response	(ΔF/F0)	and	improves	SNR	over	the	entire	physiological	dopamine	concentration	range.	Keq	is	 a	measure	 of	 the	 affinity	 between	 the	 probe	 and	 dopamine	 analyte.	 High	Keq	 (or	 low	dissociation	constant,	Kd)	 improves	response	at	 low	concentrations	of	dopamine,	but	also	leads	 to	quicker	 sensor	 saturation.	On	 the	other	hand,	 low	Keq	 results	 in	probes	 that	 are	unresponsive	to	low	concentrations	of	dopamine.	Thus,	to	maximize	the	dynamic	range	of	the	dopamine	probe	for	the	range	of	experimentally	relevant	dopamine	concentrations	of	30	nM	 –	 10	 µM	 we	 sought	 to	 identify	 parameters	 that	 are	 amenable	 to	 capturing	 in	 vivo	endogenous	 dopamine	 dynamics.	 First,	 we	 set	 a	 5%	 ∆F/F0	 lower-limit	 at	 the	 spatial	boundary	of	the	D2-type	receptor	sphere	of	influence	(17	µm),	and	this	fixed	α	=	2.	We	set	the	cooperativity	factor	at	n	=1	as	representative	for	most	validated	optical	probes.	Fixing	α	and	n,	we	 vary	Keq	 over	 several	 orders	 of	magnitude	 and	 determine	Keq	=	 1	 (μM)-1	 to	 be	optimal	 for	 a	 fluorescent	probe,	which	balances	 reversibility	 and	 sensitivity	 according	 to	biologically	 imposed	 boundary	 conditions.	 To	 evaluate	 reversibility,	we	 simulated	 probe	response	to	two	quantal	release	events	located	0.2	seconds	apart	from	the	same	terminal	(Figure	2.5a).	We	define	reversibility	as	the	fall	 in	probe	intensity	during	clearance	of	the	first	quantal	release,	divided	by	rise	in	intensity	in	response	to	the	first	quantal	release.	The	parameter	α	=	2	sets	maximum	sensor	response,	and	we	define	sensitivity	as	the	measured	peak	∆F/F0	divided	by	α.	With	these	definitions,	we	varied	Keq	over	five	orders	of	magnitude	to	develop	the	parameter	maps	shown	in	Figure	2.5b	and	Figures	2.6a,	b.	High	Keq	values	enhance	 sensitivity,	 enabling	 the	 probe	 to	 turn-on	 at	 low	 dopamine	 concentrations.	However,	high	Keq	values	cause	the	probe	to	saturate	rapidly	and	adversely	 impact	probe	reversibility	(Figures	2.5a,	b).	On	the	other	hand,	low	Keq	values	have	very	good	reversibility	but	 reduced	 sensitivity.	 At	 Keq	 =	 1	 (μM)-1,	 we	 observe	 that	 the	 probe	 both	 responds	instantaneously	to	quantal	dopamine	release,	and	also	captures	dopamine	reuptake	kinetics	to	 accurately	 discern	 between	 two	 quantal	 release	 events	 0.2	 seconds	 apart.	 Thus,	 we	identify	Keq	=	1	(μM)-1	as	optimal	for	imaging	dopamine	dynamics	in	the	dorsal	striatum,	in	which	the	fastest	sequential	quantal	release	events	occur	at	least	0.2	seconds	apart	during	tonic	firing.	41		
	
Figure	2.5	Effect	of	probe	affinity	parameter,	Keq,	on	performance.	(a)	Dynamics	of	three	quantal	release	events	(red	wedges)	imaged	using	probes	for	which	Keq	varies	over	three	orders	of	magnitude.	The	first	two	quantal	releases	are	located	0.2	s	apart.	Plots	of	∆F/F0	for	a	20	Hz	frame	rate	(eqn.	10)	corresponding	to	each	
Keq	value	are	plotted	in	dash.	At	Keq	=	100	(μM)-1	the	probe’s	affinity	for	dopamine	is	too	strong,	which	adversely	
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affects	reversibility.	The	second	release	event	cannot	be	resolved.	Peak	∆F/F0	values	increase	with	increasing	
Keq.	 At	 low	 Keq	 values,	 the	 probe	 shows	 high	 reversibility	 but	 poor	 sensitivity.	 (b)	 Parameter	 space	 for	reversibility	and	sensitivity	at	r	=	1	µm,	2	µm,	5	µm	and	10	µm	from	release	site	corresponding	to	a	20	Hz	imaging	frame	rate.	High	dopamine	concentrations	proximal	to	the	release	site	yield	high	sensor	sensitivity.	However,	maintaining	good	reversibility	suffers	proximal	to	the	release	site.	
	 The	parameter	space	we	developed	to	optimize	spatiotemporal	signal	acquisition	of	dopamine	optical	probes	with	various	Keq	values	can	now	allow	us	to	test	how	camera	frame	rates	affect	the	sensor	reversibility	and	sensitivity	parameter	space.	As	we	show	in	Figure	2.6a,	 fast	 imaging	 frame	 rates	 are	 needed	 if	 the	 probe	 binds	 the	 dopamine	 analyte	 too	strongly	(large	Keq)	to	temporally	resolve	the	two	quanta	released	0.2	s	apart.	Therefore,	we	conclude	that	an	optimal	frame	rate	is	a	necessary	but	not	sufficient	condition	to	resolve	the	temporal	 heterogeneities	 of	 dopamine	 dynamics	 in	 the	 striatum.	 The	 probe’s	 chemical	responsivity	 and	 adsorption/desorption	 kinetics,	 combined	 with	 the	 imaging	 hardware	limitations,	both	contribute	to	the	spatiotemporal	profiles	of	dopamine	evolution	that	can	be	captured.	 Corresponding	 to	 the	 1	 (µM)-1	 optimal	 Keq	 we	 identified	 previously,	 a	 20	 Hz	imaging	 rate	 offers	 the	 best	 reversibility	 (Figure	 2.6a)	 and	 SNR	 (Figure	 2.6c).	 When	sequential	release	events	faster	than	0.2	s	apart	are	considered,	the	reversibility	curves	shift	towards	sensors	with	lower	Keq	in	a	manner	similar	to	that	observed	for	imaging	close	to	the	release	site	(Figure	2.5b).	Therefore,	recording	of	 faster	dynamic	events	demands	probes	with	 lower	Keq,	 and	 comes	with	 an	 opportunity	 cost	 of	 low	 sensitivity	 (Figure	 2.5b)	 and	higher	noise	(Figure	2.6c,	Figure	2.S4).	 	The	second	chemical	parameter	of	 the	probe,	 the	turn-on	response	parameter	α,	has	little	effect	on	probe	sensitivity	and	reversibility	(Figure	2.6b),	and	which	we	set	at	α	=	2.	
	
	
	
Figure	2.6	Sensor	sensitivity,	reversibility,	and	signal-to-noise	ratio,	probed	for	varying	frame	rates,	
chemistries,	and	baseline	fluorescence.	(a)	Sensor	parameter	space	for	frame	rates	ranging	from	10	Hz	to	100	Hz	with	α	=	2.	Lower	frame	rates	adversely	impact	reversibility	and	sensitivity	but	improve	SNR	(panel	c).	(b)	 Parameter	 space	 for	 sensor	 turn-on	 response,	α,	 ranging	 from	2	 to	20.	 The	parameter	 space	 is	 largely	insensitive	to	varying	α.	(c)	SNR	shows	strong	dependence	on	frame	rate	(abscissa)	and	baseline	intensity	(F0,	dashed	 traces)	 of	 the	 probe.	 As	 frame	 rate	 increases,	 SNR	 passes	 through	 a	 maximum	 at	 10	 Hz	 and	monotonously	decreases	afterwards.	The	baseline	fluorescence	intensity	F0	is	varied	from	100	to	10,000	and	corresponds	to	the	2	Hz	frame	rate,	and	units	of	F0	are	arbitrary.	For	definition	of	F0,	see	equation	11.	
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Probe	Fluorescence	and	Imaging	Frame	Rate	Considerations	for	Optimizing	Signal-to-
Noise	Ratio				 The	 observed	 optical	 probe	 signal	 (∆F/F0)	 takes	 into	 account	 the	 relationship	between	 hardware	 (frame	 rate	 &	 instrument	 noise),	 and	 chemistry	 (fluorescent	 signal,	sensitivity	 and	 reversibility	 parameters).	 	During	 optical	 imaging	 of	 fast	 dynamic	 events,	frame	rates	cannot	be	made	arbitrarily	faster	because	of	their	adverse	impact	on	SNR.	Here,	we	provide	an	analysis	 to	 include	noise	 into	 the	observed	signal,	∆F/F0.	To	elucidate	how	hardware	and	sensor	chemistry	contribute	to	SNR,	we	consider	the	peak	signal	from	a	sensor	with	optimal	kinetic	parameters	of	α	=	2	and	Keq	=	1(µM)-1	responding	to	a	single	quantal	release	of	dopamine	at	a	radial	distance	of	r	=	5	µm.	The	mathematical	derivation	of	noise	for	∆F/F0	 is	provided	 in	Methods	 in	Appendix	 I.	We	consider	 the	primary	contribution	of	noise	to	the	SNR	to	be	Poisson	noise	(also	known	as	shot	noise)	and	do	not	take	into	account	other	 sources	 of	 noise	 inherent	 to	 the	 imaging	 system	 such	 as	 read	 noise,	which	 can	 be	significant	at	high	frame	rates.	Our	analysis	confirms	that	SNR	is	inversely	related	to	frame	rate	and	imaging	frame	rate	should	be	carefully	selected	to	optimize	SNR	in	conjunction	with	the	competing	interest	of	maintaining	high	temporal	resolution	(Figure	2.6c).	Furthermore,	we	identify	the	baseline	fluorescence	intensity	(brightness)	of	the	sensor,	F0,	as	an	important	parameter	that	influences	SNR.	SNR	varies	directly	with	F0	and	nearly	inversely	with	frame	rate,	with	a	local	maximum	at	10	Hz	(Figure	2.6c).	The	observed	maximum	at	10	Hz	arises	from	the	diffusion	induced	broadening	of	a	quantal	release	(Figure	2.2b).	For	experiments	wishing	to	optimize	the	temporal	resolution	of	multiple	dopamine	firing	events,	choosing	probes	with	strong	baseline	 fluorescence	will	enable	doing	so	via	higher	 frame	rates	that	achieve	a	decent	fluorescent	SNR.	The	strong	dependence	of	SNR	on	F0	requires	a	closer	examination.	F0	depends	on	variables	that	are	intrinsic	to	the	fluorophore	and	to	the	imaging	system	as	follows:		 								 	 	 	 	 									11		where	Γ	 represents	 frame	 rate,	N,	 the	 fluorophore	number	density,	 I,	 the	 excitation	 light	source	intensity	and	𝜎,	the	absorption	cross-section	of	the	fluorophore.		The	last	two	terms	in	equation	11	represent	the	quantum	yield	of	the	fluorophore	(𝜂)	and	the	photon	collection	efficiency	of	the	imaging	system	(𝜙).	The	direct	dependence	of	SNR	on	F0	arises	from	noise	filtering	effects	that	arise	from	counting	large	numbers	of	photons,	which	inherently	reduces	Poisson	noise.	 	 Thus,	 SNR	optimization	 can	be	 accomplished	by	 tuning	 the	 fluorophore’s	photophysical	and	chemical	properties	such	as	absorption	cross-section,	quantum	yield,	and	analyte	 specificity.	Two	 saturation	 regimes	 are	worth	noting:	 a	neurotransmitter	 analyte	saturation	regime	and	a	photon	saturation	regime.	For	the	neurotransmitter	concentration	regime:	the	fluorophore	number	density,	N,	contributes	to	improved	SNR	only	as	long	as	the	neurotransmitter	analyte	concentration	does	not	become	limiting.	If	the	number	of	active	probe	binding	sites	exceeds	available	analyte	molecules,	the	relationship	between	N	and	SNR	will	deviate	from	that	shown	in	Figure	2.6c.	For	the	photon	limiting	regime:	SNR	will	increase	proportional	to	excitation	intensity	I,	so	long	as	photobleaching	or	fluorophore	saturation	
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does	not	dominate	the	imaging	process.	These	latter	effects	demonstrate	the	importance	of	choosing	optimal	fluorophore	excitation	sources.	We	implemented	the	optical	probe’s	performance	evaluation	paradigm	we	developed	previously	to	the	dopamine	nanosensor	described	by	Kruss	et	al.	that	has	a	Keq	value	of	2.31	(µM)-1	 and	α	of	 0.55.46	We	 probed	 dopamine	 concentrations	 at	 several	 distances	 from	 a	terminal	within	the	D1-type	and	D2-type	receptor	spheres	of	influence.	Consistent	with	our	results	 above,	 the	 spatiotemporal	 dependence	 of	 dopamine	 concentration	 evolution	 and	corresponding	nanosensor	response	requires	a	20	Hz	frame	rate	to	discriminate	between	two	 sequential	 release	 events	 occurring	 0.2	 seconds	 apart	 (Figure	 2.7a).	 When	 camera	exposure	times	are	incorporated	into	our	model,	we	indeed	find	that	longer	exposure	times	decrease	 the	 nanosensor	 fluorescence	 response	 recorded	by	 the	 camera.	As	 a	 result,	 the	recorded	spatial	and	temporal	responsivity	of	the	dopamine	nanosensor	underestimates	the	physiological	 dopamine	 concentration	 and	 misses	 the	 true	 temporal	 release	 by	overestimating	the	peak	dopamine	release	time	(Figure	2.7a).	We	compare	the	discrepancy	between	true	nanosensor	response	and	imaged	nanosensor	response	for	2,	4,	10,	and	20	Hz	frame	 rates.	 The	 ability	 of	 a	 nanosensor	 to	 capture	 single	 terminal	 quantal	 release	 is	compromised	at	frame	rates	below	2	Hz,	where	observed	nanosensor	response	is	only	20%	of	the	predicted	peak	response,	and	could	introduce	a	time-delay	of	up	to	0.5	s.	Conversely,	when	 imaging	with	 a	20	Hz	 frame	 rate,	 95%	of	 the	nanosensor	 fluorescence	 response	 is	captured,	and	time-delay	of	no	more	than	50	ms	is	introduced	between	the	quantal	release	event	and	the	nanosensor	response.	Considering	 that	 there	 is	diffusion	 induced	temporal	distortion	of	30	ms	at	r	=	5µm	(Figure	2.S1),	this	temporal	delay	at	20	Hz	imaging	becomes	negligible.	For	the	dual	quantal	events	located	0.2	s	apart	corresponding	to	tonic	activity,	a	20	Hz	frame	rate	can	indeed	identify	the	two	events	(Figure	2.7a,	b,	c).	Conversely,	both	a	2	Hz	 and	 4	 Hz	 frame	 rate	 enables	 the	 nanosensor	 to	 record	 a	 spike	 in	 local	 dopamine	concentration,	but	cannot	discern	that	this	spike	is	a	result	of	two	distinct	quantal	release	events	 (Figure	 2.7a).	 However,	 because	 the	 peak	 turn-on	 response	 of	 the	 sensor	 is	 only	
α=0.55,	the	farthest	sphere	of	detection,	set	by	a	∆F/F0	of	at	least	5%,	is	15	µm	(Figure	2.7c).		
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Figure	2.7	Temporal	resolution	of	single	and	dual	quantal	dopamine	release	events.	(a)	Faster	imaging	frame	rates	enable	resolution	of	quantal	release	events.	As	imaging	frame	rate	increases,	the	observed	response	to	dopamine	more	accurately	captures	the	theoretical	probe	response.	Red	wedge	indicates	time	of	quantal	release.	Bottom	panel:	schematic	shows	how	faster	 imaging	more	precisely	 localizes	temporal	position	of	a	quantal	release.	Color	gradient	is	to	scale,	showing	the	∆F/F0	relative	to	the	theoretically	expected	at	each	frame	rate.	 (b)	 Dopamine	 concentration	 evolution	 of	 a	 dual	 quantal	 release	 of	 dopamine	 separated	 in	 time.	Discrimination	between	two	quantal	releases	improves	as	one	moves	away	from	release	site.	Red	wedges	show	times	of	quantal	release	positioned	0.2	s	apart.	(c)	Probe	response	to	the	dual	quantal	release	presented	in	(a)	and	(b)	imaged	with	a	20	Hz	frame	rate.	Evolution	of	the	two	releases	can	be	imaged	up	to	15	µm	away	from	the	release	site	with	∆F/F0	of	≥	5%.		 The	preceding	analyses	show	that	diffusion	of	dopamine	out	of	the	synaptic	cleft	and	into	 the	brain	ECS	can	be	detected	by	optical	probes	 located	up	 to	17	µm	away	 from	the	terminal	 with	 ∆F/F0	 of	 5%	 or	 more	 when	 sensor	 kinetics	 and	 imaging	 frame	 rates	 are	optimally	selected.	Furthermore,	we	exemplify	how	probes	can	be	 implemented	to	 image	temporal	 heterogeneities	 of	 dopamine	 dynamics,	 provided	 imaging	 hardware	 with	sufficiently	 high	 frame	 rates.	 Specifically,	 frame	 rates	 of	 20	 Hz	 resolve	multiple	 quantal	releases	that	occur	during	tonic	 firing.	 In	general,	 for	optimal	Keq	values,	quantal	releases	located	 x	 ms	 apart	 require	 camera	 exposure	 times	 of	 less	 than	 x/2	 ms	 to	 be	 resolved.	However,	 imaging	 frame	 rates	 cannot	 be	 increased	 infinitely	 to	 fully	 recapitulate	 the	temporal	 profile	 of	 dopamine	 release	 and	 an	 optimization	 needs	 to	 be	 carried	 out	 in	consideration	of	SNR.	While	improving	SNR,	slower	frame	rates	decrease	sensor	response	(ΔF/F0)	and	introduce	significant	temporal	distortion	on	the	measured	dopamine	response	profile.	
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Optimal	 Probe	 Kinetic	 and	 Imaging	 Parameters	 can	 Record	 Behavior-Relevant	
Dopamine	Dynamics	for	In	Vivo	Applications		
	 The	readout	from	optical	probes	located	in	the	striatal	ESC	will	report	on	the	space-averaged	dopamine	dynamics	resulting	from	terminals	in	the	volume	surrounding	the	probe.	In	practice,	we	wish	to	sample	the	cumulative	behavior	of	dopamine	over	a	region	of	interest	in	the	ECS.	Our	model	 fluorescent	single-walled	carbon	nanotube	sensors,	with	a	250	nm	length	and	1	nm	width,	diffuse	through	the	ECS	as	rigid	rods,	and	sample	ECS	subdomains	on	 a	 short	 characteristic	 time	 scale	 of	 200	 ms.47	 As	 such,	 the	 ensemble	 fluorescence	modulation	 of	 optical	 nanosensors	 and	 other	 related	 fluorescent	 probes	 reflects	 average	dopamine	concentration.	We	simulate	the	ensemble	fluorescence	modulation	of	fluorescent	indicators	in	the	ECS	by	averaging	dopamine	concentration	over	the	simulation	volume	as	described	in	Methods	in	Appendix	I.		The	 volume	 averaged	 dopamine	 dynamics	 corresponding	 to	 100	 terminals	 firing	phasically	is	shown	in	Figure	2.8a,	b	and	Figure	2.S6.	We	define	the	phasic	firing	regime	over	a	2	second	simulation	with	the	physiologically	relevant	spike	train	defined	in	Figure	2.4:	A	4	Hz	tonic	firing	rate	for	t	=	0	to	t	=	0.4	s,	a	20	Hz	burst	firing	regime	for	t=	0.4	s	to	t	=	0.7	s,	a	0.5	s	pause	(0	Hz)	until	t		=	1.2	s,	and	a	4	Hz	tonic	firing	regime	for	1.2	s	to	2.0	s.	Our	simulation	shows	that	when	neurons	fire	asynchronously	(Figure	2.8b)	tonic	dopamine	concentrations	in	 the	ECS	 fluctuate	between	10	nM	and	100	nM	 (Figure	2.8a,	 blue	 regions).	 Conversely,	synchronous	 firing	 of	 terminals	 (Figure	 2.S6b)	 gives	 rise	 to	 transient	 dopamine	concentrations	in	the	ECS	that	range	from	200	nM	to	300	nM,	with	no	basal	levels	between	the	peaks	 (Figure	 2.S6a,	 blue	 regions).	 The	 average	 tonic	 dopamine	 concentration	 in	 the	striatal	ECS	obtained	with	our	model	is	50	nM	(Figure	2.S5),	in	agreement	with	results	from	prior	computational	studies30	and	experimental	measurements.48,49	This	confirms	that	basal	striatal	dopamine	is	mediated	by	random,	uncorrelated	firing	from	dopaminergic	terminals	belonging	to	different	neurons	as	opposed	to	correlated	tonic	firing.	The	volume	averaging	result	 is	 consistent	 with	 our	 simulations	 of	 many-terminal	 behavior	 presented	 in	 the	previous	 section	 (Figure	 2.4),	 validates	 our	 volume-averaging	 model,	 and	 corroborates	previous	 experimental	 hypotheses	 about	 the	 nature	 of	 basal	 dopamine	 in	 the	 striatum	originating	from	asynchronously	firing	neurons.	We	next	compute	the	ensemble	dopamine	probe	response	profile	for	the	theoretical	versus	practical	cases	of	video-rate	fluorescence	imaging.	We	implement	our	results	for	a	20	Hz	 imaging	 frame	 rate	 identified	 previously	 as	 optimal	 for	 capturing	 striatal	 dopamine	dynamics	with	optimal	parameters	Keq	=	1	(µM)-1,	α	=	2.	During	a	firing	burst	that	lasts	0.3	seconds,	 volume-averaged	 concentration	 rises	 to	 ~	 1	 µM	 for	 both	 synchronous	 and	asynchronous	 firing.	 These	 results	 represent	 space-averaged	 concentrations;	 locally,	concentrations	are	heterogeneous	and	can	be	higher	than	the	volumetric	averages	computed	here	 (Figure	2.4a,	 b).	 Corroborating	our	prior	 results,	 imaging	at	20	Hz,	 one	 can	 capture	transient	peaks	during	tonic	firing	in	addition	to	the	global	concentration	peak	caused	by	a	burst	firing	(Figure	2.8a,	Figure	2.S6).	Furthermore,	all	behaviorally	relevant	firing	regimes	can	be	resolved,	including	the	0.5	s	pause	following	the	burst	firing.		At	an	imaging	frame	rate	of	 2	 Hz,	 one	 can	 only	 resolve	 the	 concentration	 increase	 caused	 by	 burst	 firing;	 neither	transient	activity	during	 tonic	 firing	nor	 the	pause	 following	burst	 firing	 can	be	 resolved	
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(Figure	2.8a).	High	affinity	probes	saturate	at	tonic	dopamine	levels	(Figure	2.8c)	whereas	sensors	with	low	dopamine	affinity	result	in	low	∆F/F0	(Figure	2.8d).			
	
	
	
Figure	2.8	Volume	averaged	concentration	profiles	of	100	phasically	 firing	dopamine	 terminals.	 (a)	Dopamine	concentration	profile	in	which	terminals	fire	asynchronously	and	corresponding	sensor	response	of	theoretical,	20	Hz	and	2	Hz	video-rate	frame	rates	with	Keq=1	µM-1	and	α	=	2.	(b)	Raster	plot	of	asynchronous	firing	activity	corresponding	to	(a).	(c)	Same	asynchronous	activity	imaged	with	a	sensor	with	Keq	=	100	µM-1.	The	 high	 probe-analyte	 affinity	 results	 in	 sensor	 saturation	 at	 low	 (tonic)	 levels	 of	 dopamine	 (d)	 Same	asynchronous	 activity	 imaged	with	 a	 sensor	with	Keq	 =	 0.1	 µM-1.	 The	 low	 probe-analyte	 affinity	 results	 in	decreased	sensitivity,	with	an	exemplary	burst	firing	event	resulting	in	only	10%	of	the	probe’s	peak	∆F/F0.	
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2.3	Conclusion	The	 ECS	 constitutes	 an	 interconnected,	 porous	 and	 tortuous	milieu	 that	 pervades	neural	 tissue	 and	 serves	 as	 the	medium	 through	which	neurons	 communicate	with	 each	other	by	way	of	chemical	signaling.	Our	work	quantifies	the	spatial	and	temporal	nature	of	this	chemical	signal	by	using	the	dorsal	striatum	as	a	model	system	and	identifies	optimal	imaging	and	probe	kinetic	parameters	necessary	to	record	chemical	signaling	in	real	time	in	
vivo.	 Dopamine	 chemical	 signaling	 involves	 significant	 spillover	 of	 molecules	 from	 the	synaptic	 cleft	 into	 the	 ECS,	 and	 a	 complex	 dynamic	 behavior	 arises	 as	 a	 consequence	 of	quantal	 release	and	simultaneous	diffusion	and	reuptake	processes.	This	work	elucidates	this	 dynamics	 by	 use	 of	 a	 rigorous,	 non-linear	 stochastic	 simulation,	 validated	 against	existing	experimental	and	computational	literature.	We	show	that	the	overflow	of	dopamine	can	be	detected	with	optical	probes	placed	in	the	ECS	when	proper	imagining	and	kinetic	parameters	are	chosen.	A	parameter	space	encompassing	kinetics	and	imaging	frame	rate	is	developed.	 	Our	work	can	be	used	to	guide	new	probe	development	or	 to	optimize	 those	already	developed.	We	use	a	generic	receptor-ligand	probe	kinetics	that	makes	the	results	of	our	work	broadly	applicable	to	neurochemical	imaging	in	the	brain	ECS.	Furthermore,	the	model	of	the	striatum	developed	here	can	be	easily	adapted	to	explore	dynamics	in	other	dopaminergic	systems,	such	as	the	pre-frontal	cortex	and	the	nucleus	accumbens,	or	to	study	analogous	 volume	 transmission	 phenomena	 of	monoamines	 such	 as	 norepinephrine	 and	serotonin.	The	simulation	is	modular	and	can	be	efficiently	adapted	to	investigate	broader	variety	 phenomena	 that	 involve	neurotransmitter	 dynamics	 such	 as	 pharmacokinetics	 of	therapeutic	agents	and	brain	disease	states.	
2.4	Appendix	I	
Materials	and	Methods		
Dopamine	release	sites	and	probability	of	release			 Our	 model	 is	 implemented	 to	 study	 spatiotemporal	 profiles	 of	 neurotransmitter	release	from	synapses.	As	such,	our	model	is	implemented	with	parameters	and	boundary	conditions	relevant	to	experimentally	validated	neuronal	processes.	Central	synapses	of	the	nervous	 system	 such	 as	 those	 found	 in	 the	 striatum	 contain	 a	 single	 release	 site,	 as	comprehensively	 reviewed	 in	Stevens	et	 al.33	During	an	action	potential,	 a	 single	quantal	release	 of	 dopamine	 occurs	 with	 a	 certain	 probability	 p,	 at	 each	 terminal	 (Figure	 2.1b).	Dreyer	et	al.	calculate	probability	of	6%	based	on	studies	of	neurotransmitter	release	using	FFNs19,20	and	the	dopamine	content	of	striatal	tissue.		As	such,	our	model	sets	the	probability	of	dopamine	release	to	6%	per	action	potential	per	terminal,	consistent	with	experimental	observations,	 and	 that	 this	 release	 probability	 remains	 constant	 for	 the	 simulation	 time	course.			
Simulation	of	release,	diffusion	and	reuptake			
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Our	simulation	of	dopamine	concentration	in	the	ECS	invokes	the	equation	of	change	for	species	conservation	surrounding	a	dopaminergic	terminal			 	 		 	 	 											1		We	solve	the	governing	equation	individually	for	each	dopamine	terminal,	and	superimpose	temporal	 solutions	 of	 the	 governing	 equation	 to	 determine	 dopamine	 dynamics	 at	 any	location	 within	 the	 simulation	 volume.	 Thus,	 the	 temporal	 change	 in	 dopamine	concentration	at	any	point	in	the	ECS	is	the	sum	of	the	dopamine	dynamics	contributed	by	all	terminals	in	the	point	of	interest	vicinity.	We	note	that	the	error	introduced	by	summing	the	 non-linear	 reuptake	 term	 is	 negligible:	 dopamine	 re-uptake	 approximates	 linear	behavior	at	sites	distant	from	a	release	point,	where	the	spatial	summation	occurs.	For	our	simulation	of	dopamine	release,	diffusion,	and	reuptake,	we	use	radial	steps,	dr,	of	0.2	µm	and	time	steps,	dt,	of	0.02	ms,	which	yield	stable	solutions	over	a	wide	range	of	biological	parameters.		
Discretization	scheme	and	boundary	conditions		
	 The	model	implements	finite	differences	to	solve	the	governing	equation	(eqn.	1).	We	take	advantage	of	dopamine	diffusion	symmetry	and	isotropy	to	reduce	the	problem	into	1D	in	spherical	coordinates	such	 that	 the	distance	 from	the	release	site,	r,	 is	 the	only	spatial	domain	in	the	model.	Symmetry	at	the	site	of	a	release	site	serves	as	a	boundary	condition	for	our	numerical	solution,	and	is	used	to	calculate	dopamine	concentration	at	the	center	of	the	simulation	volume.	We	provide	details	of	the	discretization	scheme	below.		The	left-hand	side	of	the	governing	equation	1	can	be	written	in	difference	form	as:		 							 	 	 	 	 									12		where	indices	n	and	j	represent	discrete	steps	in	space	and	time,	respectively.		To	cast	the	right-hand	side	of	equation	1	in	difference	form,	we	first	expand	the	Laplacian:		 												 	 	 	 									13			and	discretize	the	first	and	second	spatial	derivatives	as	follows:			 							 																																													14	
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																																																									15			Using	 these	 difference	 equations	 and	 leaving	 the	 release	 and	 uptake	 terms	 as	 Q	 and	 U	respectively,	we	can	write	an	explicit	equation	for	c(n,	j+1)	as	(eqn.16):		 		where	r=(n-1) .		The	uptake	term	U	is	written	explicitly	in	c(n,j)	space	as	a	Michaelis-Menten	rate	expression	and	the	quantal	release	term	(Q)	is	handled	as	described	previously:			 			 	 	 	 								17		 								 	 																						18		We	discretize	the	symmetry	boundary	condition	as	follows.	First	we	note	that	the	governing	equation	as	r	à	0	becomes:		 																			 	 								19		where	we	used	L’Hopital’s	rule	to	evaluate	the	limit.	The	spatial	and	temporal	derivatives	of	equation	19	are	discretized	using	equations	12	and	14	and	then	evaluated	for	n=1	(center),	yielding:		 			 	 							20		
Simulation	algorithm			 At	each	simulation	time	step,	the	algorithm	determines	whether	an	action	potential	will	invade	a	terminal	based	on	a	Poisson	probability	distribution	with	mean	firing	rate	F.	If	there	 is	 a	 firing	 event,	 a	 quantal	 release	 of	 dopamine	 will	 occur	 based	 on	 a	 release	probability,	p,	by	toggling	the	binary	variable	𝜓(𝑝)	between	1	(release)	and	0	(no	release).	If	a	quantal	release	of	dopamine	occurs,	dopamine	concentration	in	the	volume	immediately	surrounding	the	terminal	(r=0)	will	be	incremented	by	an	amount	in	equation	3.	Increment	
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at	subsequent	volume	elements	are	scaled	as	𝑒#(%#&)( ,	a	factor	that	follows	directly	from	a	Gaussian	probability	density	 function.	Once	dopamine	 reuptake	 is	determined,	dopamine	concentration	at	 the	 location	 in	 space	 is	decreased	by	an	amount	 equal	 to	 the	 computed	reuptake	 term.	 Because	 the	 discretized	 governing	 equation	 (eqn.	 16)	 fails	 for	 r=0	 (n=1),	where	it	becomes	a	singularity,	we	set	Neumann’s	symmetry	principle	at	r=0	as	a	boundary	condition	 and	use	 it	 to	 compute	 concentration	 at	 the	 center	 (eqn.	 20).	We	 construct	 our	simulation	volume	such	 that	 the	effects	of	dopamine	depletion	at	 any	point	 in	 space	will	result	from	dopamine	reuptake	by	DATs	within	the	simulation	volume.	Thus,	we	implement	the	Dirichlet	boundary	condition	to	enable	modeling	of	dopamine	reuptake	effects	at	any	distance	from	the	center	of	the	release	site.	Determining	the	exact	location	of	this	boundary	requires	solving	the	governing	equation	first,	with	a	free	boundary	condition.	We	therefore	set	 dopamine	 concentration	 to	 0	 when	 dopamine	 reuptake	 is	 higher	 than	 the	 available	dopamine	concentration	at	any	given	location	from	release	point	r=0	as	described	by	Berger	et	al.	for	the	diffusion	and	uptake	of	oxygen	in	tissue.50	The	simulation	is	implemented	using	MATLAB	2016a.			
Volume-averaged	dopamine	dynamics		
	 The	 dynamics	 from	many	 terminals	 averaged	 over	 the	 volume	 encompassing	 the	terminals	is	computed	as	follows:		
																											 																											21		where	 c(j+1)	 is	 the	 volume	 averaged	 concentration	 of	 dopamine	 at	 time	 tj+1,	 c(j)	 is	concentration	at	time	tj	,		and	j	is	the	time	index	of	the	simulation.	Nt	is	the	number	of	terminals	in	the	simulation	volume	Vsim	(1000	μm3).	Terminals	depolarize	at	designated	times	tf,	where	
tf	 is	 the	 same	 for	 all	 terminals	during	 synchronous	 firing	 and	different	 for	 each	 terminal	during	asynchronous	firing.	The	firing	frequency	sets	the	number	of	action	potentials	during	a	given	simulation	period.	A	Poisson	distribution	with	a	known	mean	 firing	 rate	 sets	 the	distribution	of	action	potentials	over	the	simulation	time.	Synchrony	in	firing	activity	 is	a	reflection	 of	 the	 underlying	 functional	 connectivity	 of	 the	 ensemble.	 Synchronous	 firing	(depolarization),	however,	does	not	mean	all	terminals	release	dopamine	simultaneously;	release	 of	 dopamine	 at	 each	 terminal	 is	 probabilistic	 and	 independent	 as	 per	 prior	experimental	literature,	and	thus	set	to	6%	in	our	simulations.	Note	also	that	where	 	is	the	density	of	dopamine	terminals	(Table	1)	and	Δt	is	the	simulation	time	step	(Δt	=	tj+1-tj).	The	volume	averaging	as	defined	in	equation	21	is	valid	only	for	large	enough	ensembles	where	diffusive	flux	out	of	the	volume	can	be	neglected.	This	is	true	if	the	volume	is	 larger	than	the	length	scale	of	dopamine	diffusion	from	a	terminal.	For	small	ensemble	volume	averaging,	diffusive	flux	out	of	the	volume	needs	to	be	taken	into	account	because	the	length	scale	of	the	volume	is	smaller	than	the	diffusion	length	scale	of	dopamine	(Figure	2.S5).	
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Signal-to-noise	ratio		
	 The	noise	on	the	signal	∆F/F0	is	related	to	the	noise	on	F	and	F0.	Using	uncertainty	propagation	rules,	we	have:			 	 	 	 					 	 	 	 																						22		where	 	 is	 the	 noise	 on	 our	 signal	 ∆F/F0.	 We	 use	 noise	 of	 √𝐹		 and	 8𝐹9	 on	 F	 and	 F0	respectively,	for	Poisson	limited	imaging.		
2.5	Appendix	II	
Supporting	Information				
	
	
Figure	2.S1.	Peak	dopamine	concentration	as	a	function	of	distance	from	release	site	following	a	single	quantal	release.	Our	simulation	shows	a	peak	dopamine	concentration	of	226µM	at	r	=	0	µm	(inside	the	synaptic	cleft),	which	dissipates	instantaneously	as	it	expands	out	into	the	ECS.	A	peak	dopamine	concentration	of	1	nM	is	observed	at	a	distance	of	20	µm	from	the	release	site	with	a	diffusion-induced	time	delay	of	90	ms	from	time	of	release.			
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Figure	2.S2.	Comparison	of	non-linear	dopamine	reuptake	versus	linear	uptake	model.	Non-linear	dopamine	reuptake	with	rmax	at	41	µM.s-1	compared	to	linear	uptake	with	rmax	at	4.1	µM.s-1.	Both	cases	are	run	with	an	equal	Km	of	0.21	µM.		D1	–type	receptor	activation	shows	similar	behavior	for	both	non-linear	(rmax	=	41µM.s-1)	and	linear	(rmax	=	4.1µM.s-1)	reuptake.	Comparison	D2	–type	receptor	activation	shows	similar	behavior.	For	both	receptor	types,	linear	uptake	underestimates	the	extent	of	receptor	activation	when	compared	to	non-linear	reuptake	model	by	an	order	of	magnitude.			
	
Figure	2.S3.	Averaging	of	multiple	simulation	runs	for	asynchronous	terminal	firing.		Average	(bold	blue	trace)	of	N=20	simulation	 runs	 (light	gray	 traces)	of	100	asynchronously	 firing	 terminals.	The	 firing	 regime	 is	 as	defined	in	Figure	2.4	of	the	main	manuscript	and	is	omitted	here	for	clarity.		
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Figure	2.S4.	Dependence	of	SNR	on	the	sensor	parameter	Keq.	High	Keq	sensors	have	stronger	turn-on	response	but	poor	reversibility.	Imaging	of	faster	dynamic	processes,	where	temporal	resolution	is	desired,	requires	fast	reversible	sensors	with	low	Keq	at	a	cost	of	lower	SNR.	Figure	is	developed	for	F0	=	10,000	and	imaging	frame	rate	of	20	Hz.			
		
Figure	2.S5.	Volume-averaged	behavior	of	25	terminals	vs.	100	terminals	firing	asynchronously.	The	result	shows	an	average	from	N	=	20	simulation	runs	for	each	25-	(blue)	or	100-	(red)	terminal	cluster.	 	Volume-averaged	 dynamics	 show	 behavior	 that	 is	 largely	 independent	 of	 cluster	 size	 for	 behavior-relevant	 firing	regimes	of	burst	firing	and	pause	in	firing.	At	smaller	cluster	sizes,	the	diffusive	flux	of	dopamine	out	of	the	averaging	volume	becomes	important	and	can	no	longer	be	ignored,	resulting	in	slightly	higher	concentrations.	
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For	the	100-terminal	cluster	where	release	from	a	terminal	does	not	escape	the	averaging	volume	size,	accurate	tonic	and	burst	concentration	levels	can	be	estimated.	Tonic	dopamine	level	approaches	50	nM.			
			
Figure	 2.S6.	 Volume-averaged	 concentration	 profiles	 of	 100	 phasically	 firing	 dopamine	 terminals.	 (a)	Dopamine	concentration	profile	in	which	terminals	fire	synchronously	and	corresponding	sensor	response	of	theoretical	and	20	Hz	video-rate	frame	rates	with	Keq=1	µM-1	and	α	=	2.	(b)	raster	plot	of	synchronous	firing	activity	corresponding	to	(a).	
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Chapter	3	
Turn-On	Fluorescence	Modulation	of	ssDNA-Functionalized	
Carbon	Nanotubes	by	Catecholamine	Neuromodulators	
Portions	 of	 this	 chapter	 are	 reproduced	 with	 permission	 from	 Ref	 51.51	 Copyright	 2018.	
American	Chemical	Society.	Non-covalent	 interactions	 between	 single-stranded	DNA	 (ssDNA)	 oligonucleotides	and	 single	 wall	 carbon	 nanotubes	 (SWCNTs)	 have	 provided	 a	 unique	 class	 of	 tunable	chemistries	 for	 a	 variety	 of	 applications,	 notably	 the	 use	 of	 these	 conjugate	materials	 as	optical	 probes	 for	 neuromodulators.	 However,	 mechanistic	 insight	 into	 both	 the	photophysical	and	intermolecular	phenomena	underlying	their	utility	is	lacking,	resulting	in	obligate	heuristic	approaches	for	producing	ssDNA-SWCNT	based	nanosensor	technologies.	In	 this	 work,	 we	 present	 an	 ultrasensitive	 “turn-on”	 nanosensor	 for	 the	 catecholamine	dopamine	and	norepinephrine	with	strong	relative	change	in	fluorescence	intensity	(ΔF/F0)	of	up	to	35-fold,	a	signal	favorable	for	in	vivo	neuroimaging.	The	nanosensor	is	synthesized	from	 the	 spontaneous	 self-assembly	 of	 (GT)6	 ssDNA	 rings	 on	 SWCNTs.	 The	 fluorescence	modulation	of	the	ssDNA-SWCNT	hybrid	structure	is	shown	to	exhibit	remarkable	sensitivity	to	 the	 ssDNA	 sequence	 chemistry,	 length,	 and	 surface	 density,	 providing	 a	 set	 of	 easily	accessible	 experimental	 parameters	 with	 which	 to	 tune	 nanosensor	 dynamic	 range	 and	strength	of	fluorescence	turn-on.	In	a	subsequent	chapter,	we	rationalize	our	experimental	observations	through	molecular	dynamics	simulations.	
3.1	Introduction	Single	 wall	 carbon	 nanotubes	 exhibit	 advantageous	 electronic	 and	 photophysical	properties	that	make	them	attractive	for	a	diverse	field	of	applications	 in	electronics52–56,	sensing57–60,	 imaging61–63,47,	 and	molecular	 transport64–66.	 SWCNT	 fluorescence	 originates	from	 radiative	 recombination	 of	 one-dimensional	 confined	 excitons,	 exhibits	 exceptional	photostability,	 and	 is	 remarkably	 sensitive	 to	 the	 nanotube	 geometric	 and	 electronic	structure	 as	 well	 as	 the	 local	 chemical	 environment.67–69	 The	 sensitivity	 of	 SWCNT	fluorescence	 to	 the	 local	 chemical	 environment	 has	 been	 leveraged	 for	 the	 synthesis	 of	optical	probes	in	which	polymer	functionalizations	serve	a	dual	purpose	of	forming	stable	SWCNT	 colloidal	 suspensions	 and	 conferring	 selective	 molecular	 recognition	capabilities.60,70	Several	SWCNT-based	probes	with	selective	analyte	mediated	modulations	in	optical	band	gaps	or	in	fluorescence	quantum	yield	with	ΔF/F0			on	the	order	of		9%	to	80%	have	been	reported	.46,60,71–74	For	in	vivo	molecular	sensing	applications,	synthesizing	suitable	elements	capable	of	transducing	in	vivo	signals	constitutes	a	formidable	challenge,	requiring	maximal	changes	in	fluorescence	intensity	from	baseline	(ΔF/F0).	The	spatiotemporal	sensitivity	required	for	in	
vivo	utility	–	in	particular	for	fast	processes	such	as	chemical	neurotransmission	in	the	brain	–	must	account	not	just	for	analyte	concentration	levels,	but	also	for	the	spatial	spread	of	the	signal	 (micrometers)	 as	 well	 as	 its	 temporal	 duration	 (milliseconds).5,16	 An	 ideal	 probe	
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therefore	must	satisfy	several	requirements,	including	high	sensitivity,	molecular	selectivity,	and	optimal	binding	kinetics,	among	others.	The	versatility	and	ease	with	which	SWCNTs	can	be	functionalized	by	a	wide	range	of	polymers	provides	a	great	opportunity	for	a	rational	design	 of	 synthetic	 optical	 probes	 capable	 of	 detecting	 biomolecules	 such	 as	neurotransmitters	 in	 their	 native	 environment.	However,	 despite	proliferating	 reports	 of	SWCNT-polymer	 conjugates	 for	 biomolecule	 sensing,	 a	 robust	 pathway	 for	 translating	SWCNT	 nanosensors	 into	 in	 vivo	 sensing	 applications	 remains	 elusive.	 We	 identify	 two	specific	limitations	in	the	development	of	SWCNT	based	optical	probes	–	lack	of	a	rational	design	principle	and	dearth	of	in	vivo	implementation	–	and	posit	that	a	lack	in	fundamental	understanding	 of	 how	 SWCNT-polymer	 hybrid	 nanomaterials	 interact	 with	 and	subsequently	 undergo	 selective	 fluorescence	 modulation	 by	 molecular	 targets	 underlies	these	limitations.	This	knowledge	gap	is	evident	in	the	status	quo	for	nanosensor	discovery,	which	relies	on	low-throughput	screening	techniques,	and	an	inability	to	tune	nanosensor	performance	once	a	discovery	has	been	made.	In	this	work,	we	report	a	high	turn-on	nanosensor	for	neuromodulators	dopamine	and	 norepinephrine.	 We	 demonstrate	 that	 we	 can	 tune	 SWCNT	 baseline	 fluorescence	intensities	to	increase	nanosensor	analyte	sensitivity	for	key	neurotransmitters	dopamine	and	 norepinephrine	 by	 over	 an	 order	 of	 magnitude	 compared	 to	 a	 previously	 reported	catecholamine	nanosensor.46	Sequence-specific	 ‘short’	ssDNA	polymers	produced	strongly	quenched	SWCNT	baseline	fluorescence	and	a	robust	turn-on	response	to	neuromodulators	dopamine	 and	 norepinephrine.	 We	 find	 this	 phenomenon	 to	 be	 sensitive	 to	 the	 base	sequence	 chemistry,	 polymer	 contour	 length,	 nanotube	 bandgap,	 and	 polymer	 surface	density.	 A	 sodium	 cholate	 (SC)-based	 corona	 exchange	 assay	 suggested	 the	 presence	 of	specific	molecular	recognition	sites	in	the	ssDNA-SWCNT	corona	which	stabilize	the	surface	adsorbed	 polymer	 when	 occupied	 by	 dopamine	 and	 norepinephrine	 analytes.	 In	 a	subsequent	chapter,	we	will	introduce	computational	methodologies	to	help	rationalize	key	experimental	observations. 
3.2	Results	and	Discussion	
Strong	Fluorescent	“Turn-on”	Neuromodulator	Nanosensors	Prior	work	has	shown	the	fluorescence	intensity	of	(GT)15-SWCNT	increases	by	60%	(∆F/F0	=	0.6)	upon	exposure	 to	100	μM	of	dopamine,	which	 translates	 to	∆F/F0	=	0.3	 at	maximal	physiological	dopamine	concentrations	that	follow	burst	neuronal	firing	events	(~1	µM).5,30,46	Here,	we	denote	the	baseline	(pre-analyte)	fluorescence	as	F0	and	the	post-analyte	fluorescence	as	F	and	define	∆F/F0	=	(F-F0)/F0.	Motivated	by	the	goal	of	producing	an	in	vivo	compatible	 neuromodulator	 nanosensor	 for	 a	 broader	 dynamic	 range	 of	 physiological	relevance,	we	synthesized	a	(GT)N	based	ssDNA-SWCNT	library	for	N	=	4,	6,	7,	8,	12,	15,	19,	22,	 26,	 and	 30	 with	 a	 previously	 described	 protocol.75	 Near	 infrared	 fluorescence	 and	absorption	spectroscopy	confirm	that	all	sequences	from	N	=	4	to	N	=	30	produced	stable	DNA-SWCNT	 suspensions,	 as	 evidenced	 by	 sharply	 defined	 spectral	 line	 shapes	corresponding	to	known	SWCNT	electronic	transitions	(Figure	3.1a,	3.1b,	Figure	3.S1,	Figure	3.S2).	We	 then	measured	each	 (GT)N-SWCNT	nanosensor	 response	 to	100	μM	dopamine.	Consistent	with	previous	results,	dopamine	addition	increases	SWCNT	fluorescence	for	all	sequences	(Figure	3.1).	However,	there	exists	a	strong	polymer	length-dependent	trend	in	
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nanosensor	 response,	 for	 which	 the	 previously	 reported	 (GT)15-SWCNT	 nanosensor	represents	an	apparent	minimum	(ΔF/F0	=	0.9),	and	(GT)6-SWCNT	a	maximum	(ΔF/F0	=	23)	(Figure	3.1a,	3.1b,	3.1e).	‘Short’	(GT)N	polymers	(N	=	4,	6,	7,	8)	yield	ΔF/F0	=	14,	23,	17,	and	10	in	response	to	100	µM	dopamine,	respectively,	for	the	(9,4)	SWCNT	chirality.	Conversely,	‘long’	(GT)N	polymers	(N	=	12,	15,	19,	22,	26,	30),	yield	lower	ΔF/F0	=	0.9,	0.9,	0.5,	0.6,	0.4,	and	1.8	responses	to	100	µM	dopamine	concentration,	respectively	(Figure	3.1e	inset).	We	identify	low	baseline	fluorescence,	F0,	for	‘short’	(GT)4-8-SWCNT	complexes	as	the	reason	for	the	large	ΔF/F0	values	of	these	constructs	(Figure	3.1a,	Figure	3.1e	insert,	Figure	3.S2,	Figure	3.S3).	We	further	note	that	the	(GT)	base	sequence	was	found	to	be	uniquely	selective	for	catecholamines	over	other	 tested	sequences	such	as	 (GA)6	 (Figure	3.S4),	 thus	we	did	not	change	the	polymer	base	sequence	identity	for	nanosensor	optimization	and	only	screened	the	 length-effect	of	 (GT)N	polymers.	 Interestingly,	 the	(GT)6-SWCNT	construct	also	shows	increased	selectivity	towards	a	new	neuromodulator	target,	norepinephrine,	with	ΔF/F0	=	35	sensitivity	(Figure	3.1d,	3.1f).		
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Figure	3.1	Nanosensor	response	and	selectivity	for	neuromodulators	dopamine	and	norepinephrine	as	
a	function	of	polymer	length	(a,	b)	Near-infrared	fluorescence	spectra	of	(GT)6-SWCNT	and	(GT)15-SWCNT	suspensions	before	(red	trace)	and	after	(black	trace)	addition	of	100	µM	dopamine	(DA).	Mean	traces	and	standard	 deviation	 bands	 from	 n=3	measurements	 are	 presented.	 (c,	 d)	 Neurotransmitter	 analyte	 library	chemical	structure	and	heat	map	of	∆F/F0	screen	against	(GT)N-SWCNT	library.	Analyte	abbreviations:	Ach	=	acetylcholine,	5-HT	=	serotonin,	DA	=	dopamine,	Hist	=	histamine,	GABA	=	γ-aminobutyric	acid,	Glu	=	glutamate,	Gly	=	glycine,	Asp	=	aspartate,	NE	=	norepinephrine.	Heat	map	∆F/F0	are	computed	for	the	peak	intensity	of	the	(9,4)	SWCNT	chirality	(~1127	nm	center	wavelength)	from	the	convoluted	spectra	and	all	measurements	were	made	at	pH~7.		(e)	ΔF/F0	of	each	sequence	suspension,	for	each	SWCNT	chirality:	(8,3)	dark	blue,	(6,5)	blue,	(7,5)	cyan,	(10,2)	green,	(9,4)	and	(7,6)	yellow,	(8,6)	and	(12,1)	red,	(10,3)	and	(10,5)	maroon.	Insert:	Baseline	fluorescence	 intensity	of	 (GT)N	suspensions	of	 the	 (9,4)	chirality	 (red	 trace)	and	change	 in	 its	 fluorescence	intensity	after	addition	of	100	µM	of	dopamine	(orange	trace).	(f)	(GT)6-SWCNT	nanosensor	response	curve	for	norepinephrine	(red)	and	dopamine	(black)	computed	for	the	(9,4)	SWCNT	peak	intensity.	Error	bars	are	
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standard	 deviation	 from	 n	 =	 3	 independent	measurements.	 Experimental	 data	 (circles)	 were	 fit	 with	 Hill	equation	(solid	line).		 Our	experimental	results	thus	identify	polymer	length	as	a	key	modulator	of	SWCNT	fluorescence	quantum	yield,	which	can	be	exploited	for	maximizing	nanosensor	sensitivity	and	 improving	 selectivity	 for	 neuromodulators.	 Larger	 diameter	 SWCNT	 chiralities	exhibited	 the	 strongest	 fluorescence	 modulation	 (lowest	 baseline	 fluorescence	 and	strongest	 response	 to	 analytes),	with	 the	 trend	 emerging	most	 strongly	 for	 SWCNT	with	diameters	larger	than	the	(6,5)	species	(Figure	3.1e,	Figure	3.S2,	Figure	3.S3).	This	apparent	diameter	dependence	will	be	discussed	later.	We	further	identify	the	(GT)6-SWCNT	complex	as	the	most	suitable	nanosensor	for	imaging	both	dopamine	and	norepinephrine,	with	∆F/F0	=	23	and	35,	 respectively,	upon	addition	of	100	µM	analyte	 concentrations.	DNA-SWCNT	absorption	spectra	remain	largely	invariant	to	the	addition	of	dopamine	and	norepinephrine	(Figure	 3.S1),	 further	 suggesting	 that	 quantum	 yield	 increases	 drive	 the	 increase	 in	nanosensor	fluorescence.	We	next	validated	the	utility	of	(GT)6-SWCNT	to	image	dopamine	and	 norepinephrine	 for	 in	 vivo	 relevant	 concentrations.	 Concentration-dependent	fluorescence	response	curves	for	(GT)6-SWCNT	show	fluorescence	modulations	lie	within	an	optimal	dynamic	range	for	 in	vivo	 imaging	of	neuromodulation	(100	nM	to	2	µM)	(Figure	3.1f).30,76,77	At	basal	dopaminergic	and	noradrenergic	neuronal	activity	corresponding	to	at-rest	conditions	(50	-	100	nM),	we	observe	that	the	(GT)6-SWCNT	construct	exhibited	∆F/F0	values	on	the	order	of	1	(100%).29,	31,	32	At	burst	firing	neuronal	activity	level	typically	arising	from	behavioral	response	to	salient	events	(1	-2	µM),	∆F/F0	values	on	the	order	of	5	(500%)	can	be	obtained	(Figure	3.1f).29,	31,	32	Equally	importantly,	the	(GT)6-SWCNT	construct	shows	an	 enhanced	 selectivity	 for	 neuromodulators	 dopamine	 and	 norepinephrine	 over	 other	potentially	 competing	 and	 ubiquitous	 neurotransmitters,	 such	 as	 glutamate	 (Glu),	acetylcholine	(Ach)	and	γ-aminobutyric	acid	(GABA)	(Figure	3.1d).	We	fit	our	concentration-dependent	experimental	data	points	 to	 the	Hill	equation	and	determined	the	dissociation	constants	(Kd)	to	be	35	µM	for	norepinephrine	and	10	µM	for	dopamine	(Figure	3.1f).	The	molecular	 selectivity	 and	 sensitivity	 towards	 catecholamine	neuromodulators	appears	to	be	highly	dependent	on	nucleobase	chemistry.	We	found	that,	among	others,	two	poly-C	sequences,	C30-SWCNT	and	C12-SWCNT,	remain	largely	non-responsive	when	exposed	to	either	analyte,	consistent	with	previous	studies	that	show	that	poly-C	ssDNA	sequences	bind	strongly	and	stably	to	SWCNT	(Figure	3.S4).78	Other	12-mer	sequences,	including	(GA)6,	(ATTT)3,	 and	 (TAT)4,	 similarly	 exhibit	 no	 or	 negligible	 sensitivity	 to	 both	 dopamine	 and	norepinephrine	(Figure	3.S4).	The	structure	of	SWCNT	surface	adsorbed	ssDNA	is	sensitive	to	 charge	 screening	by	 counter	 ions79	 and	 recent	 reports	have	 shown	 that	 solution	 ionic	strength	plays	a	role	 in	setting	 the	baseline	 fluorescence	(“brightness”)	of	ssDNA-SWCNT	constructs.80	To	rule	out	ionic	strength	effects,	we	tested	the	response	of	(GT)6-SWCNT	to	both	analytes	at	solution	ionic	strengths	that	varied	over	two	orders	of	magnitude.		We	found	that	 the	 turn-on	 response	 remained	 largely	 insensitive	 to	 ionic	 strength	 (Figure	 3.S4),	suggesting	 that	 ionic	 strength	 may	 not	 play	 a	 dominant	 role	 in	 determining	 baseline	fluorescence	 for	 short	 (GT)N	 sequences.	 We	 also	 tested	 the	 (GT)6-SWCNT	 nanosensor	response	to	both	analytes	at	low	(pH=4),	neutral	(pH=7),	and	high	(pH=10)	conditions.	The	fluorescence	 response	 to	dopamine	and	norepinephrine	 is	observed	at	 all	pH	conditions,	with	 best	 responses	 obtained	 under	 physiological	 pH	 conditions	 (Figure	 3.S4).	 We	 next	explored	 the	 robustness	 of	 the	 (GT)6-SWCNT	 nanosensor	 for	 potential	 use	 in	measuring	
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endogenous	dopamine.	Time-dependent	fluorescence	(Figure	3.S5)	and	absorbance	(Figure	3.S6)	measurements	(Methods	 in	Appendix	I)	acquired	over	the	course	of	7	days	confirm	polymer-SWCNT	stability	for	all	values	of	N	except	for	N=4.		To	probe	the	stability	of	our	nanosensors	in	biologically-relevant	milieus,	we	tested	the	 ability	 of	 (GT)6-SWCNT	 to	 respond	 to	 dopamine	 in	 both	 protein-rich	 media	 and	 in	artificial	cerebral	spinal	fluid.	We	observe	robust	∆F/F0	=	1.43	±	0.16	turn-on	responses	to	100	µM	dopamine	from	(GT)6-SWCNT	nanosensors	that	were	pre-incubated	in	cell	media	(DMEM+	 10%	 FBS,	 Methods	 in	 Appendix	 I)	 (Figure	 3.S7a).	 Furthermore,	 we	 tested	 the	compatibility	of	(GT)6-SWCNT	nanosensors	for	use	in	artificial	cerebrospinal	fluid	(ACSF),	a	common	media	used	for	ex-vivo	brain	slice	imaging	studies,	and	observe	nanosensor	∆F/F0	values	of	2.6	±	0.16	when	pre-incubated	in	ACSF	(Figure	3.S7b).	We	tested	the	compatibility	of	 our	 (GT)6-SWCNT	 nanosensors	 with	 potential	 interfering	 agents:	 pharmacological	transport	inhibitors,	and	agonists	and	antagonists	of	endogenous	dopamine	receptors.	We	found	that	(GT)6-SWCNT	fluorescence	was	insensitive	to	the	dopamine	transporter	inhibitor	nomifensine,	and	dopamine	receptor	(DRD2)	agonist	quinpirole,	and	antagonists	sulpiride	and	haloperidol	 (Figure	3.S8).	 (GT)6-SWCNT	 incubated	 in	 these	drugs	 retained	 its	 strong	turn-on	response	to	dopamine	(nomifensine:	23.7	±	1.51;	sulpiride:	22.7	±	0.67;	quinpirole:	24.27	±	0.87;	haloperidol:	25.77	±	0.98;	all	responses	to	100	µM	dopamine;	mean	±		st.	dev.	from	N=3	replicates)	permitting	the	possible	use	of	(GT)6-SWCNT	constructs	in	conjunction	with	drugs	that	target	endogenous	receptors	and	transporters	of	dopamine.	Lastly,	single-molecule	 total	 internal	 reflection	 fluorescence	 (TIRF)	microscopy	of	 surface	 immobilized	(GT)6-SWCNT	 nanosensors	 (Methods	 in	 Appendix	 I)	 suggest	 that	 ssDNA	 adsorbed	 onto	SWCNT	surface	is	resistant	to	degradation	by	endonucleases	(Figure	3.S9).	We	attribute	this	apparent	protective	effect	to	steric	hinderance	of	the	SWCNT	prohibiting	substrate	access	to	the	 nuclease’s	 active	 site.	 	 Lastly,	 prior	 work	 from	 our	 lab	 has	 shown	 that	 molecular	recognition	using	SWCNT-polymer	conjugates	is	two-photon	compatible,	suggesting	several	imaging	 modalities	 used	 in	 neuroimaging	 can	 be	 exploited	 to	 image	 (GT)6-SWCNT	 in	biological	tissue.62	Taken	together,	these	results	suggest	that	the	(GT)6-SWCNT	construct	can	serve	 as	 a	 dopamine	 and	 norepinephrine	 nanosensor	 with	 the	 dynamic	 range,	 binding	kinetics,	and	robustness	compatible	with	in	vivo	utility.		
Solvatochromic	 Shifting	 Reveals	 Dopamine	 and	 Norepinephrine-Specific	 Molecular	
Recognition	
	 We	performed	surfactant	displacement	experiments	to	gain	further	insight	into	how	analytes	modulate	the	quantum	yield	of	(GT)N	polymer	functionalized	SWCNT	constructs.	Recent	work	has	shown	that,	when	added	to	DNA-SWCNT	suspensions,	surfactants	such	as	sodium	 cholate	 (SC)	 adsorb	 to	 exposed	 SWCNT	 surface	 and	 displace	 adsorbed	 ssDNA,	thereby	 altering	 the	 SWCNT’s	 surface	 dielectric	 properties	 and	 causing	 a	 solvatochromic	shift	in	exciton	optical	transition	energies	(Figure	3.2a,	3.2b).81–83	As	expected,	addition	of	SC	to	 (GT)N-SWCNT	 induce	 solvatochromic	 shifts	 in	 (GT)N-SWCNT	 fluorescence	 center	wavelengths	(Figure	3.2b).	All	constructs	showed	characteristic	SC-induced	blue-shifting	of	center	wavelengths	corresponding	to	SWCNT	chiralities	in	the	sample.	We	next	repeated	SC	displacement	 experiments	 for	 all	 (GT)N-SWCNT	 suspensions	 pre-incubated	 in	 10	 µM	dopamine.	Surprisingly,	addition	of	dopamine	to	(GT)N-SWCNT	suspensions	before	addition	
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of	 SC	 either	 reduces	 or	 eliminates	 the	 SC-induced	 shifting	 in	 exciton	 optical	 transitions,	suggesting	 that	 the	 surfactant	 is	 unable	 to	 displace	 the	 surface	 adsorbed	 ssDNA	 in	 the	presence	 of	 dopamine	 (Figure	 3.2c,	 Figure	 3.S10a,	 3.S10c,	 3.S10d).	We	 propose	 that	 the	stabilization	of	(GT)N	polymers	on	SWCNT	arises	from	a	selective	interaction	between	the	dopamine	 analyte	 and	 dopamine-specific	 recognition	 pockets	 in	 the	 (GT)N-SWCNT	conjugate,	 and	 that	 dopamine	 trapped	 in	 binding	 pockets	 enhance	 fluorescence	 by	interacting	with	both	the	adsorbed	polymer	and	the	SWCNT.	We	posit	that	as	a	result	of	these	interactions,	polymer-mediated	binding	of	 analytes	 selectively	 enhances	 the	 fluorescence	quantum	yield	of	ssDNA-SWCNT	nanosensors,	as	we	further	explore	using	experimental	and	computational	approaches	below.	To	probe	the	selectivity	of	dopamine-induced	nanosensor	stabilization,	we	conducted	time-resolved	SC	shift	experiments	with	the	(GT)6-SWCNT	construct	in	which	p-tyramine	is	added	to	the	suspension	before	addition	of	SC.	Tyramine,	a	molecular	analogue	of	dopamine	differing	 by	 one	 hydroxyl	 group,	 does	 not	 modulate	 the	 fluorescence	 of	 (GT)6-SWCNT	(Figure	 3.S11a).	 We	 reasoned	 that	 the	 recognition	 of	 dopamine	 and	 norepinephrine	 is	mediated	 by	 unique	 recognition	 sites	 in	 the	 (GT)6-SWCNT	 corona,	 and	 that	 tyramine’s	inability	 to	modulate	 SWCNT	 fluorescence	 is	 a	 consequence	 of	 its	 inability	 to	 bind	 these	recognition	sites.	With	this	hypothesis,	the	efficacy	of	SC	in	displacing	surface	adsorbed	(GT)6	ssDNA	and	resulting	solvatochromic	shift	should	be	unaffected	by	tyramine.	Our	results	do	indeed	show	that	10	µM	tyramine,	unlike	dopamine,	does	not	attenuate	the	SC	induced	peak	shifts	 (Figure	 3.2d),	 suggesting	 that	 tyramine	 is	 unable	 to	 bind	 to	 and	 stabilize	 surface	adsorbed	ssDNA	strands.		Our	results	further	indicate	that	the	stability	imparted	to	the	SWCNT-ssDNA	corona	phase	 by	 the	 binding	 of	 dopamine	 and	 norepinephrine	 is	 related	 to	 the	 analyte-induced	fluorescence	modulation	 specific	 to	 the	 GT	 base	 sequence.	 A	 (GA)6-SWCNT	 construct,	 in	contrast	to	(GT)6-SWCNT,	exhibits	negligible	modulation	in	fluorescence	upon	addition	of	either	 dopamine	 or	 norepinephrine	 (Figure	 3.S4).	 We	 incubated	 the	 (GA)6-SWCNT	suspension	 in	dopamine	 to	measure	SC	 induced	peak	shifts.	We	observed	 that	dopamine	tentatively	stabilizes	(GA)6-SWCNT	corona	(Figure	3.2e).	However,	the	dopamine-induced	stability	 of	 (GA)6-SWCNT	 is	 short-lived,	 with	 distinctive	 solvatochromic	 peak	 shifting	occurring	 with	 a	 60	 second	 delay	 following	 SC	 addition.	 Another	 12-mer	 sequence,	 C12,	similarly	 exhibited	SC-induced	 solvatochromic	 shifting	despite	 the	presence	of	dopamine	(Figure	3.S10b).	These	results	suggests	that	SC-induced	peak	shifting	is	a	function	of	both	the	dopamine-bound	 fraction	of	 recognition	sites	 in	 the	SWCNT-polymer	corona,	and	 the	intrinsic	binding	affinity	between	the	polymer	sequence	and	SWCNT	surface.	Furthermore,	we	found	that	both	dopamine	and	norepinephrine	modulate	the	Raman	G-	band	of	the	(GT)6-SWCNT	 between	 1500	 and	 1550	 cm-1,	whereas	p-tyramine	 does	 not	 (Figure	 3.S12).	 The	increased	 intensity	 of	 the	 Raman	 G-	 band	 by	 dopamine	 and	 norepinephrine,	 but	 not	tyramine,	 is	 maintained	 regardless	 of	 the	 subsequent	 addition	 of	 SC.	 Absorbance	measurements	show	that	addition	of	analytes	does	not	change	the	E22	transition	energies	of	SWCNTs,	 (Figure	3.S1,	3.S11b)	 and	 therefore	 cannot	 explain	 the	observed	phenomena.	A	number	 of	 interactions	 can	 cause	 changes	 in	 Raman	 intensity	 or	 frequency,	 including	changes	in	polymer	conformation,	solvation	dynamics	and	variations	in	local	electric	field.	The	presence	of	degenerate	modes	in	the	G-	band	of	SWCNTs	further	raises	the	possibility	of	analyte-mediated	 symmetry	 breaking.	 The	 persistence	 of	 these	 changes	 even	 after	 SC	
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addition	 further	 supports	 the	 hypothesis	we	 propose	 regarding	 polymer-SWCNT-analyte	interaction.		
	
Figure	 3.2	 Solvatochromic	 shifts	 reveal	 neuromodulator-specific	 molecular	 interactions	 with	
nanosensors	 dependent	 on	 ssDNA	 sequence	 and	 length	 (a)	Middle	 row:	 sodium	 cholate	 (SC)	 binds	 to	exposed	 SWCNT	 surfaces	 and	 displaces	 bound	 (GT)N	 polymers.	 Bottom	 row:	 Nanosensor	 incubation	 in	dopamine	(DA)	or	norepinephrine	(NE)	stabilizes	ssDNA	polymers	on	the	SWCNT	surface,	disallowing	SC	from	accessing	 the	SWCNT	surface.	Top	 row:	 Incubation	 in	p-tyramine	 (TY)	does	not	 stabilize	 surface	adsorbed	ssDNA	against	displacement	by	SC	(b)	1	wt.%	SC	induces	a	solvatochromic	shift	in	SWCNT	fluorescence.	The	shift	 for	 the	 (GT)6-SWCNT	 conjugate	 is	 presented	 here	 as	 an	 example.	 (c)	 Fluorescence	 peak	 shift	
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corresponding	to	the	(9,4)	SWCNT	chirality	(~1127	nm)	upon	exposure	to	1	wt.%	SC	without	(dash	trace)	and	with	(solid	trace)	pre-incubation	in	10	µM	DA.	Error	bars	are	standard	deviation	from	n	=	3	measurements.	Negative	peak	shits	correspond	to	blue	shifting	of	the	peak	in	the	emission	spectrum,	as	shown	in	(b).	(d)	Time-resolved	fluorescence	measurements	of	(GT)6-SWCNT	incubated	in	10	µM	DA	(red	trace),	10	µM	p-tyramine	(TY)	(blue	trace),	and	incubated	in	neither	(orange	trace).	Upon	addition	of	0.25	wt.	%	SC	indicated	by	the	black	bar,	solvatochromic	peak	shift	in	the	dopamine	incubated	corona	is	eliminated.	(e)	SC	induced	solvatochromic	peak	shift	 in	(GA)6-SWCNT	incubated	in	10	µM	of	dopamine	suggests	(GA)6	exhibits	short	 lived	stability	on	SWCNT	following	dopamine	incubation.	
	 We	probed	whether	the	surface	density	of	the	(GT)N	polymer	on	the	SWCNT	surface	can	tune	the	density	of	molecular	recognitions	sites	available	to	analyte.	We	varied	polymer	surface	packing	of	the	(GT)6-SWCNT	construct	by	synthesizing	nanosensors	with	different	mass	proportions	of	SWCNT	(mS)	to	(GT)6	DNA	polymers	(mD).	The	resulting	(GT)6-SWCNT	conjugates	thus	have	variable	surface-adsorbed	polymer	density	(Figure	3.3a)	with	nominal	mS/mD	mass	 ratios	 of	 2,	 5,	 and	 10,	 representing	 a	 spectrum	 from	 ‘high’	 to	 ‘low’	 (GT)6	polymer	 surface	 density.	 The	 resulting	 fluorescence	 intensity	 from	 equimolar	 SWCNT	aliquots	shows	a	clear	trend	whereby	the	highest	polymer	surface	densities	(mS/mD	=	2)	exhibit	 the	 lowest	 baseline	 fluorescence	 (Figure	 3.3b).	 Addition	 of	 10	 µM	 of	 dopamine	enhances	 the	 SWCNT	 fluorescence	 of	 all	 three	 samples;	 however,	 the	 ΔF/F0	 nanosensor	response	is	highest	for	the	SWCNT	sample	with	the	highest	surface	coverage	(Figure	3.3b).	These	results	suggest	that	(i)	the	degree	of	baseline	fluorescence	quenching	of	SWCNT	by	adsorbed	(GT)6	is	directly	proportional	to	the	polymer	surface	density;	(ii)	 the	higher	the	polymer	 surface	 coverage,	 the	higher	 the	number	of	dopamine	binding	pockets;	 and	 (iii)	dopamine	enhances	SWCNT	quantum	yield	in	proportion	to	the	density	of	bound	recognition	sites.	
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Figure	3.3	DNA	surface	coverage	of	SWCNT	modulates	dopamine	binding	sites.	(a)	Preparation	of	SWCNT	sensors	with	varying	(GT)6	polymer	surface	density.	The	mass	ratio	of	SWCNT	to	ssDNA	(mS/mD)	is	varied	to	prepare	three	suspensions	with	m/n	=	2,	5	and	10.	(b)	Fluorescence	spectra	of	5	mg/L	(GT)6-SWCNT	samples	(dashed	plots),	with	corresponding	 fluorescence	spectra	after	addition	of	10	µM	of	dopamine	 (solid	plots),	normalized	to	the	peak	fluorescence	intensity	observed	for	the	mS/mD=10	sample	before	addition	of	10	µM	dopamine. 
3.3	Conclusion	We	 synthesized	 a	 SWCNT	 based	 high	 turn-on	 probe	 for	 the	 neuromodulators	dopamine	and	norepinephrine.	We	show	that	(GT)N-based	ssDNA	length	plays	a	critical	role	in	 setting	 the	 baseline	 brightness	 of	 the	 ssDNA-SWCNT	 hybrid	 structures,	which	 in	 turn	dictates	critical	optical	probe	parameters,	including	the	strength	of	turn-on	response	and	the	dynamic	 range	 of	 the	 response.	We	 demonstrate	 that	 short	 ssDNA	 length	 alone	 is	 not	 a	sufficient	 criterion	 to	 elicit	 strong	 turn-on	 responses	 and	 there	 are	 at	 least	 two	 other	parameters	that	exert	a	considerable	influence	on	probe	performance.	First,	we	show	that	the	sequence’s	nucleobase	chemistry	plays	an	important	role.	For	example,	(GA)6,	in	contrast	to	 (GT)6,	 produced	 suspensions	 with	 bright	 baseline	 fluorescence	 that	 is	 minimally	perturbed	by	the	addition	of	dopamine.	Secondly,	we	demonstrate	that	surface	density	of	adsorbed	 ssDNA	moieties	 contributes	 to	 setting	 the	 baseline	 brightness	 and	 subsequent	turn-on	 response.	 Densely	 functionalized	 SWCNTs	 exhibited	 quenched	 baseline	 and	
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stronger	response	to	dopamine.	We	introduced	a	novel	surfactant	displacement-based	assay	to	show	that	the	process	of	molecular	recognition	involves	a	three-way	interaction	between	the	SWCNT	surface,	dopamine	molecules	and	ssDNA	oligonucleotides.	This	assay	helped	us	harmonize	key	experimental	observations,	including	the	dependence	of	turn-on	response	on	sequence	 length	 and	 sequence	 chemistry.	 When	 dopamine	 molecules	 are	 absent	 from	solution,	sodium	cholate	(SC)-induced	displacement	of	ssDNA	is	facile,	inducing	well-known	solvatochromic	shifts	in	the	fluorescence	emission	spectra	of	SWCNT.	Addition	of	dopamine	eliminated	 this	 shift	 in	 a	 dose-dependent	 manner,	 suggesting	 that	 dopamine	 molecules	trapped	 by	 surface	 recognition	 sites	 either	 stabilized	 the	 adsorbed	 ssDNA	 against	 SC-induced	displacement	or	disallowed	SC	access	to	the	SWCNT	surface.	ssDNA	sequences	that	produced	diminished	turn-on	responses	(either	because	of	their	chemistry	or	length)	were	displaced	by	SC	even	in	the	presence	of	dopamine,	in	contrast	to	sequences	that	engender	strong	turn-on	response.	 	 In	Chapter	4,	we	will	 introduce	molecular	dynamics	simulation	strategies	 to	 bridge	 our	 macroscale	 experimental	 observations	 with	 molecular-level	processes	that	underpin	our	experimental	observations.	
3.4	Appendix	I	
Materials	and	Methods	
Suspension	of	SWCNT	in	ssDNA	All	 ssDNA	 oligonucleotides	 were	 purchased	 from	 Integrated	 DNA	 Technologies	(Standard	 Desalting).	 HiPCo	 SWCNT	were	 purchased	 from	NanoIntegris	 (Batch	 #	 HR27-104).	Each	ssDNA-SWCNT	colloidal	suspension	was	prepared	by	mixing	1	mg	of	ssDNA	and	2	mg	of	SWCNT	in	1	mL	of	100	mM	NaCl	solution.	The	solution	was	bath	sonicated	(Branson	Ultrasonic	1800)	for	10	minutes	and	probe-tip	sonicated	for	10	minutes	at	5	W	power	(Cole	Parmer	Ultrasonic	Processor,	3	mm	tip	diameter)	in	an	ice-bath.	The	sonicated	solution	was	incubated	at	room	temperature	for	30	minutes.	The	product	was	subsequently	centrifuged	at	16,000	g	(Eppendorf	5418)	for	90	minutes	to	remove	unsuspended	SWCNT	bundles	and	amorphous	carbon,	and	the	supernatant	was	recovered	for	further	characterization.	To	vary	ssDNA	SWCNT	surface	packing,	we	used	2	mg,	5	mg,	or	10	mg	of	starting	SWCNT	masses	in	1	mg	of	(GT)6	dissolved	in	100	mM	NaCl.	
Characterizations	of	SWCNT-ssDNA	suspensions		All	 absorption	 measurements	 were	 taken	 with	 a	 UV-VIS-NIR	 spectrophotometer	(Shimadzu	 UV-3600	 Plus)	 or	 UV-VIS	 (ThermoFisher	 Scientific	 Genesys	 20).	 SWCNT	concentrations	of	as-made	ssDNA-SWCNT	suspensions	were	determined	using	absorbance	at	632	nm	(UV-VIS)	and	extinction	coefficient	of	e	=	0.036	(mg/L)-1	cm-1.80	Full	 spectrum	absorbance	measurements	were	recorded	with	UV-VIS-NIR	after	dilution	to	5	mg/L	SWCNT	concentration	 in	 100	 mM	 NaCl.	 For	 fluorescence	 measurements,	 each	 suspension	 was	diluted	to	5	mg/L	in	100	mM	NaCl	and	aliquots	of	198	µL	volume	were	placed	in	each	well	of	a	96-well	plate	(CORNING).	Fluorescence	measurements	were	obtained	with	a	20X	objective	on	 an	 inverted	 Zeiss	microscope	 (Axio	Observer.D1)	 coupled	 to	 a	 Princeton	 Instruments	spectrometer	(SCT	320)	and	liquid	nitrogen	cooled	Princeton	Instruments	InGaAs	detector	
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(PyLoN-IR).	A	721	nm	laser	(OptoEngine	LLC)	was	used	as	the	excitation	light	source.	To	investigate	solution	ionic	strength,	(GT)6-SWCNT	suspensions	were	diluted	to	5	mg/L	in	1	mM,	10	mM,	50	mM,	100	mM,	and	200	mM	NaCl	solution	and	allowed	to	incubate	for	24	hrs.	before	 fluorescence	measurements	were	 taken.	 pH	 adjustments	were	made	using	HCl	 or	NaOH	 and	 fluorescence	 measurements	 were	 taken	 after	 1	 hr.	 equilibration	 at	 room	temperature.	We	used	2	s	exposure	times	at	laser	power	of	65	mW	for	most	measurements.	In	 very	 bright	 SWCNT	 suspensions,	 exposure	 times	 were	 reduced	 to	 0.5	 s	 or	 1	 s	 and	fluorescence	 counts	 were	 rescaled	 for	 comparison	 and	 analysis.	 All	 absorbance	 and	fluorescence	measurements	were	background	corrected	with	a	blank	100	mM	NaCl	solution.	All	 measurements	 were	 made	 in	 triplicate.	 Reported	 results	 are	 averages	 and	 standard	deviations	of	the	triplicate	measurements.	
(GT)N-SWCNT	stability	experiments	We	 tested	 the	 stability	 of	 all	 (GT)N-SWCNT	 suspensions	 with	 fluorescence	 and	absorbance	 spectroscopy.	 Prior	work	 has	 shown	 that	 DNA-SWCNT	 fluorescence	 stability	directly	 correlates	 with	 DNA	 polymer	 stability	 on	 the	 SWCNT	 surface.78	 To	 rule	 out	 the	possibility	that	spontaneous	DNA	polymer	rearrangement	or	dilution	effects	contribute	to	the	 large	 increase	 in	 nanosensor	 fluorescence	 we	 observed	 for	 ‘short’	 sequences,	 we	measured	the	time-dependent	fluorescence	stability	of	all	(GT)N-SWCNT	suspensions	with	near	 infrared	 fluorescence	 spectroscopy.	 The	 fluorescence	 spectra	 of	 all	 (GT)N-SWCNT	suspensions	were	collected	for	a	period	of	>	2	hrs.		immediately	following	dilution	to	5	mg/L	in	100	mM	NaCl.	Most	(GT)N-SWCNT	suspensions	exhibit	stable	fluorescence	(ΔF/F0	<	-15%)	with	the	exception	of	(GT)4-SWCNT,	which	shows	higher	degree	of	fluorescence	instability	(ΔF/F0	=	-40%)	(Figure	3.S5).	Importantly,	all	sequences	exhibit	a	decrease	in	intensity	that	is	over	an	order	of	magnitude	less	than	the	fluorescence	increase	observed	in	response	to	both	 analytes	 (Figure	 3.S5)	 suggesting	 that	 nanosensor	 response	 to	 analytes	 arises	 from	specific	molecular	 interaction	between	 (GT)N-SWCNT	and	 the	 analyte	 and	does	not	 arise	from	volume	or	dilution	effects.	The	differences	in	time-dependent	fluorescence	modulation	exhibited	by	each	suspension,	as	shown	in	Figure	3.S5,	suggests	that	polymer	length	affects	the	base	stacking	stability	of	the	(GT)N-SWCNT	suspensions	with	an	apparent	instability	for	N	=	4.		Absorbance	measurements	were	also	carried	out	 to	study	the	stability	of	different	(GT)N	polymers	on	SWCNT.	After	synthesis	of	each	(GT)N-SWCNT	construct,	excess	ssDNA	was	removed	from	the	colloidal	suspension	(Amicon	Ultra	100kDA	MWCO),	and	absorption	spectra	were	recorded	with	a	UV-VIS-NIR	spectrophotometer.	The	filtered	suspension	was	then	 left	 to	 incubate	at	room	temperature	 for	1	week	(7	days).	After	1	week,	absorbance	spectra	were	again	collected	for	each	(GT)N-SWCNT	construct	and	compared	to	the	sample’s	initial	absorbance.	Absorbance	values	near	260	nm,	the	DNA	absorbance	peak,	reveal	that	negligible	ssDNA	polymer	desorption	occurs	 from	(GT)N-SWCNT	constructs	within	 the	1-week	timeframe,	with	the	exception	of	(GT)4-SWCNT	that	shows	appreciable	(GT)4	polymer	desorption	from	the	SWCNT	surface	(Figure	3.S6).	Our	results	suggest	that	(GT)N	sequences	with	N>4	form	stable	non-covalent	conjugates	with	SWCNT.	For	(GT)4-SWCNT,	we	observe	a	 significant	 increase	 in	 absorbance	 at	 ~260nm	 (presumably	 due	 to	 absorbance	 in	 the	sample	filtrate	from	desorbed	DNA).	We	further	note	that	sequences	shorter	than	(GT)4	did	
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not	 enable	 suspension	 of	 SWCNT.	 These	 results	 provide	 further	 evidence	 for	 colloidal	stability	of	(GT)6-SWCNT,	the	ultrasensitive	dopamine	and	norepinephrine	nanosensor.	
	
Analyte	fluorescence	response	measurements	All	 neurotransmitters	 were	 purchased	 from	 Sigma-Aldrich.	 For	 neurotransmitter	response	measurements,	we	collected	fluorescence	from	198	µL	volumes	of	suspensions	(5	mg/L	SWCNT	concentration)	before	and	after	addition	of	2	µL	of	10	mM	solutions	of	each	analyte	 (for	 100	µM	 final	 analyte	 concentration	 in	 each	well).	 For	 dose	 response	 curves,	analyte	stock	concentrations	were	prepared	to	obtain	the	target	concentration	in	each	well	upon	addition	of	the	2	µL	volumes.	Responses	to	drugs	were	measured	in	the	same	manner.	We	used	96-well	plates	(CORNING,	200	µL	total	volume	per	well)	for	screening	experiments.	Analytes	 were	 incubated	 for	 5	 minutes	 before	 taking	 post-analyte	 fluorescence	measurements.	Responses	were	calculated	for	the	(9,4)-SWCNT	chirality	peak	(~1127	nm	center	wavelength)	as	∆F/F0	=	(F-F0)/F0,	where	F0	is	fluorescence	before	analyte	addition	and	F	is	fluorescence	after	analyte	addition	and	following	a	5-minute	incubation	period.	Peak	heights	 (amplitudes)	at	center	wavelengths	corresponding	 to	known	SWCNT	(n,m)	chiral	index	 in	 the	 convoluted	 spectra	 are	 used	 for	 all	 ∆F/F0	 calculations	 (Figure	 3.1e).	 Dose-response	measurements	were	fitted	to	Hill	equation,	from	which	dissociation	constants	were	evaluated.84,85	All	measurements	were	made	in	triplicate.	Reported	results	are	averages	and	standard	 deviations	 of	 the	 triplicate	 measurements.	 To	 measure	 dopamine	 response	 of	(GT)6-SWCNT	 in	DMEM	 (Dulbecco’s)	 supplemented	with	 10%	 Fetal	 Bovine	 Serum	 (FBS)	(Gibco,	 ThermoFisher	 Scientific),	 we	 diluted	 the	 as	made	 suspension	 to	 5	mg/L	 SWCNT	concentration	in	the	media	and	allowed	1	hr.	 incubation	at	room	temperature.	Dopamine	response	was	measured	 as	 described	 above.	 The	 same	 procedure	was	 used	 for	 artificial	cerebrospinal	fluid	(ACSF)	(119	mM	NaCl,	26.2	mM	NaHCO3,	2.5	mM	KCl,	1mM	NaH2PO4,	1.3	mM	MgCl2,	10	mM	Glucose,	2	mM	CaCl2).	
Single	molecule	TIRF	experiments	We	used	 visible	 fluorophore	 (Cy5)	 tagged	 single	 strand	DNA,	 Cy5-(GT)6	 and	 total	internal	reflection	fluorescence	(TIRF)	to	show	that	ssDNA	adsorbed	on	SWCNT	surface	are	resistant	 to	 degradation	 by	 nucleases.	 To	 do	 this,	 we	 dissolved	 biotinylated-Cy5-tagged	(GT)6	(referred	to	as	Cy5-(GT)6	in	this	study)	(Integrated	DNA	Technologies)	in	100	mM	NaCl	(nuclease	free)	by	gentle	shaking	at	50	RPM	(Waverly	S1C-E)	for	30	minutes,	then	diluted	it	to	150	pM	concentration.	Cy5-tagged	(GT)6-SWCNT	suspensions	(referred	to	as	Cy5-(GT)6-SWCNT	in	this	study)	were	prepared	as	described	previously,	and	spin-filtered	with	100	kDa	Amicon	filters	(Ultra-0.5mL	Centrifugal	Filter)	10	times	with	nuclease-free	water	to	remove	free	 (unsuspended)	 (GT)6.	 The	 SWCNT	 concentration	 of	 the	 resulting	 supernatant	 was	measured	 and	 the	 solution	 diluted	 to	 0.2	 mg/L	 SWCNT	 concentration.	 S1	 nuclease	(Promega)	was	diluted	using	1x	reaction	buffer	to	250	nM.	We	used	6-channel	slides	(ibidi	
µ-Slide	VI	0.5	Glass).	Prior	to	use,	each	channel	was	washed	by	adding	100	µL	of	100	mM	NaCl	to	one	end	and	removing	60	µL	on	the	opposite	end.	The	addition	of	any	subsequent	solution	was	immediately	followed	by	the	removal	of	an	equal	volume	of	solution	at	the	other	end	of	the	channel.	In	all	subsequent	steps,	substrates	were	added	in	50	µL	volumes,	and	
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channels	flushed	with	50	µL	solution	(100	mM	NaCl)	to	remove	unbound	substrates	post-incubation.	First,	0.25	mg/mL	of	biotinylated	Bovine	Serum	Albumin	(BSA-Biotin)	and	0.05	mg/mL	NeutrAvidin	(ThermoFisher	Scientific)	were	added	to	each	channel	and	incubated	for	5	minutes.	Non-specific	adhesion	afforded	labeling	of	the	glass	surface	with	BSA-Biotin-NeutrAvidin	 complexes.	 Next,	 Cy5-(GT)6	 or	 Cy5-(GT)6-SWCNT	 were	 incubated	 in	experimental	channels	for	5	minutes.	Biotin-Cy5-(GT)6	would	bind	to	surface	immobilized	BSA-Biotin-NeutrAvidin	complexes	through	specific	biotin-NeutrAvidin	interactions.	On	the	other	hand,	non-specific	adhesion	between	SWCNT	surface	and	BSA/Neutravidin	proteins	affords	 immobilization	 of	 the	 nanosensor	 (Figure	 3.S9).	 After	 DNA	 or	 SWCNT-DNA	immobilization,	 each	 channel	 was	 incubated	 for	 15	minutes	 in	 250	 nM	 S1	 nuclease	 and	rinsed	with	50	µL	NaCl	solution	to	remove	degraded	DNA.	All	images	were	collected	with	laser	excitation	at	642	nm,	a	655	nm	LP	emission	filter,	TIRF	angle	of	65.35o,	and	exposure	time	 of	 1000	 ms	 (Zeiss	 Elyra	 PS.1).	 The	 channels	 were	 imaged	 pre	 and	 post	 nuclease	incubation.	A	negative	control	for	each	ibidi	slide	involved	using	100	mM	NaCl	solution	in	place	of	DNA	or	DNA-SWCNT.	A	second	negative	control	used	incubation	in	100	mM	NaCl	solution	 in	 place	 of	 S1	 nuclease	 (Figure	 3.S9).	 The	 acquired	 images	 were	 processed	 in	MATLAB.	 An	 algorithm	 removed	 dead	 pixels	 and	 background	 noise	 before	 the	 image	underwent	thresholding	to	obtain	a	binary	image.	A	built-in	function	quantified	the	number	of	Cy5	fluorophores	(spot	count)	present	per	field	of	view.		Approximately	25	fields	of	view	were	acquired	per	channel,	and	each	channel	experiment	was	conducted	in	triplicate.	Spot	counts	for	each	channel	were	averaged	over	the	25	fields	of	view	and	the	percentage	change	computed	for	each	channel	using	pre	and	post	nuclease	incubation.	
Surfactant-induced	solvatochromic	shift	experiments	We	used	sodium	cholate	(SC)	(Alfa	Aesar)	for	surfactant	displacement	experiments.	SC	solutions	was	prepared	in	deionized	water	and	aliquots	were	added	to	each	well	of	a	96-well	plate	for	final	SC	concentrations	of	0.25	wt.%	for	time-resolved	experiments	and	1	wt.%	for	steady-state	experiments.	For	time-resolved	solvatochromic	shift	experiments,	spectra	were	collected	at	1	s	intervals	and	SC	was	added	10	s	after	start	of	acquisition	to	obtain	0.25	wt.%	SC	in	each	well.	Each	acquisition	lasted	between	2	and	5	minutes	and	SC	was	allowed	to	diffuse	passively	 through	 the	well	 during	 acquisition.	 For	 analyte	 incubated	wells,	 the	wells	were	spiked	to	final	analyte	concentrations	of	10	µM	for	time-resolved	experiments	or	100	 µM	 for	 steady-state	 experiments.	 Analytes	 were	 allowed	 to	 incubate	 for	 5	 minutes	before	addition	of	SC	to	a	final	concentration	of	0.25	wt.%	or	1	wt.%.	
(GT)6-SWCNT	Raman	measurements	Raman	 spectra	 were	 acquired	 on	 a	 Horiba	 LabRAM	 HR	 Raman	 microscope.	 	 All	samples	were	excited	with	a	532	nm	laser	 line	(50	mW)	through	a	20x	objective	and	the	Raman	spectra	were	collected	 in	a	backscattering	geometry	 from	200	µL	volume	96-well	plates.		For	all	experiments,	(GT)6-SWCNTs	were	prepared	to	a	concentration	of	20	mg/L	in	100	 mM	 NaCl.	 	 Stock	 solutions	 containing	 dopamine	 (DA),	 norepinephrine	 (NE)	 and	tyramine	(TY)	were	added	to	each	well	for	a	final	analyte	concentration	of	100	μM.		Sodium	cholate	(SC)	was	added	to	select	samples	for	a	final	concentration	of	0.5	wt.%	in	each	well.		
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In	measurements	containing	analytes	and	SC,	 the	analyte	was	added	to	the	(GT)6-SWCNT	solution	first	and	allowed	to	incubate	for	1	minute	before	SC	was	added. 
3.5	Appendix	II	
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Figure	 3.S1.	 Absorption	 spectra	 of	 (GT)6-SWCNT	 before	 and	 after	 analyte	 addition.	 Absorbance	 of	 (GT)6-SWCNT	 before	 (red	 trace)	 and	 after	 (black	 and	 blue	 traces)	 addition	 of	 100	 µM	 dopamine	 (DA)	 and	norepinephrine	 (NE)	 shows	 little	 change	 at	 721	 nm,	 the	 excitation	 wavelength	 used	 for	 all	 fluorescence	measurements	in	this	study.	E22	transitions	are	unaffected	whereas	addition	of	analytes	is	observed	to	reduce	transition	bleaching	in	the	E11	region	of	the	spectrum.		
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Figure	 3.S2	 Fluorescence	 spectra	 of	 three	 short	 (N=4,	 6,	 8)	 and	 long	 (N=15,	 26,	 30)	 of	 (GT)N-SWCNT	suspensions.	Fluorescence	before	addition	(red	trace)	and	after	(black	trace)	addition	of	100	µM	of	dopamine	(DA)	is	shown.	Mean	traces	and	standard	deviation	(gray	band)	from	N=3	technical	replicates	are	presented.	
	
Figure	3.S3	Baseline	 fluorescence	 intensity	of	(GT)N-SWCNT	before	any	analyte	addition	shows	a	diameter	dependent	fluorescence	quenching.	SWCNT	chiralities	bigger	than	the	(6,5)	species	show	the	lowest	baseline	fluorescence	that	increases	with	increasing	N.	Error	bars	are	standard	deviation	of	N=3	technical	replicates.	
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Figure	3.S4	Nanosensor	stability	over	varying	ionic	strengths	and	pH.	(a)	Nanosensor	response	to	dopamine	and	 norepinephrine	 is	 observed	 for	 a	 wide	 range	 of	 solution	 pH,	 with	 maximal	 response	 occurring	 at	physiological	pH	of	7.	(b)	Nanosensor	response	to	dopamine	and	norepinephrine	under	NaCl	ionic	strength	conditions	 that	 vary	 over	 two	 orders	 of	 magnitude.	 (c)	 Response	 to	 dopamine	 and	 norepinephrine	 is	 GT	sequence	specific.	Experiments	with	other	12-mer	constructs	show	marginal	∆F/F0	compared	to	(GT)6.	Error	bars	are	standard	deviation	of	N=3	technical	replicates.	All	∆F/F0	are	reported	for	the	peak	intensity	change	at	the	center	wavelength	of	(9,4)	SWCNT	chirality	(~1127	nm)	from	the	convoluted	fluorescence	spectra.		
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Figure	3.S5	Change	in	(GT)N-SWCNT	fluorescence	intensity	as	a	function	of	time.	All	suspensions	were	diluted	to	a	SWCNT	concentration	of	5	mg/L	in	100	mM	NaCl	and	their	fluorescence	spectrum	was	monitored	over	two	hours	immediately	following	dilution.		
	
Figure	3.S6	DNA	desorption	from	SWCNT	over	the	course	of	1	week.	Change	in	absorbance	for	(GT)N-SWCNT	suspensions	 after	 1	week	 of	 incubation,	 indicating	 the	 relative	 instability	 of	 the	 (GT)4-SWCNT	 suspension	compared	to	(GT)6-SWCNT	and	longer.	Absorption	at	260	nm	corresponds	to	desorbed	ss(GT)N	polymer.	For	more	details,	see	Methods	in	Appendix	I.	
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Figure	3.S7	(a)	(GT)6-SWCNT	response	to	dopamine	(DA)	after	1-hr	incubation	in	DMEM+10%	FBS.	(GT)6-SWCNT	was	diluted	and	equilibrated	in	DMEM+10%	FBS	for	1	hr.	before	dopamine	response	measurements	were	taken.	(b)	Another	set	of	dopamine	response	experiments	were	repeated	with	nanosensors	equilibrated	in	artificial	cerebrospinal	fluid	(ACSF).	Data	is	presented	as	a	mean	trace	and	standard	deviation	(gray	band)	from	N=3	measurements.		
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Figure	3.S8	Response	of	 (GT)6-SWCNT	 to	various	drugs.	No	 response	or	negligible	negative	 responses	are	observed	for	(a)	10	µM	of	nomifensine	and	1	µM	each	of	(b)	sulpiride,	(c)	quinpirole	and	(d)	haloperidol.	After	incubation	in	each	drug,	subsequent	responses	to	100	µM	of	dopamine	are	measured	and	show	no	attenuation	(orange	 traces).	 All	 traces	 are	 presented	 as	mean	 and	 standard	 deviation	 (gray	 band)	 from	N=3	 technical	replicates.		
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Figure	3.S9	Single	molecule	TIRF	is	used	to	evaluate	degradation	of	ssDNA	by	S1	nuclease.	(a)	Cy5-(GT)6	and	Cy5-(GT)6-SWCNT	were	surface	 immobilized	on	a	glass	slide	(Methods	in	Appendix	I).	(b)	A	representative	field	of	view	in	a	channel	with	Cy5-(GT)6	(top	row)	and	Cy5-(GT)6-SWCNT	(bottom	row)	before	and	after	15-minute	incubation	in	S1	nuclease.	S1	nuclease	mediated	degradation	of	ssDNA	diminishes	Cy5	fluorescence.	Scale	bars	=	5	µm.	(c)	Percentage	change	in	Cy5	spot	count	shows	(GT)6	adsorbed	on	SWCNT	are	not	degraded	as	effectively	by	S1	nuclease	compared	with	free	(GT)6	(p	<	0.001).	(d)	Scatter	plot	of	spot	counts	in	a	control	lane	 treated	with	100	mM	NaCl	 (Background)	shows	negligible	non-specific	 fluorescence.	Four	channels	 in	which	Cy5-(GT)6	are	immobilized	shows	that	treatment	with	100	mM	NaCl	has	no	effect	on	spot	counts	(NaCl)	and	 treatment	with	S1	nuclease	(S1N(1),	S1N(2),	S1N(3))	diminishes	spot	counts.	Each	dot	represents	Cy5	counts	from	a	field	of	view	either	before	(red)	incubation	in	buffer	or	nuclease	or	after	(black)	incubation	in	buffer	or	nuclease,	and	then	(e)	repeated	with	Cy5-(GT)6-SWCNT	as	the	substrate.			
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Figure	3.S10	Solvatochromic	shifts	 induced	by	the	addition	SC	surfactant	 to	ssDNA-SWCNT	constructs.	 (a)	Shifts	caused	by	0.25	wt.%	SC	when	no	dopamine	(DA)	or	norepinephrine	(NE)	is	present	(orange	trace)	is	eliminated	in	the	presence	of	10	µM	of	DA	(blue	trace)	and	10	µM	of	NE	(red	trace).	Black	bar	indicates	time	of	SC	addition.	(b)	For	C12-SWCNT	construct,	incubation	in	10	µM	of	DA	does	not	eliminate	shift	caused	by	0.25	wt.%	SC	(c)	Peak	shifts	of	the	(6,5)	and	(7,5)	chirality	with	DA	(100	µM)	(solid	trace)	and	no	DA	(dash)	show	analyte	 induced	 corona	 stability	 is	 limited	 for	 smaller	 diameter	 SWCNTs,	 consistent	with	 their	 diminished	∆F/F0	 in	 response	 to	DA.	 (d)	On	 the	 other	 hand,	 bigger	 diameter	 peaks	 (9,4)	 and	 (8,6),	which	 exhibit	 the	strongest	analyte	mediated	fluorescence	modulation	are	strongly	stabilized	by	the	addition	of	DA.	Peak	shifts	are	computed	by	as	the	difference	between	steady-state	(long	time	behavior)	and	initial	peak	positions.	Final	SC	concentrations	for	(c)	and	(d)	are	1	wt.%.	Error	bars	are	standard	deviations	from	n=3	replicates.	
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Figure	3.S11	(a)	Fluorescence	modulation	of	(GT)6-SWCNT	upon	addition	of	p-tyramine	(TY).	Addition	of	10	µM	 TY	 causes	 negligible	 fluorescence	 modulation	 of	 the	 (GT)6-SWCNT	 construct.	 (b)	 Absorbance	measurements	 before	 (red	 trace)	 and	 after	 (black	 trace)	 addition	 of	 100	 µM	 of	 TY.	 Negligible	 absorption	modulations	are	observed	in	the	E11	and	E22	regions	of	the	spectrum.	
	
Figure	3.S12	Selective	Raman	peak	broadening	of	(GT)6-SWCNT	by	dopamine	and	norepinephrine.	The	effects	on	the	Raman	spectra	for	(GT)6-SWCNT	in	the	G-band	region	are	shown	for	the	addition	three	analytes.	The	blue	 spectra	 correspond	 to	20	mg/L	of	 (GT)6-SWCNT.	Orange	 spectra	 contain	20	mg/L	 (GT)6-SWCNT	with	sodium	cholate	(SC)	added	to	0.5	wt.%.		Green	spectra	show	(GT)6-SWCNT	with	the	respective	analyte	added	to	a	final	concentration	of	100	μM	after	1	minute	of	incubation.	Both	dopamine	and	norepinephrine	produce	a	strong	response	in	the	G-	portion	of	the	spectrum,	which	is	absent	from	the	tyramine	measurements.	The	effect	is	maintained	regardless	of	the	subsequent	addition	of	SC,	suggesting	the	molecular	recognition	of	dopamine	and	norepinephrine	analytes	disallows	SC	adsorption. 
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Chapter	4	
Molecular	Dynamics	Simulations	of	(GT)N	ssDNA	Adsorbed	on	
Single	Wall	Carbon	Nanotubes	
Portions	 of	 this	 chapter	 are	 reproduced	 with	 permission	 from	 Ref	 51.51	 Copyright	 2018.	
American	Chemical	Society.	
	In	this	chapter,	we	employed	classical	and	quantum	mechanical	molecular	dynamics	simulations	to	rationalize	key	experimental	observations	from	Chapter	3.	Our	calculations	show	that	(GT)6	ssDNA	form	ordered	rings	around	(9,4)	SWCNT,	inducing	periodic	surface	potentials	that	modulate	exciton	recombination	lifetimes,	thereby	setting	the	photophysical	behavior	of	the	ssDNA-SWCNT	hybrid	structure.	This	ordered	ring	structure	contrasts	with	helically	adsorbed	(GT)15	ssDNA	on	(9,4)	SWCNT.	Further	work	elucidates	how	dopamine	analyte	binding	modulates	SWCNT	fluorescence.	We	discuss	the	implications	of	our	findings	for	SWCNT-based	molecular	imaging	applications.	
4.1	Introduction	Molecular	dynamics	(MD)	simulations	can	provide	key	insights	into	complex	systems	that	are	otherwise	difficult	to	probe	experimentally.	MD	simulations	generate	atomic	scale	evolutions	among	a	system	of	interacting	particles	by	solving	classical	equations	of	motion	and	producing	detailed	movies	of	the	whole	system’s	evolution,	either	at	atomic	or	domain-scale	 resolutions.	 MD	 simulations	 have	 previously	 been	 utilized	 to	 probe	 the	 energetic	interactions	of	biomolecular	complexes	with	single	wall	carbon	nanotubes	and	have	made	considerable	contributions	in	elucidating	ssDNA	conformations	on	the	SWCNT	surfaces.86,87	In	our	work,	we	employed	MD	simulations	to	explore	the	self-assembly	of	(GT)6	and	(GT)15	ssDNA	on	SWCNTs	in	order	to	gain	insight	into	two	key	experimental	observations	we	made	from	our	work	presented	 in	Chapter	3.	First,	we	sought	 to	understand	 the	photophysical	processes	that	govern	the	relationship	between	fluorescence	turn-on	response	and	ssDNA	sequence	length,	particularly	with	respect	to	the	observed	quenched	baseline	fluorescence	of	 the	 (GT)6-SWCNT	 hybrid.	 Second,	we	wanted	 to	 elucidate	 how	molecular	 interactions	between	 dopamine	 molecules	 and	 ssDNA-SWCNT	 hybrids	 generate	 perturbations	 that	engender	fluorescence	modulation	of	the	underlying	SWCNT	scaffold.	
4.2	Results	and	Discussion			Towards	this	goal,	we	performed	multiscale	simulations	of	(GT)(N=6,15)-(9,4)-SWCNT	complexes	 to	 disclose	 mechanisms	 responsible	 for	 a	 strongly	 quenched	 baseline	fluorescence	 and	 a	 large	 nanosensor	 response	 to	 neuromodulators	 observed	 in	 (GT)6-SWCNT	constructs,	in	contrast	to	(GT)15-SWCNT.	First,	we	equilibrated	both	(GT)6-SWCNT	and	 (GT)15-SWCNT	 systems	 with	 atomistic	 molecular	 dynamics	 (MD)	 simulations.	 The	(GT)15	polymer,	which	was	 initially	helically	wrapped	around	the	SWCNT	consistent	with	
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previous	 work,86–90	 remained	 in	 a	 helical	 conformation	 during	 a	 200	 ns	 MD	 simulation	(Figure	4.1a).	On	the	contrary,	the	(GT)6	polymer	on	the	(9,4)	SWCNT	rearranged	from	its	initial	helical	conformation	into	a	ring-like	conformation	in	each	of	the	five	independent	200	ns	 trajectories	performed,	 regardless	of	 the	handedness	of	 the	SWCNT	simulated	 (Figure	4.1b,	Figure	4.S8b,	Figure	4.S9).		The	indifference	to	SWCNT	handedness	is	in	agreement	with	previous	 studies	 that	 show	 that	 recognition	 of	 chiral	 nanotubes	 by	 aromatic	 systems	(graphene	ribbons)	can	only	be	achieved	at	low	temperatures	(200	K)	due	to	small	energy	differences	of	different	adsorbed	states.91	We	 further	 examined	 the	 adsorption	 of	 multiple	 –	 instead	 of	 singular	 –	 (GT)6	polymers	 on	 the	 (9,4)	 SWCNT	 in	 a	 250	 ns	 long	 simulation.	 We	 observed	 helix-to-ring	transitions	 in	 all	 (GT)6	 polymers	 (Figure	 4.1b,	 Figure	 4.S7b).	 The	 ring	 conformations	 of	neighboring	(GT)6	ssDNAs	become	highly	ordered	throughout	the	simulation	time	course,	as	observed	from	the	distinct	sharp	peaks	positioned	at	approximately	equal	intervals	of	~0.25	nm	in	the	radial	distribution	function	of	DNA	phosphate	groups	(Figure	4.S1).	In	contrast,	(GT)6	 polymers	 adsorbed	 on	 the	 smaller	 diameter	 (6,5)	 SWCNT	 predominantly	 adopt	 a	helical	 conformation	 in	 a	 160	 ns	 long	 simulation	 (Figure	 4.S8a).	 Previous	 simulations	 of	(GT)6	polymers	on	 (8,6)-SWCNT	show	 that	 these	polymers	assume	helical	 and	elongated	conformations	along	the	SWCNT	axis,	in	partial	agreement	with	our	results	in	Figure	4.1e.92	However,	the	ring	(GT)6	motif	is	unique	to	this	study.	Differences	between	these	studies	may	arise	from	differences	in	initialization,	sampling	times,	the	temperature	range	selected	for	the	simulated	systems,	and	the	complexity	of	the	system	examined.92	To	confirm	that	the	ring-like	conformation	is	a	favorable	adsorbed	state	of	(GT)6	on	the	(9,4)	SWCNT,	we	calculated	the	free	energy	landscape	of	this	ssDNA	on	the	(9,4)-SWCNT	surface	at	room	temperature	(T	=	300	K)	(Figure	4.1e),	using	replica	exchange	molecular	dynamics	 (Methods	 in	 Appendix	 I).90	 The	 landscape	 reveals	 two	 distinct	 stable	conformations	 for	 (GT)6,	 a	 left-handed	 helix	 and	 a	 non-helical	 ring-like	 conformation,	corresponding	to	free	energy	minima	at	(x,y)	=	(2.5	Å,	-10	Å)	and	(3.2	Å,	6	Å),	respectively,	where	 x	 represents	 the	 root	mean	 square	 deviations	 (RMSD)	 of	 the	 DNA	 structure	with	respect	to	the	representative	left-handed	DNA	helix,	and	y	represents	the	distance	along	the	long	SWCNT	axis	of	two	selected	atoms	of	the	3´-	and	5´-end	DNA	nucleotides.	These	two	conformations	have	approximately	the	same	free	energies,	and	as	such	they	are	expected	to	be	 equivalently	 sampled.	 Moreover,	 because	 the	 free	 energy	 barrier	 between	 each	conformation	 is	 only	 ~1.2	 kcal/mol,	 frequent	 interconversions	 between	 the	 two	conformations	 is	 likely	 at	 room	 temperature	 for	 single	 or	 sparsely	 adsorbed	 polymers.	However,	in	experimental	suspensions,	SWCNT	surface	is	likely	to	be	covered	by	multiple	ssDNA	 polymers.	 In	 that	 case,	 the	 ring-like	 ssDNA	 conformations	 are	 likely	 to	 be	 more	prevalent	over	 the	helical	 conformation	due	 to	 steric	hindrance,	 as	 the	 ring-like	polymer	packing	structure	provides	better	ssDNA	surface	packing	on	the	SWCNT.	We	suggest	that	the	ring-like	ssDNA	conformation	is	 likely	enhanced	by	the	fact	that	the	(GT)6	contour	 length	matches	 the	 circumference	 of	 the	 (9,4)	 SWCNT,	 affording	 ordered	 self-assembly	 of	 the	oligonucleotides	 on	 the	 SWCNT	 surface.	 On	 the	 other	 hand,	 the	 polymer	 length-SWCNT	circumference	 mismatch	 between	 (GT)6	 and	 the	 (6,5)	 SWCNT	 species	 renders	 the	 ring	configuration	less	likely	and	favors	a	helical	conformation	(Figure	4.S8a).		The	free	energy	landscape	in	Figure	4.1e	also	reveals	the	existence	of	several	local	minima,	whose	associated	structures	are	shown	in	Figure	4.S10.	However,	these	local	minima	have	higher	free	energies	
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than	the	two	structures	shown	in	Figure	4.1e	and	are	likely	to	be	sampled	less	frequently	by	the	(GT)6	polymer.		
	
Figure	 4.1	 Computational	 modeling	 of	 ssDNA-SWCNT	 nanosensor	 complexes.	 (a)	 Representative	conformation	of	(GT)15-SWCNT.	SWCNT	is	depicted	as	a	gray	surface,	(GT)15	and	its	backbone	are	shown	in	licorice	and	black	ribbon	representations,	and	ssDNA	atoms	are	shown	in	gray	(C),	red	(O),	blue	(N),	and	orange	(P).	(b)	Representative	conformation	of	(GT)6-SWCNT,	containing	three	(GT)6	polymers.	The	color	scheme	is	the	same	as	in	panel	a.	(c)	Electrostatic	potential	energy	profile	at	the	SWCNT	surface	in	the	(GT)15-SWCNT	system	as	 a	 function	of	 SWCNT	axial	 length.	The	profile	 is	 averaged	over	2	ns	 and	over	 the	 radial	SWCNT	dimension	and	includes	the	effects	of	the	complete	SWCNT	environment	present	in	MD	simulations	(ssDNA,	water,	and	ions).	(d)	Electrostatic	potential	energy	profile	at	the	SWCNT	surface	for	the	(GT)6-SWCNT	system	plotted	as	a	function	of	SWCNT	axial	length.	(e)	Free	energy	landscape	of	(GT)6-SWCNT	at	300	K.	The	structures	corresponding	to	two	free	energy	minima	are	labeled	by	indices	1	and	2.	(f)	Net	charges	of	molecular	fragments	in	 the	 (GT)2-SWCNT	 system,	 evaluated	 in	 quantum	mechanical	 calculations.	 (g)	 Net	 charges	 of	 molecular	fragments	in	the	(GT)2-SWCNT	system	with	an	adsorbed	dopamine	molecule,	evaluated	in	quantum	mechanical	calculations.	The	color	scheme	in	panels	f	and	g:	black	(DNA),	silver	(non-terminal	SWCNT	atoms),	blue	surface	(terminal	-CH	groups	capping	the	SWCNT),	yellow	(sodium	ions),	green,	blue,	red	and	white	spheres	(C,	N,	O	and	 H	 atoms	 on	 dopamine).	 (h)	 Electron	 (red)	 and	 hole	 (blue)	 probability	 densities	 in	 a	 Kronig-Penney	potential	 (Methods	 in	 Appendix	 I).	 Probability	 density	 values	 are	 labeled	 on	 the	 left	 axis,	 and	 the	 values	associated	with	the	potential	energy	well	are	labeled	on	the	right	axis.		
	 Since	 the	 charged	 (GT)6	 and	 (GT)15	polymers	have	different	 conformations	on	 the	(9,4)	 SWCNT,	 we	 reasoned	 that	 they	 should	 create	 electrostatic	 potentials	 of	 different	profiles	 close	 to	 the	 SWCNT	 surface.	 To	 investigate	 this	 phenomenon,	we	 calculated	 the	average	 electrostatic	 potential	 at	 the	 SWCNT	 surface	 generated	 by	 all	 molecules	 in	 the	system	(ssDNA,	water,	 and	 ions,	 including	 the	Na+	cations	adsorbed	over	 long	 timescales	
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within	ssDNA	pockets)	(Figures	4.S2	and	Figure	4.S3).	(GT)15	creates	regions	of	negative	and	positive	electrostatic	potential	under	the	polymer	as	a	 ‘footprint’,	which	extend	~4	nm	in	contiguous	length	and	roughly	follow	the	ssDNA	helical	pattern	(Figure	4.2a,	4.2b).	Negative	potential	pockets	are	primarily	beneath	guanine	nucleotides,	while	positive	pockets	occur	beneath	thymine	nucleotides.	When	averaged	over	the	radial	SWCNT	dimension,	as	shown	in	 Figure	 4.1c,	 the	 electrostatic	 potential	 profile	 at	 the	 SWCNT	 surface	 under	 (GT)15	 is	roughly	 constant	 across	 the	 entire	 helix,	 with	 random	 fluctuations.	 The	 electrostatic	potential	around	SWCNT	with	adsorbed	(GT)6	rings	also	follows	the	polymer,	which	results	in	distinct	ring-like	regions	of	alternating	positive	and	negative	potentials	along	the	SWCNT	axis,	where	each	contiguous	electrostatic	pocket	is	~1.5	nm	in	length	(Figure	4.2c,	4.2d).	In	contrast	 to	 (GT)15-SWCNT,	 when	 averaged	 over	 the	 radial	 SWCNT	 dimension,	 these	electrostatic	potentials	exhibit	large	periodic	oscillations	across	multiple	rings	(Figure	4.1d).	We	posit	that	from	the	perspective	of	exciton	confinement	in	the	SWCNT	quasi-1D	structure,	these	 periodic	 electrostatic	 potentials	 created	 by	 the	 (GT)6	 rings	 effectively	 form	 a	superlattice	(Figure	4.1d).		
	
	
Figure	4.2	Electrostatic	potential	pattern	at	the	SWCNT	surface	induced	by	adsorbed	ssDNA	moieties	(a)	The	extended	electrostatic	potential	pattern	at	the	SWCNT	surface	of	the	(GT)15-SWCNT	system.	Red	and	blue	regions	represent	negative	and	positive	potential	domains,	respectively.	For	clarity,	isolated	positive	and	negative	regions	are	shown	separately	on	the	right.	(b)	Plot	of	the	complete	potential	energy	surface	at	the	SWCNT	for	the	system	shown	in	panel	a.	(c)	The	localized	potential	pattern	at	the	SWCNT	surface	of	the	(GT)6-SWCNT	system.	The	color	scheme	is	as	in	panel	a.	(d)	Plot	of	the	potential	energy	surface	at	the	SWCNT	for	the	system	shown	in	panel	c.			Next,	 quantum	 mechanics/molecular	 dynamics	 (QM/MD)	 calculations	 were	performed	 to	 better	 understand	 exciton	 relaxation	 in	 the	 (GT)6-(9,4)-SWCNT	 conjugates	(Figure	4.S4).	The	SWCNT	is	polarized	by	the	presence	of	the	charged	DNA	polymer,	with	overall	 partial	 positive	 charges	 on	 the	 SWCNT	 surface	 covered	 with	 ssDNA,	 and	 partial	
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negative	charges	at	the	SWCNT	ends	(Figure	4.1f).	This	charge	distribution	can	be	seen	as	an	effective	 doping	 of	 the	 SWCNT,	 affecting	 the	 exciton	 relaxation	 processes.	 In	 QM/MD	calculations,	we	 observed	 a	 relatively	 small	 charge	 transfer	 between	 ssDNA	 and	 SWCNT	(Figure	 4.1f,	 Table	 4.S1).	 Dopamine	 adsorption	 on	 the	 DNA-wrapped	 SWCNT	 slightly	decreased	the	SWCNT	polarization	(Figure	4.1g	and	Table	4.S2).	However,	this	effect	is	only	local,	and	if	the	molarity	of	adsorbed	dopamine	molecules	is	low,	it	is	unlikely	to	effectively	alter	 the	 polarizability	 of	 a	 large	 (GT)6	 -SWCNT	 complex	 (Figure	 4.S5,	 Figure	 4.S6).	Conversely,	adsorption	of	dopamine	molecules	is	capable	of	locally	perturbing	the	periodic	electrostatic	 potential,	 which	 can	 influence	 SWCNT	 photoluminescence,	 as	 we	 discussed	below.	These	MD	and	QM/MD	results	provide	insight	into	possible	relaxation	pathways	of	excitons	 in	 the	 (GT)N-SWCNT	 complexes	 with	 and	 without	 adsorbed	 dopamine	 analyte	molecules.	 We	 thus	 propose	 the	 following	 mechanisms	 to	 explain	 the	 strong	 turn-on	response	of	(GT)6-SWCNT	nanosensors	to	dopamine:	(i)	SWCNT	polarization	induced	by	the	adsorption	 of	 multiple	 (GT)6	 polymers	 can	 give	 rise	 to	 non-radiative	 exciton	 relaxation	mechanisms,	 because	 effective	 doping	 activates	 phonon-assisted	 relaxation	 channels	 for	SWCNT	 excitons,	 as	 has	 been	 suggested	 in	 previous	 studies.	 93,94	 (ii)	 At	 the	 same	 time,	radiative	exciton	relaxation	in	a	(GT)6-(9,4)-SWCNT	complex	is	expected	to	be	significantly	suppressed	by	the	presence	of	closely-spaced	periodic	potentials	of	multiple	(GT)6	strands	(Figure	4.1d,	4.2c).	In	positive	and	negative	regions	of	this	potential,	the	electron	and	hole	wave	 function	 components	 tend	 to	 avoid	 each	 other	 (Figure	 4.1h),	 which	 results	 in	 a	significant	 cancelation	 of	 their	 overlap	 integral	 present	 in	 the	 oscillator	 strength.	 (iii)	However,	in	the	presence	of	adsorbed	dopamine	molecules,	the	cancellation	of	the	overlap	integral	 can	 be	 disturbed	 because	 dopamine	 induces	 a	 disordered	 superlattice	 (Figure	4.S7a).	 Therefore,	 radiative	 transitions	 can	 become	 active	 simultaneously	 with	 the	 non-radiative	transitions,	giving	rise	to	a	fluorescent	turn-on	nanosensor.	Adsorbed	dopamine	molecules	may	result	in	marginal	reduction	in	SWCNT	polarization	and	reduce	the	effective	doping	caused	by	the	adsorbed	(GT)6	rings.	However,	our	work	suggests	that	this	mechanism	is	 unlikely	 to	 contribute	 significantly	 to	 the	 turn-on	 response.	 We	 further	 attribute	 the	SWCNT-diameter	dependence	of	the	strong	turn-on	response	(Figure	3.1e,	Figure	3.S2)	to	two	 phenomena:	 (i)	 doping-induced	 quenching	 of	 SWCNT	 photoluminescence	 becomes	more	 efficient	 with	 increasing	 SWCNT	 diameter93,94	 and	 (ii)	 the	 ordered	 periodic	superlattice	formed	by	(GT)4-8	is	 less	 likely	to	occur	on	smaller	diameter	SWCNTs	(Figure	4.S8).	
4.3	Conclusion	In	Chapter	3,	we	reported	(GT)6-SWCNT	as	a	strong	turn-on	optical	reporter	for	the	neuromodulators	 dopamine	 and	 norepinephrine,	 with	 a	 dynamic	 range	 compatible	 with	applications	 for	 in	vivo	neurochemical	 investigations.	 In	 this	 chapter,	we	 investigated	 the	photophysical	and	molecular	underpinnings	of	this	strong	and	selective	turn-on	response	computationally.	We	employed	multi-scale	molecular	dynamics	computational	approaches	to	rationalize	several	experimental	findings.	We	find	that	the	self-assembly	of	(GT)6	ssDNA	on	the	SWCNT	surface	produces	highly	ordered	ring	structures,	which	effectively	dopes	the	SWCNT	through	polarization	and	forms	a	superlattice	from	the	perspective	of	a	1-D	confined	
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SWCNT	exciton.	The	effective	doping	activates	exciton	non-radiative	transitions,	while	the	periodic	potential	suppresses	their	radiative	relaxation.	The	baseline	SWCNT	fluorescence,	dimmed	 in	 this	manner,	 is	 enhanced	 by	 an	 analyte	 that	 binds	 selectively	 to	 the	 SWCNT	surface-adsorbed	polymer	and	perturbs	the	superlattice	to	promote	a	competitive	radiative	relaxation.	These	insights	and	results	have	important	implications	for	the	development	of	nanosensors	for	specific	biomolecular	analytes	of	interest,	for	tuning	the	dynamic	range	of	those	already	developed,	and	for	orthogonal	fields	of	research	such	as	SWCNT	purification	by	chiral	index	and	photovoltaics.	
4.4	Appendix	I	
Materials	and	Methods	
 
Molecular	dynamics	simulations	Atomistic	 simulations	 were	 conducted	 to	 investigate	 ssDNA-SWCNT	 nanosensors	with	and	without	added	dopamine	analyte.	 In	all	 simulations,	 conjugates	of	 (9,4)	SWCNT	with	(GT)15	and	(GT)6	polymers	were	prepared.	(9,4)	SWCNT	segments,	39	Å	or	66.73	Å	in	length,	were	built	in		VMD.95	Conjugates	of	(GT)6	polymers	with	two	other	SWCNTs	were	also	examined.	An	 analogous	 (9,4)	 SWCNT	 segment	 of	 the	 opposite	 handedness,	 also	 39	Å	 in	length,	 was	 built	 by	 transforming	 the	 initially	 built	 (9,4)	 SWCNT	 into	 its	 mirror	 image.	Separately,	a	(6,5)	SWCNT,	53	Å	in	length,	was	built	in		VMD.95	The	initial	configurations	of	(GT)15	and	(GT)6	ssDNA	polymers	were	built	in	Material	Studio	with	nucleotides	arranged	to	form	helical	conformations	with	radii	several	Ångstroms	wider	than	the	radius	of	the	(9,4)	SWCNT.	 The	 helical	DNAs	were	 positioned	 to	wrap	 SWCNTs,	with	 ssDNA	bases	 not	 pre-adsorbed	on	the	SWCNTs	surfaces.	The	length	of	the	SWCNT	was	selected	to	result	in	optimal	SWCNT	surface	coverage	by	the	adsorbed	(GT)15	ssDNA	via	base	stacking,	which	prevents	excessive	lateral	ssDNA	diffusion	on	SWCNT.	The	prepared	ssDNA-SWCNT	conjugates	were	solvated	with	TIP3P	water	and	neutralized	with	0.1	M	NaCl	with	solvate	and	 ionize	VMD	plugins,	 respectively.95	 In	 simulations	 of	 DNA-SWCNT	 conjugates	 with	 dopamine,	 two	dopamine	 molecules	 were	 placed	 ~10	 Å	 away	 from	 SWCNTs	 into	 pre-relaxed	 systems	prepared	without	dopamine.	The	final	systems	contained	approximately	11,000	atoms.		The	 systems	 were	 described	 with	 CHARMM36	 and	 CHARMM	 general	 force	 field	(dopamine)	parameters.96–98	MD	simulations	were	performed	with	NAMD2.11	package.99	All	simulations	were	conducted	with	Langevin	dynamics	(Langevin	constant	γLang	=	1.0	ps-1)	in	the	NpT	ensemble,	where	temperature	and	pressure	remained	constant	at	310	K	and	1	bar,	respectively.	The	particle-mesh	Ewald	(PME)	method	was	used	to	calculate	Coulomb	interaction	energies,	with	periodic	boundary	conditions	applied	in	all	directions.100	The	time	step	was	set	to	2.0	fs.	The	evaluation	of	long	range	van	der	Waals	and	Coulombic	interactions	was	performed	every	1	and	2	 time	steps,	 respectively.	After	1,000	steps	of	minimization,	solvent	molecules	were	 equilibrated	 for	 2	 ns	 around	 the	DNA	 and	 SWCNTs,	which	were	restrained	using	harmonic	forces	with	a	spring	constant	of	1	kcal/(mol	Å2).	Next,	the	systems	were	equilibrated	in	250	ns	production	MD	runs,	with	restraints	applied	only	on	the	edge	SWCNT	atoms.		To	 analyze	 the	 electrostatic	 potential	 created	 by	 the	 surroundings	 at	 the	 SWCNT	surface,	we	computed	potential	energy	maps	at	SWCNT	surfaces	for	several	configurations	
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of	 DNA-wrapped	 SWCNTs.	 In	 each	 configuration,	 selected	 from	 equilibration	 MD	trajectories,	SWCNT	and	DNA	atoms	were	restrained	with	a	hard	(1.0	kcal/mol/Å2)	and	soft	(0.1	kcal/mol/Å2)	harmonic	restraint,	respectively,	and	simulated	for	1	ns.	We	evaluated	the	potential	 energy	 map	 at	 the	 SWCNT	 surface	 by	 averaging	 electrostatic	 potential	 energy	contributions	and	Lennard-Jones	contributions	from	1	ns	simulations	of	restrained	systems.	The	electrostatic	potential	energy	of	each	SWCNT	atom	was	computed	by	setting	its	charge	to	 q	 =	 −1e	 for	 the	 purpose	 of	 evaluating	 the	 electrostatic	 potential	 energy	 (in	 1	 ns	simulations,	each	atom	had	the	charge	q	=	0).	The	average	potential	energy	of	each	carbon	atom	 in	 its	 environment	was	 evaluated	with	 the	NAMDEnergy	plugin	 in	VMD	 (each	1	ns	trajectory	resulted	in	500	potential	energy	data	points).95	
Free	energy	calculations	The	free	energy	landscape	(Figure	4.1e)	was	obtained	through	replica	exchange	MD	(REMD)	 simulation	 of	 a	 (GT)6-SWCNT	 system	 solvated	 in	 3.63	×	 3.63	×	 4.92	 nm3	 box,	containing	6,605	atoms.	The	box	 contained	1,881	water	molecules,	modeled	using	TIP3P	model.	 In	 addition	 to	Na+	 counterions	 neutralizing	 the	 system,	 36	Na+	 and	 Cl-	 ions	were	included	to	match	the	physiological	salt	concentration	in	the	experimental	system.	Periodic	boundary	conditions	were	imposed	in	all	dimensions,	and	PME	method	was	used	to	calculate	long-range	 electrostatics.	 Additionally,	 both	 ends	 of	 SWCNT	 were	 in	 contact	 with	 their	periodic	images.	Energy	minimization	and	100	ps	of	heating	(NVT)	were	performed	to	reach	the	 starting	 temperature	 of	 310	 K.	 To	 perform	 REMD	 simulations	 in	 NVT	 ensemble,	 54	replicas	and	a	290-727.4	K	temperature	range	were	chosen	to	maintain	exchange	acceptance	ratios	around	25%	with	2	ps	exchange	time.	The	total	REMD	simulation	time	was	54	×	270	ns	(per	replica)	=	14.58	µs.	The	simulation	time	step	was	2	fs	and	trajectories	were	extracted	every	2	ps.	Therefore,	135,000	configurations	per	replica	were	collected.	The	 last	80,000	(160	ns)	configurations	of	room	temperature	replica	were	analyzed	to	obtain	the	free	energy	landscape.	To	generate	the	free	energy	landscape	shown	in	Figure	4.1e,	two	independent	order	parameters	of	the	(GT)6	structure	were	calculated	from	the	obtained	system	configurations:	1)	end-to-end	distance	of	DNA	polymer	(the	z-distance	between	centers	of	mass	of	the	first	guanine	and	last	thymine	residues;	z	coordinate	aligns	with	the	long	axis	of	the	CNT);	and	2)	Root	mean	square	deviation	(RMSD)	of	phosphorous	atoms	of	the	DNA	backbone,	compared	to	 the	 configuration	 these	 atoms	 have	 in	 the	 ideal	 left-handed	 helix	 of	 (GT)6	 wrapping	SWCNT.	The	probability	distribution	function	(𝑃(𝑥, 𝑦))	of	these	two	order	parameters	were	calculated	and	combined	to	generate	free	energy	(∆𝐹(𝑥, 𝑦))	according	to	the	formula:	∆𝐹(𝑥, 𝑦)𝑘A𝑇 = − ln G𝑃(𝑥, 𝑦)𝑃HIJ K	In	above	formula,	𝑃HIJ	is	the	maximum	value	of	𝑃(𝑥, 𝑦).	Figure	4.1e	was	obtained	at	300	K	by	calculating	two-dimensional	free	energy	landscape	according	to	the	above	formula,	where	x	 and	 y	 represent	 end-to-end	 distance	 and	 the	RMSD	 of	 left-helix	 ssDNA	wrapping	 CNT,	respectively.	
QM/MD	simulations	
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Quantum	mechanics/molecular	dynamics	(QM/MD)	simulations	were	performed	for	systems	 containing	 SWCNT,	 (GT)2	 DNA,	 Na+	 counterions,	 with	 or	 without	 dopamine,	 all	described	 quantum	 mechanically,	 and	 TIP3P	 water,	 described	 classically.	 The	 systems	examined	 on	 the	 QM/MD	 level	 were	 extracted	 from	 the	 well-equilibrated	 classical	 MD	simulation	of	 the	 (GT)6–SWCNT	system	with	dopamine	 trapped	 in	binding	 site	2	 (Figure	4.S6).	 Since	 (GT)6	 can	 stably	host	Na+	 ions,	 separate	 simulations	were	performed	 for	 the	systems	with	 and	without	 the	 hosted	Na+	 ions.	 All	 extracted	 systems	were	 solvated	 and	equilibrated	 in	 2	 ns	 classical	 MD	 simulations,	 where	 all	 species,	 except	 water,	 were	restrained	 with	 the	 harmonic	 restraint	 (1.0	 kcal/mol/Å2).	 The	 initial	 configurations	 of	QM/MD	simulations	were	obtained	from	the	final	configurations	of	the	above	classical	MD	simulations,	in	which	the	water	box	was	cut	into	a	sphere	of	28	Å	radius.		The	QM/MD	simulations	were	performed	using	TeraChem	software	(Terachem).	The	quantum	parts	of	the	system	were	described	at	the	ωB97X/6-31G**	level,	with	dispersion	corrections	 (DFT-D2).101,102	We	 used	 an	 X-matrix	 tolerance	 of	 10−4,	 and	 a	wave	 function	convergence	threshold	of	10−4.	The	MD	simulations	were	performed	at	T	=	310	K,	using	the	Langevin	dynamics	with	a	damping	coefficient	of	γLang	=	1	ps−1	and	a	time	step	of	1	fs.	No	periodic	boundary	conditions	were	used;	the	system	was	simulated	within	a	water	droplet	(Figure	4.S4).	Atomic	charges	of	the	quantum	parts	of	the	systems	were	calculated	using	the	Mulliken	population	analysis.		
Electron	and	hole	wavefunctions	in	periodic	square	wells	To	 approximate	 the	 effect	 of	 periodic	 potentials	 along	 the	 SWCNT	 surface	 on	 the	exciton	relaxation,	we	examined	the	behavior	of	negatively	(electrons)	and	positively	(holes)	charged	particles’	wavefunctions	in	periodic	square	wells,	using	the	Kronig-Penney	model.	Figure	4.1h	plots	the	probability	densities	of	electrons	and	holes	(squared	wavefunctions).	The	periodic	energy	wells	are	centered	at	0	J	and	their	valleys	and	peaks	occur	at	–	1.602	x	10-20	 J	 and	1.602	 x	10-20	 J,	 respectively,	 to	 roughly	match	 the	periodic	potential	 energies	created	at	the	SWCNT	surface	by	the	ring	(GT)6	ssDNAs.	The	wavefunction	energies	were	chosen	as	–	0.641	x	10-20	J.	The	periodic	square	wells	are	1.5	nm	in	length,	also	matching	the	periodic	potential	shape	created	by	the	ring	DNAs.		
4.5	Appendix	II	
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Figure	4.S1	DNA	distribution	and	surface	coverage	on	SWCNTs.	(a)	Radial	distribution	functions	of	phosphate	groups	(P-atom)	of	(GT)15	and	(GT)6	DNAs	on	SWCNTs,	calculated	for	the	last	100	ns	of	simulations.	(b)	Contact	areas	between	DNA	strands	and	SWCNTs,	averaged	over	the	last	100	ns	of	simulations.			
	
Figure	4.S2	Residence	times	of	Na+	ions	hosted	by	(GT)15	DNAs.		(a)	Residence	times	of	Na+	ions	hosted	by	guanine	(a)	and	thymine	(b)	nucleotides	of	(GT)15	DNA	on	(9,4)	SWCNT.	The	residence	times	were	calculated	based	on	radii	of	gyration	of	selected	nucleotide	atoms	and	trapped	Na+	ions.			
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Figure	4.S3	Residence	times	of	Na+	ions	hosted	by	(GT)6	DNAs.		Residence	times	of	Na+	ions	hosted	by	guanine	nucleotides	of	(GT)6	DNA	on	(9,4)	SWCNT.	Guanine	residues	5	and	9	of	every	single	(GT)6	strand	on	SWCNT	hosted	Na+	ions	(the	system	analyzed	is	shown	in	Figure	3,	and	top,	middle	and	down	refers	to	three	(GT)6		strands).	The	residence	times	were	calculated	as	in	Figure	S9.		
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Figure	 4.S4	Representative	 systems	 examined	 in	 QM/MD	 simulations.	(a)	 (GT)2–SWCNT	 system	with	 one	hosted	 Na+	ion	 and	 three	 solution	 Na+	ions.	 (b)	 Dopamine	 (binding	 site	 2)	 in	 the	 (GT)2–SWCNT	 system,	containing	three	solution	Na+	ions.	Classically	described	water	in	the	system	is	shown	as	a	transparent	surface.	The	 atoms	 in	 the	 system	 are	 shown	 in	 yellow	 (Na),	silver	 (non-terminal	 SWCNT	 atoms),	black	 (atoms	 of	nucleotides),	blue	surface	(terminal	-CH	groups	capping	the	SWCNT),		green	(carbon	atoms	of	dopamine),	red	(O),	dark	blue	(N),	orange	(P)	and	white	(H).		
	
	
Table	 4.S1.	Net	 charges	 of	 different	 parts	 of	 SWCNT,	 SWCNT-ion,	 and	 SWCNT-DNA	 systems,	 described	 in	quantum	mechanical	calculations.	The	charge	is	reported	in	units	of	e,	the	unit	charge.	All	systems	had	SWCNT,	ions,	and	DNA	described	quantum	mechanically,	and	the	water	described	classically.	The	calculation	details	are	described	in	the	Methods	in	Appendix	I.			
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Table	4.S2.	Net	charges	of	different	parts	of	SWCNT-DNA	systems	with	and	without	the	dopamine	molecule,	described	in	quantum	mechanical	calculations.	All	the	systems	had	SWCNT,	ions,	DNA,	and	dopamine	(when	present)	 described	 quantum	mechanically,	 and	 the	water	 described	 classically.	 The	 dopamine	 binding	 site	examined	is	the	binding	site	2	of	the	(GT)6-SWCNT	system,	shown	in	Figure.	S6b.			
	
	
Figure	4.S5	Residence	times	of	dopamine	molecules	in	their	binding	sites.	(a)	Residence	times	of	dopamine	in	(GT)15-SWCNT	systems	in	binding	sites	(red)	1	and	2	(green).	(b)	Residence	times	of	dopamine	in	(GT)6-SWCNT	systems	in	binding	sites	1	(red)	and	2	(green).	Residence	times	were	calculated	by	tracking	the	radial	distance	between	the	dopamine	ring	center	of	mass	and	the	central	axis	of	SWCNT.	Dopamine	binds	more	stably	 to	(GT)15	than	to	(GT)6.	
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Figure	4.S6	Dopamine	binding	to	DNA-SWCNT	systems.	Two	representative	binding	poses	of	dopamine	(a)	in	the	(GT)15-SWCNT	system	and	(b)	in	the	(GT)6-SWCNT	system.	Atoms	of	dopamine	are	shown	in	green	(C),	red	(O),	blue	(N),	and	white	(H).	Dopamine	opens	a	space	between	consecutive	bases	of	(GT)15	and	binds	with	its	amine	group	to	the	DNA	phosphate.	The	helical	arrangement	of	nucleotides	in	(GT)15	allows	for	the	opening	of	consecutive	bases	and	dopamine	 insertion.	Conversely,	 the	ring	arrangement	of	 (GT)6	nucleotides	prevents	spreading	 of	 consecutive	 nucleotides	 (which	 would	 allow	 dopamine	 insertion),	 and	 dopamine	 primarily	interacts	with	bases	of	neighboring	(GT)6	strands	in	a	bridge-like	binding	mode.			
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Figure	4.S7	Adsorption	of	dopamine	to	(GT)6.	(a)	(GT)6	ring	structures	become	distorted	due	to	dopamine	adsorption.	 Two	 snapshots	 of	 dopamine	 adsorbed	 to	 (GT)6-wrapped	 SWCNTs,	 after	 1.6	 µs	 and	 1.9	 µs	 of	 a	classical	MD	simulation.	(GT)6	ring	structures	become	distorted	due	to	the	presence	of	dopamine	after	1.9	µs.	(b)	(GT)6	polymers	mainly	preserve	ring	structures	in	a	4.6	µs	long	MD	simulation.	(GT)6	rings	occasionally	convert	to	helical	conformations,	followed	by	returns	to	the	ring	conformations;	the	largest	changes	from	ring	conformations	are	observed	when	DNA	strands	interact	directly	with	dopamine.	The	backbones	of	three	(GT)6	strands	are	shown	over	the	course	of	a	4.6	µs	long	MD	simulation;	snapshots	were	selected	every	50	ns.	Blue,	white,	and	red	colors	of	the	(GT)6	backbone	snapshots	represent	the	beginning,	the	middle	and	the	end	of	the	trajectory.			
	
	
	
Figure	4.S8	MD	simulations	of	(GT)6	polymers	complexed	with	SWCNTs	of	different	diameter	and	handedness.	(a)	Conformations	of	 a	 (GT)6	polymer	on	a	 (6,5)	SWCNT.	The	 (GT)6	 strand	predominantly	adopts	a	helical	conformation.	(b)	Conformations	of	a	(GT)6	strand	on	a	(9,4)	SWCNT	of	an	opposite	handedness	than	the	(9,4)	SWCNT	explored	 in	Figure	3.	The	(GT)6	strand	predominantly	adopts	ring-like	conformations.	SWCNTs	are	shown	 as	 gray	 surfaces,	 backbones	 of	 (GT)6	 strand	 are	 shown	 as	 orange	 ribbons.	 Backbones	 of	 (GT)6	 are	aligned,	and	80	conformations,	assumed	every	2	ns	in	MD	simulations,	are	overlaid.	The	conformations	shown	represent	the	dynamics	of	(GT)6	in	160	ns	MD	trajectories.			
	
	
Figure	4.S9	(GT)6	spontaneously	assumes	a	ring-like	conformation	on	a	(9,4)	SWCNT	in	five	independent	200	ns	long	MD	simulations.	
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Figure	4.S10	Free	energy	landscape	of	(GT)6-SWCNT	at	300	K	on	the	(9,4)	SWCNT	species.	The	conformations	associated	with	various	free	energy	minima	and	a	transition	state	are	labeled	by	indices	1-6.	The	state	labeled	by	index	3	marks	the	transition	state	between	free	energy	minima	labeled	by	indices	1	and	2.														
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Chapter	5	
Imaging	Striatal	Dopamine	Release	Using	a	Single	Wall	Carbon	
Nanotube-Based	Fluorescent	Catecholamine	Indicator	
Portions	of	this	chapter	are	reproduced	from	Ref	103	under	a	creative	commons	license.103	CC	
BY-NC	4.0.	Copyright	2019.	American	Association	for	the	Advancement	of	Science.			 Neuromodulation	plays	a	critical	role	 in	brain	 function	 in	both	health	and	disease.	New	 optical	 tools	 are	 needed	 that	 can	 image	 neuromodulation	 with	 high	 spatial	 and	temporal	 resolution,	 which	 will	 add	 an	 important	 new	 dimension	 of	 information	 to	neuroscience	research.	Here,	we	demonstrate	the	use	of	a	catecholamine	nanosensor	with	fluorescent	 emission	 in	 the	 1000-1300	 nm	 near-infrared	window	 to	measure	 dopamine	transmission	 in	 brain	 tissue.	 These	 near-infrared	 catecholamine	 nanosensors	 (nIRCats)	represent	 a	 broader	 class	 of	 nanosensors	 that	 can	 be	 synthesized	 from	 non-covalent	conjugation	of	single	wall	carbon	nanotubes	(SWCNT)	with	single	strand	oligonucleotides.	We	show	that	nIRCats	can	be	used	to	detect	catecholamine	efflux	in	brain	tissue	driven	by	both	electrical	stimulation	or	optogenetic	stimulation.	Spatial	analysis	of	electrically-evoked	signals	 revealed	 dynamic	 regions	 of	 interest	 approximately	 2	 microns	 in	 size	 in	 which	transients	 scaled	 with	 simulation	 intensity.	 Optogenetic	 stimulation	 of	 dopaminergic	terminals	 produced	 similar	 transients,	whereas	 optogenetic	 stimulation	 of	 glutamatergic	terminals	 showed	 no	 effect	 on	 nIRCat	 signal.	 Bath	 application	 of	 nomifensine	 prolonged	nIRCat	fluorescence	signal,	consistent	with	reuptake	blockade	of	dopamine.	We	further	show	that	 the	 chemically	 synthetic	 molecular	 recognition	 elements	 of	 nIRCats	 permit	measurement	of	dopamine	dynamics	in	the	presence	of	dopamine	D2	receptor	agonists	and	antagonists	which	 revealed	 heterogeneity	 in	 D2	 autoreceptor	modulation	 of	 presynaptic	dopamine	 release.	 These	 nIRCat	 nanosensors	 are	 advantageous	 because	 i)	 they	 do	 not	require	gene	delivery	or	protein	expression,	ii)	their	near-infrared	fluorescence	facilitates	imaging	 in	optically	 scattering	brain	 tissue	and	 is	 compatible	 for	use	 in	 conjunction	with	other	optical	neuroscience	tool	sets,	iii)	the	broad	availability	of	unique	near-infrared	colors	have	the	potential	for	simultaneous	detection	of	multiple	neurochemical	signals,	and	iv)	they	are	 compatible	 with	 pharmacology.	 Together,	 these	 data	 suggest	 nIRCats	 and	 other	nanosensors	 of	 this	 class	 can	 serve	 as	 versatile	 new	 optical	 tools	 to	 report	 dynamics	 of	extracellular	neuromodulation	in	brain	tissue.	
5.1	Introduction	The	catecholamines	dopamine	and	norepinephrine	are	neuromodulators	known	to	play	 an	 important	 role	 in	 learning	 and	 attention	 and	 are	 implicated	 in	 multiple	 brain	disorders.	 104–108	Dopamine,	 in	 particular,	 is	 thought	 to	 play	 a	 critical	 role	 in	 learning109,	motivation	110,111,	and	motor	control	112,	and	aberrations	in	dopamine	neurotransmission	are	implicated	in	a	wide	range	of	neurological	and	psychiatric	disorders	including	Parkinson’s	disease	113,	schizophrenia	114,	and	addiction.	115		
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Modulatory	neurotransmission	 is	 thought	 to	occur	on	a	broader	spatial	 scale	 than	classic	neurotransmission,	the	latter	of	which	is	largely	mediated	by	synaptic	release	of	the	amino	acids	glutamate	and	γ-aminobutyric	acid	(GABA)	 in	the	central	nervous	system.	 In	synaptic	glutamatergic	and	GABAergic	neurotransmission,	neurotransmitter	concentrations	briefly	 rise	 in	 the	 synaptic	 cleft	 to	 mediate	 local	 communication	 between	 the	 pre-	 and	postsynaptic	 neurons	 through	 the	 rapid	 activation	 of	 ligand-gated	 ion	 channels.116	 In	contrast,	 neuromodulators	 (catecholamines,	 neuropeptides)	 may	 diffuse	 beyond	 the	synaptic	cleft	and	act	via	extrasynaptically-expressed	metabotropic	receptors.15,29,30,117–119	Thus,	modulatory	neurotransmitter	 activity	 extends	beyond	 single	 synaptic	partners	 and	enables	 small	 numbers	 of	 neurons	 to	modulate	 the	 activity	 of	 broader	 networks.120	 The	absence	of	 direct	 change	 in	 ionic	 flux	 across	 cell	membranes,	which	 is	measurable	using	available	tools	like	electrophysiology	or	genetically	encoded	voltage	indicators	(GEVIs),	has	necessitated	the	use	of	methods	borrowed	from	analytical	chemistry	such	as	microdialysis	and	 amperometry	 to	 study	 the	 dynamics	 of	 neuromodulation.	 However,	 the	 spatial	limitations	 of	 fast-scan	 cyclic	 voltammetry	 and	 spatial	 and	 temporal	 limitations	 of	microdialysis	limited	our	ability	to	interpret	how	neuromodulators	affect	the	plasticity	or	function	of	individual	neurons	and	synapses.	To	understand	how	neuromodulation	 sculpts	 brain	 activity,	we	 sought	 to	develop	new	tools	that	can	optically	report	modulatory	neurotransmitter	concentrations	in	the	brain	extracellular	 space	 (ECS)	 in	 a	 manner	 that	 is	 compatible	 with	 pharmacology	 and	 other	available	tools	to	image	neural	structure	and	activity.	To	this	end,	we	designed	a	synthetic	optical	probe	 that	can	report	extracellular	catecholamine	dynamics	with	high	spatial	and	temporal	 fidelity	 within	 a	 unique	 near-infrared	 spectral	 profile.	 Near-infrared	 (nIR)	fluorescent,	polymer-functionalized	semiconducting	single	wall	carbon	nanotubes	provide	a	versatile	platform	for	optical	probe	synthesis	to	image	a	diverse	set	of	biomolecular	analytes	57,73,92.	 In	 this	 work,	 we	 describe	 the	 design,	 characterization,	 and	 implementation	 of	 a	nanoscale	near-infrared	non-genetically	 encoded	 fluorescent	 reporter	 that	 allows	precise	measurement	of	 catecholamine	dynamics	 in	brain	 tissue.	This	 technology	makes	use	of	a	single	 wall	 carbon	 nanotube	 (SWCNT)	 non-covalently	 functionalized	 with	 single	 strand	(GT)6	 oligonucleotides	 to	 form	 the	 near-infrared	 catecholamine	 nanosensor	 (nIRCat).	nIRCats	 respond	 to	 dopamine	 with	 ΔF/F	 of	 up	 to	 24-fold	 in	 the	 fluorescence	 emission	window	of	1000-1300	nm	51,	 a	wavelength	 range	 that	has	 shown	utility	 for	non-invasive	through-skull	imaging	in	mice.	63	First,	 we	 show	 in	 vitro	 characterization	 of	 the	 nanosensor’s	 specificity	 for	 the	catecholamines	dopamine	and	norepinephrine,	and	demonstrate	its	relative	insensitivity	to	the	neurotransmitters	GABA,	glutamate,	and	acetylcholine	as	well	as	the	neuromodulators	histamine,	 serotonin,	 tyramine	 and	 octopamine.	 Second,	 we	 demonstrate	 that	 nIRCats	exhibit	a	fractional	change	in	fluorescence	that	has	the	dynamic	range	and	signal-to-noise	ratio	to	report	dopamine	efflux	in	response	to	brief	electrical	or	optogenetic	stimulation	of	dopaminergic	terminals.	Next,	we	use	optogenetic	stimulation	to	demonstrate	selectivity	of	the	nIRCat	nanosensor	response	to	dopaminergic	over	glutamatergic	terminal	stimulation.	In	both	stimulation	contexts,	we	show	that	bath	application	of	D2-type	dopamine	receptor	antagonist	sulpiride	and	agonist	quinpirole	modulates	nIRCat	signals	in	a	manner	consistent	with	 predicted	 effects	 of	 presynaptic	 D2	 autoreceptor	 manipulation.	 These	 latter	experiments	 can	 resolve	 previously	 undetectable	 heterogeneity	 in	 D2	 autoreceptor	modulation	 of	 presynaptic	 dopamine	 release	 upon	 exposure	 to	 sulpiride	 or	 quinpirole.	
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Finally,	we	 show	 that	 the	 presence	 of	 a	 dopamine	 reuptake	 inhibitor	 yields	 a	 prolonged	nIRCat	fluorescent	signal	indicating	that	the	sensors	report	a	change	in	the	time	course	of	dopamine	diffusion	and	reuptake	in	striatal	brain	tissue.	These	data	indicate	that	nIRCats	provide	a	unique	synthetic	tool	compatible	with	pharmacology	to	 interrogate	the	release,	diffusion,	and	reuptake	of	neuromodulators	in	neural	tissue.	
5.2	Results	and	Discussion	
A	near	infrared	dopamine	and	norepinephrine	nanosensor	
	 We	 report	 near-infrared	 fluorescent	 catecholamine	 nanosensors	 (nIRCats)	 that	enable	 imaging	 of	 synaptic	 and	 extrasynaptic	 catecholamines	 and	 their	 release	 and	 re-uptake	 dynamics	 in	 the	 ECS	 of	 brain	 tissue.	 Using	 a	 previously	 established	 nanosensor	generation	platform,	46,60	synthetic	bio-mimetic	polymers	were	pinned	onto	the	surface	of	intrinsically	near-infrared	fluorescent	SWCNTs.	The	resulting	non-covalent	nanometer-scale	conjugate	produced	the	catecholamine-selective	nIRCat	(Figure	5.1a).	 	 In	 in	vitro	 solution	phase	 experiments	 (Methods	 in	 Appendix	 I),	 nIRCats	 exhibited	 a	 chirality-dependent	maximal	change	in	fluorescence	(ΔF/F)	of	up	to	24	(Figure	5.1b,	5.1c)	with	a	dynamic	range	spanning	4	orders	of	magnitude,	reporting	detectable	fluorescence	changes	from	10	nM	to	100	 µM	 dopamine	 concentration	 (Figure	 5.S1a).	 nIRCats	 were	 also	 sensitive	 to	norepinephrine	 with	 a	 maximal	 response	 of	 ∆F/F=35	 and	 a	 similar	 dynamic	 range.	 We	further	found	that	nIRCats	had	a	~3-fold	higher	affinity	for	dopamine	over	norepinephrine	(Figure	5.S1a).	nIRCats	were	insensitive	to	GABA,	glutamate,	and	acetylcholine	(Figure	5.1c)	and	could	report	fluctuations	in	dopamine	concentration	in	the	presence	of	ascorbic	acid,	which	 is	 present	 in	 cerebrospinal	 fluid	 (Figure	 5.S1b).	 nIRCats	 were	 also	 insensitive	 to	octopamine	 and	 tyramine,	 biogenic	 amines	 that	 act	 as	 neurotransmitters	 within	invertebrates	(Figure	5.1c,	5.S1	c	and	5.S1d),	and	differ	from	dopamine	by	a	single	hydroxyl	group	 in	 the	case	of	 tyramine,	or	 the	placement	of	a	single	hydroxyl	group	 in	 the	case	of	octopamine	 (Figure	5.S1c,	 5.S1d).	 Single-molecule	 imaging	 revealed	 that	 nIRCat	 signal	 in	response	to	repeated	perfusions	of	10	µM	dopamine	was	reversible,	an	important	feature	for	measuring	 neuromodulator	 transients	 (Figure	 5.S2).	 In	 previous	 work,	 we	 performed	stochastic	 simulations	 that	 suggest	 nIRCats	 have	 sufficient	 sensitivity	 to	 detect	physiologically	relevant	fluctuations	in	dopamine	concentration	in	brain	tissue	arising	from	the	activity	of	a	single	dopaminergic	terminal,	which	can	briefly	exceed	concentrations	of	1	µM	from	the	release	site	in	a	distance-dependent	manner.	5					
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Figure	5.1	Synthesis	and	testing	of	near-infrared	catecholamine	nanosensors	(nIRCats).	(a)	Schematic	of	optical	catecholamine	reporters,	nIRCats.	Pristine	SWCNT	are	 functionalized	with	(GT)6	oligonucleotides	 to	generate	turn-on	optical	reporters	for	dopamine	(DA)	and	norepinephrine	(NE)	(b)	Fluorescence	spectra	of	nIRCats	before	(black)	and	after	(red)	addition	of	10	µM	of	dopamine	in	an	in	vitro	preparation	in	phosphate	buffered	saline	(without	tissue).	Multiple	emission	peaks	correspond	to	unique	SWCNT	chiralities	contained	within	the	multi-chirality	mixture.	(c)	Nanosensor	optical	response	to	100	µM	dopamine	(DA),	norepinephrine	(NE),	glutamate	(GLU),	γ-aminobutyric	acid	(GABA),	acetylcholine	(ACH),	serotonin	(5-HT),	histamine	(HIST),	octopamine	(OCT)	and	tyramine	(TYR)	(data	from	 in	vitro	testing).	Black	bars	represent	averages	from	n=3	independent	measurements	and	error	bars	are	calculated	as	standard	deviations	of	the	n=3	measurements.		
Imaging	of	electrical	stimulation-evoked	dopamine	release	in	striatal	brain	tissue		 To	determine	the	efficacy	of	nIRCats	for	imaging	dopamine	in	brain	tissue,	we	used	brain	slices	from	the	dorsal	striatum	of	the	mouse.	Given	that	the	dorsal	striatum	is	densely	innervated	by	dopaminergic	projections	from	the	substantia	nigra	pars	compacta	(SNc)	but	lacks	innervation	from	neurons	that	release	norepinephrine	(NE)	121,	we	leveraged	nIRCats	capacity	to	serve	as	a	dopamine	sensor	in	the	striatum.	The	majority	of	neurons	within	the	striatum	 are	 GABAergic	 medium	 spiny	 neurons	 (MSNs)	 with	 a	 minority	 fraction	 of	interneuron	 populations	 that	 include	 GABAergic	 and	 cholinergic	 interneurons.8	Glutamatergic	inputs	from	the	cortex	and	thalamus	are	the	major	drivers	of	MSN	activity	and	dopaminergic	terminals	in	close	proximity	to	these	inputs	are	thought	to	play	an	important	role	 in	modulating	 the	 activity	 of	MSNs	 and	 plasticity	 at	 striatal	 synapses.122	 Due	 to	 the	
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composition	 of	 local	 axons,	 intrastriatal	 electrical	 stimulation	 is	 predicted	 to	 drive	 the	release	 of	 a	 mix	 of	 neurotransmitter	 including	 GABA,	 glutamate,	 acetylcholine,	 and	dopamine,	but	negligible	amounts	of	other	catecholamines	like	norepinephrine.		Coronal	mouse	brain	 slices	were	prepared	 as	 described	previously.123	 Slices	were	subsequently	incubated	with	artificial	cerebrospinal	fluid	(ACSF)		containing	2	mg/L	nIRCats	for	15	minutes	to	enable	sensors	to	diffuse	into	the	brain	tissue	(Figure	5.S3a).	Slices	were	subsequently	rinsed	to	remove	excess	nIRCats	and	incubated	in	standard	ACSF	for	another	15	minutes	before	imaging.	Imaging	of	nIRCat	fluorescence	modulation	in	dorsal	striatum	was	accomplished	with	a	custom-built	visible	and	near-infrared	microscope	to	enable	serial	imaging	 of	 both	 visible	 (400	 nm	 –	 750	 nm)	 and	 near-infrared	 (750	 nm	 –	 1700	 nm)	wavelengths	on	the	same	detector	(Figure	5.S3b).	The	 loading	protocol	enabled	even	and	widespread	labeling	of	the	coronal	slices	containing	the	dorsal	striatum	(Figure	5.S3c).	Using	this	 method,	 Godin	 et	 al.	 47	 have	 found	 SWCNTS	 localize	 in	 extracellular	 space.	 For	 the	imaging	procedure,	a	785	nm	laser	for	excitation	of	nIRCats	or	mercury	bulb	for	generating	brightfield	 images	were	directed	onto	 the	back	 focal	 plane	of	 an	 epifluorescence	upright	microscope,	 and	 imaging	 channels	 were	 selected	 using	 a	 sliding	 mirror.	 Serially,	 either	brightfield	 or	 near-infrared	 images	 were	 collected	 on	 a	 Ninox	 Vis-SWIR	 640	 broadband	camera	(Raptor	Photonics)	with	appropriate	dichroic	filters	(Methods	in	Appendix	I)	and	a	60X	water	dipping	objective	(Nikon)	providing	an	imaging	field	of	178	µm	by	142	µm,	likely	containing	hundreds	of	dopaminergic	terminals.	To	 investigate	 striatal	 neuromodulator	 release	 with	 temporal	 control	 of	 tissue	stimulation,	we	used	a	bipolar	stimulating	electrode	to	evoke	terminal	release	within	 the	dorsomedial	 striatum	of	 the	mouse	 (stimulus	 protocol:	 3	millisecond	wide	 single	 square	pulses	 over	 5	 biological	 replicates).	We	 found	 a	 single	 pulse	 could	 elicit	 a	 nIRCat	 signal	transient	(Figure	5.2a),	and	that	increasing	the	strength	of	the	stimulus	led	to	larger	evoked	changes	in	nIRCat	DF/F	signal,	(ΔF/F)max	0.1	mA	=	0.047	±	0.025;	0.3	mA	=	0.122	±	0.026;	and	0.5	mA	=	0.2	±	0.033;	mean	±	s.	d.,	n=5	for	all	measurements,	p=0.008	between	0.1	mA	vs.	0.3	mA,	p=0.008	between	0.3	mA	vs.	0.5	mA)	(Figure	5.2b).		Similar	responses	were	additionally	obtained	 in	an	ex	vivo	 slice	of	a	previously	wild-caught	species	of	mouse	(Mus	spicilegus)	(Figure	5.S4a,	5.S4b).	We	included	this	species	in	order	to	illustrate	the	potential	of	this	tool	for	 use	 in	 species	 not	 typically	 found	 in	 laboratories,	 and	 in	 which	 surgical	 or	 genetic	manipulation	may	be	a	barrier	to	measurement.		To	 further	 test	 if	 evoked	 nIRCat	 signals	 in	 the	 mouse	 tracked	 striatal	 dopamine	release	 and	 reuptake	 kinetics,	 we	 investigated	 the	 effect	 of	 nomifensine,	 a	 dopamine	reuptake	 inhibitor	 that	 slows	 the	 clearance	 of	 dopamine	 from	 the	 ECS	 by	 competitively	binding	to	dopamine	transporters	(DATs).	Addition	of	10	µM	nomifensine	to	the	bath	yielded	nIRCat	signal	with	higher	peak	fluorescence	modulation	((∆F/F)max	=	0.108	±	0.029	vs.	0.189	±	0.023;	mean	±	s.	d.,	n=3,	p=0.0178)	and	a	prolonged	fluorescent	signal	compared	to	signals	obtained	in	ACSF	from	the	same	field	of	view	(decay	time	constant,	t=2.43		±	0.24	s	vs.	10.95		±	 1.15	 s;	 mean	 ±	 s.	 d.,	 n=3,	 p=0.0002)	 	 (Figure	 5.2a	 top	 vs.	 bottom	 row,	 Figure	 5.2c).	Application	 of	 0	mM	 extracellular	 Ca2+	ACSF	 abolished	 detectable	 nIRCat	 responses	 (P	 <	0.0001	relative	 to	2.5	mM	Ca2+	ACSF),	whereas	4	mM	Ca2+	significantly	enhanced	evoked	∆F/F	transients	(p	<	0.0001)	(Figure	5.2d),	confirming	that	nIRCat	signals	reflect	a	calcium	dependent	process.	
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Figure	5.2	Imaging	and	spatiotemporal	analysis	of	dopamine	release	evoked	by	electrical	stimulation	
in	 striatal	 tissue.	 (a)	 Repeat	 images	 of	 the	 same	 field	 of	 view	 and	 ΔF/F	 of	 nIRCat	 signal	 after	 electrical	stimulation	 of	 0.3	 mA	 in	 standard	 ACSF	 (top	 row)	 and	 in	 ACSF	 plus	 10	 µM	 nomifensine	 (bottom	 row,	+Nomifensine).	 Three	 example	 still	 frames	 are	 presented:	 “Pre”	 is	 before	 electrical	 stimulation	 is	 applied,	“Stim”	represents	frame	corresponding	to	peak	∆F/F	following	stimulation,	and	“Post”	is	a	frame	after	nIRCat	fluorescence	has	returned	to	baseline.	Scale	bars	=	10	µm.	(b)	Nanosensor	fluorescence	modulation	scaled	with	single	pulse	electrical	 stimulation	amplitudes.	Field	of	view	mean	 traces	and	standard	deviation	bands	are	presented	for	three	stimulation	amplitudes	of	0.1	mA,	0.3	mA,	and	0.5	mA	(c)	Time	traces	of	∆F/F	for	0.3	mA	single	pulse	stimulation	in	standard	ACSF	(red)	and	in	ACSF	plus	10	µM	nomifensine	(purple,	+NOMF).	Mean	traces	with	standard	deviation	bands	are	presented.	(d)	nIRCat	∆F/F	responses	are	abolished	in	0	mM	Ca2+	ACSF	and	vary	with	extracellular	 [Ca2+].	 (e)	A	single	 frame	 from	a	 time	series	gathered	 in	 the	dorsomedial	striatum	showing	the	entire	field	of	view,	overlaid	with	ROIs	identified	using	per-pixel	∆F/F	stack	projections	of	nIRCat	fluorescence	modulation	(Methods	in	Appendix	I).	Color	bar	represents	nIRCat	labeling	fluorescence	
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intensity.	 Scale	bar	=	20	µm.	 (f)	 Frequency	histogram	of	ROI	 sizes	depicted	 in	 (e),	 exhibiting	 a	 log-normal	distribution	with	median	ROI	size	of	2	µm.	(g)	A	higher	magnification	view	of	an	ROI	with	an	effective	radius	of	5	µm.	Maximum	∆F/F	projection	of	the	ROI	shows	presence	of	smaller	fluorescence	hotspots	within	the	ROI.	Scale	bar	=	5	µm.	(h)	Overlay	of	representative	normalized	FSCV	(gray)	and	nIRCat	(blue)	traces	showing	that	nIRCat	ROI	signals	exhibit	heterogeneity	in	decay	kinetics.	Inset:	An	example	of	nIRCat	experimental	data	(blue	dots)	 fitted	 to	 first	 order	 decay	 kinetics	 (red	 line)	 to	 compute	 decay	 time	 constants	 (t).	 (i)	 Normalized	frequency	histogram	of	t’s	computed	from	FSCV	and	nIRCat	individual	ROI	time	traces.	Data	from	n=	4	fields	of	view	representing	n=2	biological	replicates	were	pooled.	Medians	of	each	distribution:	nIRCats	t	=	1.1	s	and	FSCV	t	=	0.4	s.		
	 To	 identify	 nIRCat	 fluorescence	 change	 hotspots	 (i.e.,	 regions	 of	 high	 ∆F/F),	 we	analyzed	 our	 video-rate	 acquisitions	 using	 a	 custom-built	 program	 that	 accounted	 for	background	fluorescence	and	identified	regions	with	fluctuations	in	fluorescence	intensity	in	the	post-stimulation	epoch	(Methods	in	Appendix	I).	We	defined	nIRCat	∆F/F	hotspots	as	regions	 of	 interest	 (ROIs)	 based	 on	 a	 per-pixel	 stack	 projection	 of	 maximal	∆F/F	 in	 the	imaging	time	series.	Using	data	from	single	pulse	electrical	stimulation	experiments,	we	used	custom	software	that	 identified	ROIs	whose	sizes	varied	from	1	µm	to	15	µm,	with	a	 log-normal	distribution	and	a	median	ROI	size	of	2	µm	(Figure	5.2e,	5.2f).	Repeat	stimulations	with	the	same	stimulation	amplitude	 in	 fields	of	view	of	 the	dorsomedial	striatum	across	biological	replicates	generated	similar	size	distributions	(Figure	5.S5	a).	We	found	that	∆F/F	hotspots	do	not	necessarily	correspond	to	high	nIRCat	labeling	of	the	brain	tissue,	suggesting	that	the	hotspots	are	a	consequence	of	variation	in	dopamine	release	and	not	nanosensor	loading	in	the	tissue	(Figure	5.S5	b	-	f).	Closer	examination	of	several	larger	ROIs	(>	5µm)	suggested	these	may	be	comprised	of	smaller	hot-spots	in	close	proximity	(Figure	5.2g	and	Figure	5.S5b,	5.S5c).	For	 further	 examination	 of	 the	 temporal	 resolution	 of	 nIRCats,	 we	 compared	 the	temporal	profile	of	evoked	transients	measured	with	nIRCats	to	transients	measured	with	fast	 scan	 cyclic	 voltammetry	 (FSCV).	 FSCV	 is	 a	 technique	 that	 has	 been	 widely	 used	 to	measure	temporal	catecholamine	dynamics	both	in	vivo	and	in	vitro	in	the	striatum	and	other	brain	areas	124–126.	FSCV	and	nIRCat	experiments	were	conducted	on	separate	experimental	rigs	with	the	same	solutions,	temperature	settings,	electrodes,	and	stimulation	parameters.	Evoked	 transients	measured	with	 FSCV	 (Figure	 5.S5g)	 and	nIRCat	 fluorescence	 emission	showed	comparable	temporal	profiles	in	the	rising	phase	(latency	to	peak:	FSCV	=	0.25	±	0.0	s	vs.	nIRCat	=	0.40	±	0.18	 s;	mean	±	 s.	d.,	 n=4	 fields	of	 view	 from	2	biological	 replicates,	p=0.23).	Meanwhile,	nIRCat	signals	exhibited	a	wider	diversity	of	decay	kinetics	(t:	FSCV	=	0.51	±	0.08	s	vs.	nIRCats	=	2.43	±	0.24	s;	mean	±	s.	d.	n=4	fields	of	view	from	2	biological	replicates,	p=0.0002).	A	subset	of	ROIs	exhibited	decay	time	constants	that	overlapped	with,	or	were	faster	than,	those	of	FSCV	signals	(Figure	5.2h,	5.2i).				
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Figure	5.3	Imaging	dopamine	release	in	the	presence	of	dopamine	receptor	agonists	and	antagonists.	(a)	In	vitro	solution	phase	maximal	∆F/F	(amplitude	change	at	~1128	nm)	of	nIRCat	in	presence	of	100	µM	dopamine	 (DA),	 the	dopamine	 receptor	drugs	 sulpiride,	haloperidol	 (DRD2	antagonists),	quinpirole	 (DRD2	agonist),	 and	 SCH	 23390	 (DRD1	 antagonist),	 and	 dopamine	 receptor	 drugs	 +	 DA.	 Addition	 of	 1	 µM	 drug	quantities	did	not	induce	nIRCat	fluorescence	modulation	in	the	absence	of	DA	(p	<	0.0001	compared	to	DA	
∆F/F).	 Subsequent	 addition	 of	 DA	 to	 drug-incubated	 nIRCat	 solutions	 produced	 ∆F/F	 responses	indistinguishable	from	DA-only	responses.	Error	bars	represent	standard	deviations	from	n=3	measurements	(b)	 Top:	 a	 schematic	 of	 the	 effect	 of	 D2R	 agonist	 and	 antagonist	 drugs	 on	 dopamine	 release.	 Quinpirole	suppressed	 nIRCat	 fluorescence	modulation	 (p<0.0001),	 whereas	 sulpiride	 facilitated	 nIRCat	 fluorescence	(p=0.001)	 in	n=3	biological	 replicates.	 Individual	data	points	represent	(∆F/F)max	 ratio	of	 the	average	 trace	collected	in	same	field	of	view	(post-drug	application/pre-drug	application).	(c,	d)	In	brain	slice,	quinpirole	(1	µM)	suppressed	nIRCat	fluorescence	modulation	in	response	to	a	single	electrical	pulse	(0.5	mA,	3	ms)	(red	trace)	compared	to	pre-drug	ACSF	(black	trace)	but	recovered	following	drug	wash-out	(purple	and	orange	traces).	(e,	f)	Sulpiride	(1	µM)	enhanced	nIRCat	fluorescence	modulation	in	response	to	single	electrical	pulse	stimulation,	yielding	brighter	nIRCat	∆F/F	hotspots	compared	to	drug-free	ACSF.	Scale	bars	=	10	µm.	All	error	bands	(c,	e)	represent	standard	deviation	from	the	mean	trace.			 We	 next	 evaluated	 the	 ability	 of	 nIRCats	 to	 detect	 dopamine	 in	 the	 presence	 of	dopamine	receptor	drugs.	First	using	in	vitro	solution	phase	experiments	(without	biological	
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tissue),	we	found	that	nIRCat	fluorescence	intensity	was	not	modulated	by	exposure	to	1	µM	concentration	of	D2R	antagonists	sulpiride,	haloperidol,	the	D2R	agonist	quinpirole,	or	the	D1R	antagonist	SCH-23390	(Figure	5.3a).	Furthermore,	with	these	 in	vitro	solution	phase	experiments,	 we	 showed	 that	 dopamine-induced	 nIRCat	 fluorescence	 signals	 were	 not	altered	in	the	presence	of	these	same	dopamine	receptor	drugs.	These	data	confirmed	that	nIRCats	retained	their	functionality	in	the	presence	of	drugs	that	serve	as	dopamine	agonists	and	antagonists	(Figure	5.3a).		We	next	moved	to	brain	slice	where	presynaptic	dopamine	autoreceptors	are	known	to	play	a	critical	role	in	regulating	dopamine	release.	In	the	dorsal	striatum	of	acute	slices	from	n=3	biological	replicates,	we	found	that	a	dopamine	D2R	agonist	suppressed	nIRCat	transients	while	a	D2R	antagonist	enhanced	them	(Figure	5.3b).	Application	of	quinpirole	(1	µM)	 suppressed	 nIRCat	 fluorescent	 transients	 in	 response	 to	 single	 electrical	 pulse	stimulation	 which	 recovered	 following	 15-minute	 drug	 wash-out	 (Figure	 5.3c,	 5.3d).	Conversely,	application	of	sulpiride	(1	µM)	significantly	increased	nIRCat	∆F/F	(Figure	5.3e,	5.3f).	Importantly,	the	effects	of	these	agonists	and	antagonists	were	present	in	ex	vivo	brain	tissue	while	they	were	absent	in	in	vitro	solution	phase	experiments	above.	Our	results	are	therefore	consistent	with	powerful	inhibition	of	presynaptic	dopamine	release	by	the	D2R	agonist	quinpirole	and	facilitation	of	presynaptic	dopamine	release	by	the	D2R	antagonist	sulpiride.		
	
	
	
Figure	5.4	Effects	of	quinpirole	and	sulpiride	on	nIRCat	response	at	 the	 level	of	ROIs	 (4	microns	or	
smaller).	(a)	∆F/F	of	ROIs	in	ACSF	and	in	ACSF	with	0.25	µM	and	1	µM	of	quinpirole.	Each	∆F/F	data	point	corresponding	 to	 an	 ROI	 is	 an	 average	 from	 n=3	 stimulation	 repeats.	 (b)	Distribution	 of	 nIRCat	 response	attenuation	upon	addition	of	0.25	µM	(blue)	or	1µM	(red)	quinpirole	for	ROIs	in	(a).	(c)	Scatter	plot	of	response	
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to	drug	vs.	pre-drug	∆F/F	amplitude	for	data	in	(a).	(d)	∆F/F	of	ROIs	in	ACSF	and	following	addition	of	1	µM	of	sulpiride.	 Each	∆F/F	 data	 point	 corresponding	 to	 an	 ROI	 is	 an	 average	 from	n=3	 stimulation	 repeats.	 	 (e)	Distribution	of	post-to-pre	drug	∆F/F	ratio	for	data	in	(d).	(f)	Scatter	plot	of	response	to	drug	vs.	pre-drug	∆F/F	amplitude	for	data	in	(d).	For	(a)	and	(d),	means	and	error	bars	(standard	deviation)	are	presented	next	to	each	distribution.		 Optical	 recording	capability	and	nanoscale	size	of	nIRCats	enables	 investigation	of	dopamine	dynamics	and	pharmacological	manipulation	with	higher	spatial	resolution	than	can	be	achieved	using	other	tools.	Therefore,	we	next	examined	the	effects	of	quinpirole	and	sulpiride	on	individual	ROIs	(Methods	in	Appendix	I).	We	also	used	an	intermediate	dose	to	provide	 greater	 information	 about	 differential	 dose	 response.	 We	 again	 used	 electrical	stimulation	 in	 the	dorsal	 striatum	 to	drive	dopamine	 release	 and	 compared	 the	 effect	 of	quinpirole	before	and	after	bath	application	of	the	drug.	We	focused	on	ROIs	4	microns	or	smaller	to	capture	the	majority	of	ROIs	while	excluding	the	long	tail	of	larger	ROIs	that	are	likely	to	contain	many	dopaminergic	synapses	(Figure	5.2	f,	5.2g).	Averaging	all	active	ROIs	4	microns	or	smaller,	a	high	(1	µM)	concentration	of	quinpirole	yielded	post-drug	to	pre-drug	∆F/F	 amplitude	 ratio	 of	 0.48	 ±	 0.35	 (Figure	 5.4a,	 5.4b).	 	 A	 lower	 concentration	 of	quinpirole	(0.25	µM)	resulted	in	an	amplitude	ratio	of	0.91	±	0.36	(mean	±	s.	d.	of	n=150	ROIs	identified	within	 the	 field	 of	 view)	 (Figure	 5.4a,	 5.4b).	We	 repeated	 the	 experiment	 and	analysis	 with	 bath	 application	 of	 sulpiride	 (1	 µM)	 and	 observed	 a	 sulpiride-induced	amplitude	ratio	of	2.34	±	1.3	(mean	±	s.	d.	of	n=150	ROIs	within	field	of	view)	(Figure	5.4d,	5.4e).	 Analyses	of	 individual	ROIs	 (all	 smaller	 that	4	µm)	 	 revealed	heterogeneity	 in	ROI	responses	upon	bath	application	of	 either	quinpirole	or	 sulpiride.	Notably,	 application	of	quinpirole	preferentially	suppressed	ROIs	that	exhibited	higher	∆F/F	before	application	of	the	drug	(Pearson	correlation	of	r	=	-0.21,	p	=	0.01	for	0.25	µM	data	and	r	=	-0.17,	p	=	0.03	for	1	µM	data	in	Figure	5.4c).	Additional	quinpirole	wash-on	results	are	presented	in	Figure	5.S6	 a-c	 and	 Figure	 5.S9.	 Conversely,	 our	 analysis	 showed	 that	 application	 of	 sulpiride	enhanced	nIRCat	response	in	ROIs	that	had	lower	∆F/F	before	application	of	the	drug	(Figure	5.4f,	Pearson	correlation	of	r	=	-0.53,	p	<	0.0001)	(see	additional	data	in	Figure	5.S6	d-f).	Our	work	 uncovers	 a	 statistically	 significant	 correlation	 between	 an	 ROI’s	 pre-drug	 ∆F/F	amplitude	and	its	post-drug	response.	It	is	possible	that	the	observed	heterogeneity	in	ROI	responses	maps	onto	variation	in	D2	autoreceptor	expression	and/or	function	(37,	39),	but	further	characterization	will	be	necessary	to	confirm	this	hypothesis.			
	
Imaging	of	optogenetically-evoked	dopamine	release	in	striatal	tissue		 To	 further	 confirm	 striatal	 nIRCat	 nanosenor	 signals	 were	 indeed	 reporting	dopamine	 release,	 we	 compared	 channelrhodopsin	 (ChR2)	 stimulation	 of	 cortical	glutamatergic	and	nigrostriatal	dopaminergic	terminals	in	the	dorsal	striatum.	Acute	striatal	brain	slices	were	prepared	from	mice	virally	transfected	to	express	the	light	sensitive	cation	channel	ChR2	in	either	glutamatergic	terminals	of	the	striatum	(targeted	by	viral	injection	in	the	frontal	cortices,	ChR2-GLU)	(Figure	5.5a,	Figure	5.S7a,	5.S7b)	or	dopaminergic	terminals	(targeted	by	viral	injection	in	the	midbrain	in	DAT-cre	mice;	ChR2-DA)	(Figure	5.5c,	Figure	5.S7	c).	Upon	optical	stimulation	of	ChR2-DA	terminals	with	a	473	nm	laser	(5	pulses	at	25	Hz,	1	mW/mm2)	in	the	dorsal	striatum,	we	observed	significant	fluorescence	modulation	of	
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nIRCat	 signal	 (Figure	 5.5d).	 In	 contrast,	 when	 optogenetic	 stimulation	 was	 targeted	 at	cortical	glutamatergic	terminals	in	the	striatum,	fluorescent	nIRCat	signals	did	not	rise	above	baseline	 fluctuation.	 Notably,	 we	 could	 confirm	 in	 control	 experiment	 that	 optogenetic	stimulation	of	 cortical	 glutamatergic	 terminals	was	able	 to	evoke	excitatory	postsynaptic	currents	(EPSCs)	in	striatal	MSNs	(Figure	5.5b	inset,	Figure	5.S7d,	5.S7e).		Returning	to	ChR2-DA	stimulation,	we	next	varied	the	number	of	stimulation	pulses	(5	ms	pulse	duration,	25	Hz,	1	mW/mm2)	and	observed	scaling	in	nIRCat	∆F/F	amplitude	from	1	pulse	to	10	pulses	(p=0.005),	and	trend	level	differences	between	1	pulse	and	5	pulses	(p=0.0645)	and	5	pulses	and	10	pulses	(p=0.086)	(Figure	5.5e).	When	we	varied	the	pulse	frequency	 while	 holding	 the	 number	 of	 pulses	 constant	 at	 5,	 we	 observed	 scaling	 with	significant	 differences	 detectable	 between	 1	 Hz	 and	 10	 Hz	 (p=0.036).	 The	 amplitude	difference	between	10	Hz	and	25	Hz	did	not	reach	significance	(p=0.179)	(Figure	5.5f).	In	single	pulse	 experiments	 in	which	we	varied	pulse	width,	nIRCat	 fluorescence	 responses	scaled	 with	 pulse	 duration.	 This	 effect	 was	 significant	 when	 comparing	 2	 ms	 to	 5	 ms	(p=0.002)	but	the	difference	from	5	ms	to	10	ms	did	not	reach	significance	(p=0.055)	(Figure	5.5g).	 Finally,	 we	 tested	 the	 effect	 of	 dopaminergic	 pharmacological	 agents	 on	optogenetically	evoked	dopamine	release	(ChR2-DA).	Bath	application	of	quinpirole	(1	µM)	powerfully	suppressed	nIRCat	fluorescence	(p	<	0.0001),	and	this	effect	was	reversed	after	drug	washout	(Figure	5.5h).	Consistent	with	results	from	electrical	stimulations,	optogenetic	stimulations	 also	 showed	 that	 quinpirole	 suppressed	 the	most	 active	ROIs	 preferentially	(Figure	5.S8).		Nomifensine	(10	µM)	enhanced	nIRCat	signal	decay	time,	consistent	with	the	predicted	slowing	of	dopamine	clearance	from	the	ECS	(Figure	5.S9).			
84 
	
85 
Figure	 5.5	 nIRCat	 detection	 of	 striatal	 dopamine	 release	 evoked	 by	 optogenetic	 stimulation	 (a)	Schematic	 of	 ChR2	 expression	 in	 cortical	 glutamatergic	 terminals	 synapsing	 in	 the	dorsal	 striatum.	 (b)	No	nIRCat	fluorescence	modulation	was	observed	after	stimulation	of	glutamatergic	terminals.	Inset:	glutamate	release	was	confirmed	by	excitatory	postsynaptic	current	on	medium	spiny	neuron.	 (c)	Schematic	of	ChR2	expression	 in	nigrostriatal	dopaminergic	 terminals	of	 the	dorsal	 striatum.	 (d)	 Stimulation	of	dopaminergic	terminals	resulted	in	nIRCat	fluorescence	modulation.	Stimulation	protocol	in	(b)	and	(d)	was	5	pulses	at	25	Hz	 and	 power	 flux	 of	 1	mW/mm2	 and	 each	 pulse	 had	 a	 duration	 of	 5ms.	 (e)	 nIRCat	∆F/F	 in	 response	 to	increasing	number	of	pulses	delivered	at	25	Hz,	5	ms	pulse	duration.	(f)	nIRCat	∆F/F	in	response	to	increasing	pulse	frequency	(1,	10,	25	Hz)	of	5	pulses.	Each	pulse	had	a	duration	of	5	ms.	(g)	nIRCat	∆F/F	in	response	to	single	pulses	of	2	ms,	5	ms	and	10	ms	duration.	(h)	Bath	application	of	1	µM	of	quinpirole	suppresses	dopamine	release	and	results	in	depressed	nIRCat	∆F/F.	Drug	wash-out	rescues	dopamine	release	and	nIRCat	∆F/F.	All	error	bands	represent	standard	deviation	from	the	mean	trace.	
5.3	Conclusion	To	 understand	 how	 neuromodulation	 alters	 the	 plasticity	 and	 activity	 of	 distinct	populations	of	neurons,	there	is	need	for	new	optical	tools	that	can	measure	the	extracellular	dynamics	 of	 neuromodulator	 release	 and	 reuptake	 at	 spatiotemporal	 resolution	commensurate	 with	 methods	 used	 to	 record	 neural	 activity	 (e.g.	 electrophysiology	 and	calcium	 imaging).	 Here,	 we	 demonstrated	 the	 feasibility	 of	 using	 of	 a	 non-genetically	encoded	fluorescent	sensor,	nIRCat,	to	enable	optical	detection	of	catecholamine	release	and	reuptake	 with	 sub-second	 temporal	 and	 with	 micrometer	 spatial	 resolution.	 We	 used	electrical	 and	 optogenetic	 methods	 in	 striatal	 brain	 tissue	 to	 demonstrate	 that	 nIRCat	fluorescent	 signals	 faithfully	 report	 evoked	 dopamine	 release	 and	 pharmacologically	induced	changes	in	dopamine	dynamics.	We	 focused	nIRCat	 imaging	 experiments	within	 the	 dorsal	 striatum,	 a	 region	 that	receives	 dense	 dopaminergic	 innervation	 and	 negligible	 norepinephrine	 innervation.	 121	Therefore,	 while	 nIRCats	 are	 not	 selective	 for	 dopamine	 over	 norepinephrine,	 nIRCats	effectively	 function	 as	 a	 dopamine	 sensor	within	 the	 context	 of	 the	 striatum.	 Given	 that	striatal	 dopamine	 regulates	 fundamental	 processes	 including	motor	 function,	motivation	and	 learning,	 nIRCats	 represent	 an	 important	 addition	 to	 the	 neuroscience	 investigative	toolkit.	 Furthermore,	 of	 the	 biogenic	 amines	 present	 in	 invertebrate	 species	 (dopamine,	tyramine,	 octopamine,	 serotonin,	 histamine),	 we	 demonstrated	 in	 vitro	 that	 nIRCats	 are	exclusively	 sensitive	 to	dopamine.	Hence	 for	 invertebrate	 species	 such	as	drosophila,	we	predict	 that	 nIRCats	 may	 serve	 as	 selective	 and	 highly	 sensitive	 dopamine	 sensors	throughout	the	brain.	While	 other	 tools	 are	 emerging	 to	 optically	 report	 dopamine	 fluctuations	 via	 cell-surface	 engineered	 proteins,3,4	 nIRCats	 are	 likely	 to	 fulfill	 a	 niche	 amongst	 currently	available	 methods	 for	 detecting	 dopamine	 neurotransmission	 due	 to	 their	 unique	 near-infrared	fluorescence,		the	fact	that	they	do	not	rely	on	genetic	delivery	and	expression,	their	relative	 ease	 of	 deployment,	 and	 their	 functionality	 in	 the	 presence	 of	 pharmacological	dopamine	receptor	ligands.	This	is	in	contrast	to	receptor-based	fluorescent	sensors	which	currently	cannot	report	on	endogenous	dopamine	dynamics	in	the	presence	of	ligands	to	the	engineered	 receptor	 but	 do	 exhibit	 selectivity	 for	 dopamine	 over	 norepinephrine.3,4	Furthermore,	 the	 synthetic	 nature	 of	 nIRCats	 eliminates	 concern	 about	 potential	 GPCR-mediated	residual	signaling	 that	may	be	present	 in	protein-based	optical	probes.	nIRCats	also	 offer	 spatial	 advantages	 over	 FSCV,	 and	 our	 initial	 experiments	 suggest	 that	 the	
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temporal	 resolution	 of	 the	 nIRCat	 signal	 can	 be	 comparable	 to	 that	 of	 FSCV.	 nIRCat	fluorescence	decay	profiles	exhibit	a	wider	temporal	range	than	that	observed	from	FSCV	data	and	included	a	significant	number	of	ROIs	that	showed	seconds-long	time	constants	in	addition	to	time	constants	faster	than	those	measured	by	FSCV.	It	is	debatable	if	these	results	capture	 the	 unique	 spatial	 properties	 of	 specific	 striatal	 ROIs	 or	 are	 related	 to	 tool	differences	alone.	nIRCats,	unlike	FSCV	probes,	should	sample	catecholamine	concentration	at	a	 single	point	 in	 space,	 such	 that	each	distributed	nIRCat	 construct	 can	act	as	a	probe	within	 the	 ECS	 and	 therefore	 yield	 a	 “higher	 resolution”	 picture	 of	 neuromodulator	dynamics.	 Future	 experiments	 will	 investigate	 how	 the	 heterogeneity	 of	 nIRCat	 signals	(amplitude,	 kinetics,	 and	 modulation	 by	 drugs)	 relates	 to	 structural	 and	 functional	properties	at	dopamine	terminals	and	within	the	ECS.	We	predict	that	new	optical	tools	for	measuring	dopamine	dynamics	with	high	spatial	resolution	will	be	enable	new	insights	into	the	regulation	of	dopamine	release	and	reuptake	at	the	level	of	individual	synapses.20,127,128	Furthermore,	we	see	potential	for	future	expansion	of	a	larger	family	of	SWCNT	based	near-infrared	nanosensors	(nIRNS)	similar	to	nIRCats	for	multiple	neurochemical	imaging	applications.	Several	lines	of	evidence	illustrate	their	future	potential.	First,	nIRNS	are	easily	functionalized	with	a	wide	range	of	synthetic	molecular	recognition	moieties,	affording	fine	control	of	their	surface	functional	elements	and	their	 interactions	with	the	 local	chemical	environment	57,67,79.	SWCNT	fluorescence	can	be	finely	tuned	to	monochromatic	emission	in	the	near-infrared	 II	 (1000-1700	nm)	window	by	controlling	 the	SWCNT	chirality.129	This	chirality-dependent	fluorescence	in	the	near-infrared	II	window	provides	further	avenues	for	 designing	 color-specific	 responses	 to	 multiple	 molecular	 analytes	 simultaneously,	thereby	affording	synthesis	of	ratiometric	and	multiplexed	analyte	imaging	platforms,	as	we	have	 shown	 previously.71	 Second,	 SWCNT-based	 nanosensors	 rely	 on	 near-infrared	fluorescence,	which	greatly	reduces	the	impact	of	tissue	scattering	in	the	emission	window	and	 therefore	may	 enable	 through-cranium	 imaging.63	 nIRNS	 are	 compatible	with	multi-photon	imaging	with	1600	nm	excitation62	and	as	such	could	permit	nanoscale	imaging	of	intact	neuronal	structures	pending	parallel	developments	in	all-infrared	microscopy,	as	has	been	shown	with	visible	wavelength-emitting	fluorophores.130	Third,	nIRNS	exhibit	robust	non-photobleaching	photostability,	allowing	their	use	in	long-term	imaging	experiments.131	Fourth,	because	nIRNS	are	not	genetically-encoded,	they	could	enable	use	in	species	where	gene	delivery	and	protein	expression	is	intractable,	time	consuming,	or	undesirable.	Finally,	the	 nanosecond-scale	 binding	 kinetics	 and	 nanoscale	 dimensions	 of	 nIRNS	 are	 likely	 to	enable	 generation	 of	 other	 neuromodulator	 nanosensors	 with	 improved	 temporal	 and	spatial	 resolution.	 In	 sum,	 nIRCats	 are	 versatile	 catecholamine	 probes	 amenable	 to	multiplexing	 with	 existing	 tools	 for	 concurrent	 investigation	 of	 dopaminergic	neuromodulation	with	other	core	mechanisms	of	brain	function.		
	
5.4	Appendix	I	
Materials	and	Methods	
	
Nanosensor	synthesis		
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(GT)6	 oligonucleotides	 were	 purchased	 from	 Integrated	 DNA	 Technologies	 (IDT,	Standard	Desalting).	HiPCo	SWCNT	were	purchased	from	NanoIntegris	(Batch	#	HR27-104).		(GT)6-SWCNT	colloidal	suspension	(nIRCat)	was	prepared	by	mixing	1	mg	of	(GT)6	and	1	mg	of	SWCNT	in	1	mL	of	a	100	mM	NaCl	solution.	The	solution	was	bath	sonicated	(Branson	Ultrasonic	1800)	for	10	minutes	and	probe-tip	sonicated	for	10	minutes	at	5	W	power	(Cole	Parmer	Ultrasonic	Processor,	3	mm	tip	diameter)	in	an	ice-bath.	The	sonicated	solution	was	incubated	at	room	temperature	for	30	minutes.	The	product	was	subsequently	centrifuged	at	16,000	g	(Eppendorf	5418)	for	90	minutes	to	remove	unsuspended	SWCNT	bundles	and	amorphous	carbon,	and	the	supernatant	was	recovered	for	characterization	and	use.	Each	nanosensor	suspension	was	stored	at	4°C	until	use.		
Nanosensor	characterization		 To	characterize	nIRCats	post-synthesis,	the	full	visible	and	near-infrared	absorption	spectrum	was	taken	for	each	nanosensor	batch	(UV-VIS-NIR	spectrophotometer,	Shimadzu	UV-3600	Plus)	or	UV-VIS	(ThermoFisher	Scientific	Genesys	20).	SWCNT	concentrations	of	as-made	nanosensor	batches	were	determined	using	absorbance	at	632	nm	(UV-VIS)	with	an	extinction	coefficient	of	e	=	0.036	(mg/L)-1	cm-1.	Full	spectrum	absorbance	measurements	were	made	with	UV-VIS-NIR	after	dilution	to	5	mg/L	SWCNT	concentration	in	100	mM	NaCl.	For	fluorescence	spectroscopy,	each	sensor	batch	was	diluted	to	a	working	concentration	of	5	mg/L	in	100	mM	NaCl,	and	aliquots	of	198	µL	were	placed	in	each	well	of	a	96-well	plate	(Corning).	Fluorescence	measurements	were	obtained	with	a	20	X	objective	on	an	inverted	Zeiss	microscope	(Axio	Observer.D1)	coupled	to	a	Princeton	Instruments	spectrograph	(SCT	320)	and	liquid	nitrogen	cooled	Princeton	Instruments	InGaAs	linear	array	detector	(PyLoN-IR).	 A	 721nm	 laser	 (OptoEngine	 LLC)	 was	 used	 as	 the	 excitation	 light	 source	 for	 all	characterization	experiments.	
	
Neurotransmitter	analyte	library	and	dopamine	receptor	drug	screening	
	 For	neurotransmitter	response	screens,	we	collected	the	near-infrared	fluorescence	spectrum	from	198	µL	aliquots	of	nanosensor	(5	mg/L	SWCNT	concentration)	before	and	after	addition	of	2	µL	of	10	mM	solutions	of	each	analyte	neurotransmitter	(for	a	100	µM	final	analyte	concentration	 in	each	well	of	a	96-well	plate).	All	neurotransmitter	analytes	were	 purchased	 from	 Sigma-Aldrich.	 Neurotransmitter	 analytes	 were	 incubated	 for	 5	minutes	before	taking	post-analyte	fluorescence	measurements.	Responses	were	calculated	for	 the	 integrated	 fluorescence	 count	 as	∆F/F0	 =	 (F-F0)/F0,	where	F0	 is	 total	 fluorescence	before	 analyte	 addition	 and	 F	 is	 total	 fluorescence	 after	 analyte	 addition	 or	 for	 peak	fluorescence	 change	 corresponding	 to	 the	 (9,4)	 SWCNT	 chirality	 (~1128	 nm	 center	wavelength).	 All	measurements	were	made	 in	 triplicate.	 Reported	 results	 are	mean	 and	standard	 deviations	 of	 the	 triplicate	measurements.	 All	 nIRCat	 nanosensor	 batches	were	tested	for	catecholamine	responses	prior	to	use	for	tissue	catecholamine	imaging.	Dopamine	receptor	drugs	were	purchased	from	Tocris	(quinpirole	and	sulpiride),	abcam	(SCH	23390)	and	 Sigma-Aldrich	 (haloperidol).	 nIRCat	 fluorescence	 modulation	 to	 dopamine	 receptor	drugs	were	measured	after	addition	of	1	µM	drug	quantities	(final	concentration	in	well)	in	each	well.	 Post-drug	 fluorescence	 spectra	were	 taken	after	5-minute	drug	 incubation.	To	measure	nIRCat	response	 to	dopamine	 in	 the	presence	of	drugs,	dopamine	aliquots	were	
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added	 to	 each	 drug-incubated	 well	 to	 obtain	 100	 µM	 dopamine,	 and	 post-dopamine	fluorescence	spectra	were	taken	after	an	additional	5-minute	incubation	period.		
Nanosensor	reversibility	testing	
	 A	 #1.5	 glass	 coverslip	 was	 functionalized	 with	 (3-Aminopropyl)	 triethoxysilane	(APTES,	Sigma	Aldrich)	by	soaking	in	10%	APTES	in	ethanol	for	5	min.	The	coverslip	was	then	rinsed	with	DI	water	and	left	to	dry.	The	coverslip	was	then	fixed	onto	an	ibidi	sticky-Slide	VI	0.4	 forming	6	microfluidic	channels.	First,	100	μL	of	PBS	was	pipetted	 through	a	channel.	Next,	the	channel	was	filled	50	μL	of	a	5	mg/L	solution	of	nIRCats	and	left	to	incubate	at	 room	 temperature	 for	 5	min.	 The	 channel	was	 rinsed	 using	 three	 50	 μL	 PBS	washes,	keeping	the	channel	filled	with	solution	at	all	times.	The	surface	immobilized	nIRCats	in	PBS	were	 imaged	on	an	epifluorescence	microscope	with	721	nm	excitation	and	a	Ninox	VIS-SWIR	640	camera	(Raptor).	One	end	of	the	flow	channel	was	connected	to	a	syringe	pump	(Harvard	 Appartus)	 using	 Luer	 lock	 fittings.	 Prior	 to	 the	 start	 of	 image	 acquisition,	 the	opposite	 flow	 reservoir	 was	 filled	 with	 PBS	 and	 the	 pump	 was	 set	 to	 refill	 mode	 at	 a	volumetric	flow	rate	of	40	μL	min-1.	Once	the	liquid	in	the	reservoir	was	depleted,	40	μL	of	10	μM	dopamine	in	PBS	was	added.	The	process	was	repeated	using	alternating	additions	of	80	μL	of	PBS	washes	and	40	μL	of	dopamine	solution.	
	
Acute	slice	preparation	and	nanosensor	labeling	
		 Mice	were	C57	Bl/6	strain,	60	days	old,	and	both	male	and	female	mice	were	used.	Mice	were	group	housed	after	weaning	at	P21	and	kept	with	nesting	material	on	a	12:12	light	cycle.	 All	 animal	 procedures	 were	 approved	 by	 the	 UC	 Berkeley	 Animal	 Care	 and	 Use	Committee	 (ACUC).	 Acute	 brain	 slices	 were	 prepared	 using	 established	 protocols.123	Briefly,	mice	were	deeply	anesthetized	via	 intraperitoneal	 injection	of	ketamine/xylazine	cocktail	and	 transcardial	perfusion	was	performed	using	 ice-cold	cutting	buffer	 (119	mM	NaCl,	26.2	mM	NaHCO3,	2.5	mM	KCl,	1mM	NaH2PO4,	3.5	mM	MgCl2,	10	mM	Glucose,	0	mM	CaCl2),	after	which	the	brain	was	rapidly	extracted.	The	cerebellum	and	other	connective	tissues	were	trimmed	using	a	razor	blade	and	the	brain	was	mounted	onto	the	cutting	stage	of	a	vibratome	(Leica	VT	1200S).	Coronal	slices	(300	µm	in	thickness)	including	the	dorsal	striatum	were	prepared.	Slices	were	incubated	at	37°C	for	60	minutes	in	oxygen	saturated	ACSF	(119	mM	NaCl,	26.2	mM	NaHCO3,	2.5	mM	KCl,	1mM	NaH2PO4,	1.3	mM	MgCl2,	10	mM	Glucose,	2	mM	CaCl2)	before	use.	Slices	were	then	transferred	to	room	temperature	for	30	minutes	before	starting	imaging	experiments	and	were	maintained	at	room	temperature	for	the	remainder	of	experimentation.	For	 nanosensor	 labeling,	 slices	 were	 transferred	 into	 a	 small	 volume	 brain	 slice	incubation	 chamber	 (Scientific	 Systems	Design,	 Inc.,	AutoMate	 Scientific)	 and	kept	under	oxygen	saturated	ACSF	(total	5	mL	volume).	100	µL	of	100	mg/L	nIRCat	nanosensor	was	added	to	the	5mL	volume	and	the	slice	was	incubated	in	this	solution	for	15	minutes.	The	slice	was	subsequently	recovered	and	rinsed	in	oxygen	saturated	ACSF	to	wash	off	nIRCats	that	did	not	localize	into	the	brain	tissue.	The	rinsing	step	was	performed	by	transferring	the	slice	through	3	wells	of	a	24	well	plate	(5	seconds	in	each	well)	followed	by	transfer	to	the	recording	chamber	with	ACSF	perfusion	for	a	15-minute	equilibration	period	before	starting	the	imaging	experimentation.	All	imaging	experiments	were	performed	at	32°C.	
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Acute	slice	preparation	for	FSCV	recording	
	 Acute	 slices	 were	 prepared	 as	 described	 previously.	 Extracellular	 dopamine	concentration	evoked	by	 local	electrical	stimulation	was	monitored	with	FSCV	at	carbon-fiber	microelectrodes	 (CFMs)	 using	Millar	 voltammeter.	 CFMs	were	~	 7	 µm	 in	 diameter	encased	in	glass	capillary	pulled	to	form	a	seal	with	the	fiber	and	cut	to	final	tip	length	of	70-120	µm.	The	CFM	was	positioned	~100	µm	below	the	tissue	surface	at	a	45-degree	angle.	A	triangular	waveform	was	applied	to	the	CFM	scanning	from	-0.7	V	to	+1.3	V	and	back,	against	Ag/AgCl	reference	electrode	at	a	rate	of	800	V/s.	Evoked	dopamine	transients	were	sampled	at	 8	 Hz,	 and	 data	 were	 acquired	 at	 50	 kHz	 using	 AxoScope	 10.5	 (Molecular	 Devices).	Oxidation	 currents	 evoked	 by	 electrical	 stimulation	 were	 converted	 to	 dopamine	concentration	from	post-experimental	calibrations.	Recorded	FSCV	signals	were	identified	as	dopamine	by	comparing	oxidation	(+0.6	V)	and	reduction	(-0.2	V)	potential	peaks	from	experimental	 voltammograms	 with	 currents	 recorded	 during	 calibration	 with	 2	 µM	dopamine	 dissolved	 in	 ACSF.	 For	 stimulation,	 a	 bipolar	 stimulation	 electrode	 (FHC	CBAEC75)	was	positioned	on	top	of	the	brain	slice	and	approximately	100	µm	away	from	the	CFM.	Following	30-minute	slice	equilibration	in	the	recording	chamber,	dopamine	release	was	evoked	using	a	square	pulse	(0.3	mA	pulse	amplitude,	3	ms	pulse	duration)	controlled	by	Isoflex	stimulus	isolator	(A.M.P.I)	and	delivered	out	of	phase	with	the	voltammetric	scans.	Stimulation	 was	 repeated	 3	 times.	 To	 compare	 FSCV	 and	 nIRcat	 data,	 each	 signal	 was	normalized	against	 its	peak	value	 ([DA]max	or	 (∆F/F)max)	and	co-aligned	at	 stimulation	time.	Latency	to	peak	were	computed	as	tpeak	-	tstim	where		tpeak	is	the	time	at	which	peak	signal	is	attained	and	tstim	is	time	of	stimulation.	Decay	time	constants	(t)	were	computed	from	model	fits	to	a	first	order	decay	process.	
	
Microscope	construction	and	slice	imaging		
Ex	 vivo	 slice	 imaging	 was	 performed	 with	 a	 modified	 upright	 epifluorescent	microscope	 (Olympus,	 Sutter	 Instruments)	mounted	onto	 a	motorized	 stage.	Nanosensor	excitation	was	 supplied	by	 a	785	nm,	CW,	DPSS	 laser	with	 adjustable	 output	power	 to	 a	maximum	of	300	mW	and	a	near	TEM00,	top	hat	beam	profile	(OptoEngine	LLC).	The	beam	was	 expanded	 using	 a	 Keplerian	 beam	 expander	 comprised	 of	 two	 plano-convex	 lenses	(Thorlabs,	f=25	mm,	f=75	mm,	AR	coating	B)	to	a	final	beam	diameter	of	approximately	1	cm.	The	 beam	 was	 passed	 through	 a	 custom	 fluorescence	 filter	 cube	 (excitation:	 800	 nm	shortpass	 (FESH0800),	 dichroic:	 900	 longpass	 (DMLP990R),	 emission:	 900	 longpass	(FELH0900),	Thorlabs)	to	a	60X	Apo	objective	(1.0	NA,	2.8	mm	WD,	water	dipping,	high	NIR	transmission,	Nikon	CFI	Apo	60XW	NIR).	Emission	photons	collected	from	the	sample	were	passed	 through	 the	 filter	 cube	 and	 were	 focused	 onto	 a	 two-dimensional	 InGaAs	 array	detector	(500-600	nm:	40%	quantum	efficiency	(QE);	1000-1500	nm:	>85%	QE;	Ninox	640,	Raptor	Photonics)	and	recorded	using	Micro-Manager	Open	Source	Microscopy	Software.132	Laser	power	was	adjusted	to	maximize	collected	photons	and	fill	the	pixel	bit	depth	on	the	detector	but	did	not	exceed	70	mW	at	the	objective	back	focal	plane.	YFP	fluorescence	was	imaged	by	switching	the	filter	cube	(U-N41017XL	Olympus)	and	using	a	mercury-vapor	lamp	(Olympus)	for	excitation.				
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Electrical	 and	 optical	 stimulation-evoked	 dopamine	 imaging	 with	 near-infrared	
microscopy	
	 For	 electrical	 stimulation	 experiments,	 a	 bipolar	 stimulation	 electrode	 was	positioned	in	field	of	view	within	the	dorsomedial	striatum	identified	using	a	4X	objective	(Olympus	xFluor	4x/340).	Using	60X	objective,	the	stimulation	electrode	was	brought	into	contact	with	 top	 surface	 of	 the	 brain	 slice	 and	 an	 imaging	 field	 of	 view	was	 chosen	 at	 a	nominal	distance	of	150	µm	from	the	stimulation	electrode	within	the	dorsomedial	striatum.	All	 stimulation	 experiments	were	 recorded	 at	 video	 frame	 rates	 of	 9	 frames	 per	 second	(nominal)	and	single	pulse	electrical	stimulations	were	applied	after	200	frames	of	baseline	were	 acquired.	 Each	 video	 acquisition	 lasted	 600	 frames.	 Stimulation	 amplitudes	 were	staggered	and	each	stimulation	amplitude	was	repeated	three	times	within	a	field	of	view.	Slices	were	allowed	to	recover	for	5	minutes	between	each	stimulation	with	the	excitation	laser	 path	 shuttered.	 For	 optogenetic	 stimulation,	 a	 fiber-coupled	 473	 nm	 blue	 laser	(OptoEngine	 LLC	 DPSS)	 was	 positioned	 in	 close	 proximity	 to	 the	 brain	 slice	 using	 a	micromanipulator.	Expression	of	ChR2	was	confirmed	via	visible	fluorescence	imaging	and	an	imaging	field	of	view	was	chosen	in	dorsomedial	striatum	with	robust	expression	level.	Stimulation	pulses	(5	pulses,	5	ms	duration	per	pulse,	delivered	at	25	Hz,	1	mW/mm2)	were	delivered	after	acquiring	200	baseline	frames	and	the	video	acquisition	lasted	600	frames	at	nominal	9	frames	per	second.	Drugs	were	bath	applied	to	the	imaging	chamber	through	ACSF	perfusion.	ACSF	with	10	µM	of	nomifensine	or	1	µM	of	each	DRD	drug	was	used.	When	the	effect	of	a	drug	needed	to	be	evaluated,	stimulation/imaging	experiments	were	carried	out	with	drug-free	ACSF	in	an	imaging	field	of	view	to	collect	drug-free	data.	Normal	ACSF	was	then	switched	to	ACSF	prepared	with	the	drug	of	interest	and	applied	for	10	minutes	before	stimulation/imaging	experiments	resumed.	
	
Viral	transfection	of	mice	for	optogenetic	stimulation		 Adult	 male	 and	 female	 mice	 (>P60)	 were	 used	 for	 all	 surgeries.	 Bilateral	 viral	injections	 were	 performed	 using	 previously	 described	 procedures	 133	 at	 the	 following	stereotaxic	 coordinates:	 dorsomedial	 prefrontal	 cortex	 (dmPFC):	 1.94	mm	 from	Bregma,	0.34	mm	lateral	from	midline,	and	0.70	mm	vertical	from	cortical	surface;	substantia	nigra	pars	compacta	(SNc):	 -3.08	mm	from	Bregma,	1.25	mm	lateral	 from	midline,	and	4.0	mm	vertical	 from	 cortical	 surface.	 For	 glutamatergic	 corticostriatal	 axon	 stimulation	experiments,	mice	were	injected	with	0.5	µL	of	CAG-ChR2-EYFP	virus	bilaterally	into	dmPFC.	For	nigrostriatal	dopaminergic	axon	stimulation	experiments,	DAT-Cre	mice	were	injected	with	0.5	µL	DIO-ChR2-EYFP	virus	bilaterally.	For	all	optogenetic	experiments,	we	waited	at	least	 three	weeks	 from	 viral	 injection	 to	 experimental	 stimulation	 to	 allow	 for	 sufficient	ChR2	gene	expression.	To	confirm	that	dopamine	neurons	were	transfected	with	ChR2	in	animals	used	for	optogenetic	dopamine	stimulation	experiments,	we	perfused	DAT-Cre	mice	that	had	been	injected	into	the	SNc	with	Cre-dependent	ChR2-EYFP	virus	with	4%	paraformaldehyde	in	PBS	and	post-fixed	brains	overnight.	Coronal	sections	that	included	the	injection	site	(SNc)	and	 imaging	site	(dorsal	striatum)	were	cut	at	50	µM	and	immunolabeled	using	antibody	against	 tyrosine	 hydroxylase	 (TH)	 (rabbit	 anti-TH	 1:1000,	 Millipore),	 the	 rate-limiting	enzyme	 for	 catecholamine	 synthesis.	 Goat	 anti-rabbit	 Dylight	 594	 secondary	 antibody	
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(1:1000,	Invitrogen)	was	used	to	visualize	TH.	Image	acquisition	was	performed	on	a	Zeiss	Axio	ScanZ.1	using	a	5x	objective.			
Image	processing	and	data	analysis	for	nIRCat	fluorescence	response		 Raw	movie	files	were	processed	using	a	custom-built	MATLAB	program	(available	for	download:	 https://github.com/jtdbod/Nanosensor-Brain-Imaging).	 Briefly,	 for	 each	 raw	movie	 stack	 (600	 frames),	 a	 per	pixel	∆F/F	 defined	 as	 (F-F0)/F0	was	 calculated	using	 the	average	intensity	for	the	first	5%	of	frames	as	F0,	and	F	represents	the	dynamic	fluorescence	intensity	at	each	pixel.	Regions	of	 interest	(ROIs)	were	 identified	by	calculating	a	median	filter	convolution	and	then	performing	thresholding	using	Otsu’s	method	to	 identify	ROIs	with	strong	fluorescence	modulation	over	background,	followed	by	a	morphological	dilation	operation.	∆F/F	traces	were	then	calculated	for	each	generated	ROI	by	averaging	pixel	values	over	the	ROI.	ROI	sizes	were	computed	using	the	measured	pixel	area	and	approximating	each	as	a	circle	to	calculate	an	equivalent	radius.	To	 compare	 responses	 across	 stimulation	 amplitudes	 and	 bath	 application	 of	nomifensine,	mean	results	were	obtained	as	follows:	First,	all	identified	ROIs	from	a	field	of	imaging	were	 averaged.	Mean	 traces	were	 further	 averaged	 over	 different	 fields	 of	 view	within	the	same	slice	and	across	slices	(1-2	field	of	view	per	slice,	1-2	slices	per	animal)	and	then	averaged	over	experimental	animals.	Decay	time	constants	(t)	were	computed	by	fitting	
∆F/F	time	traces	to	a	first	order	decay	process	on	an	ROI	basis	or	field	of	view	average	basis.	Latency	to	peak	were	computed	as	tpeak	-	tstim	where		tpeak	is	the	time	at	which	peak	signal	is	attained	and	tstim	 is	time	of	stimulation.	All	statistical	tests	of	significance	(p-values)	were	computed	and	reported	from	unpaired,	two-tailed	t-test.	ROI	level	analysis	of	drug	washes	were	computed	by	generating	an	ROI	mask	from	one	of	the	triplicate	stimulations,	and	then	computing	∆F/F	traces	using	the	same	ROI	mask	for	all	 experimental	 runs	 (before	and	after	application	of	drug).	Each	raw	movie	 file	was	corrected	 for	 translational	 and	 rotational	 drift	 using	 StackReg	 plug-in	 in	 FIJI	 and	 then	processed	using	our	custom	MATLAB	script.	We	removed	all	ROIs	that	were	greater	than	4	µm	in	size	for	subsequent	analysis.	For	each	ROI,	post-to-pre	drug	ratios	were	computed	as	(∆F/F)max-post-drug	/	 (∆F/F)max-pre-drug	 .	Here,	we	define	 (∆F/F)max	as	 the	amplitude	of	nIRCat	response	in	the	post-stimulation	epoch.	Mean	values	from	triplicate	stimulation	were	used	to	evaluate	the	ratio.	
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Figure	5.S1.	nIRCats	are	compatible	with	concentrations	and	conditions	expected	in	brain	tissue.	(a)	In	vitro	(without	 tissue)	normalized	dose	response	curves	of	nIRCats	 for	dopamine	(DA)	and	norepinephrine	(NE).	Circles	represent	experimental	measurements	and	solid	lines	represent	Hill	equation	model	fit	to	experimental	data.	Each	measurement	point	is	a	mean	of	n=3	independent	measurements	with	standard	deviation	error	bars.	∆F/F	is	calculated	from	the	normalized	change	in	peak	intensity	at	the	center	wavelength	of	the	(9,4)	chirality	SWCNT	(~1128	nm).	(b)	Response	of	nIRCats	to	100	µM	of	DA	after	exposure	to	100	µM	of	ascorbic	acid	(AA).	∆F/F	 is	calculated	from	the	change	 in	peak	 intensity	at	 the	center	wavelength	of	 the	(9,4)	chirality	SWCNT	(~1128	nm).	(c)	Fluorescence	spectra	of	nIRCats	before	(black)	and	after	addition	of	10	µM	of	dopamine	(red,	DA),	tyramine	(blue,	TYR)	and	octopamine	(purple,	OCT)	in	an	in	vitro	preparation	in	phosphate	buffered	saline	(without	tissue).	(d)	Molecular	structures	of	dopamine	(DA),	tyramine	(TYR)	and	octopamine	(OCT).							
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Figure	5.S2.	Surface	immobilized	single	nIRCats	are	reversible	upon	repeat	exposure	to	dopamine.		nIRCats	are	immobilized	in	a	microfluidic	device	and	imaged	with	a	100	X	objective	(Zeiss	Plan	Apochromat	1.4	NA	;	Methods).	After	acquiring	baseline	nIRCat	fluorescence	(1),	exposure	to	10	µM	dopamine	(red	bar)	results	in	a	nIRCat	fluorescence	turn-on	response	(2).	The	response	is	preserved	while	dopamine	remains	in	the	imaging	chamber	but	is	reversed	when	dopamine	is	replaced	by	phosphate	buffered	saline	(PBS	wash;	yellow	bar)	and	baseline	nIRCat	fluorescence	is	recovered	(3).	The	experiment	is	repeated	in	(4)	and	(5).	Bottom	row	shows	diffraction-limited	 images	 of	 surface-immobilized	 nIRCats	 suggesting	 individual	 nanosensors	 undergo	reversible	turn-on	response.	The	data	trace	presented	is	averaged	fluorescence	from	all	nIRCats	in	the	field	of	view.	Scale	bars	=	5	µm.		 		
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Figure	 5.S3	 Brain	 slice	 nIRCat	 loading	 protocol	 and	 schematic	 of	 visible	 and	 near-infrared	 fluorescence	microscopy	 for	 imaging	nIRCats	 in	brain	 tissue.	 (a)	Experimental	 schematic	depicting	preparation	of	acute	brain	slices	and	subsequent	incubation	in	2	mg/L	nIRCat	solution	to	load	the	nanosensors	into	brain	tissue.	(b)	Schematic	of	visible/near-infrared	microscope.	A	785	nm	CW	laser	is	beam-expanded	and	co-aligned	with	a	mercury	vapor	 lamp	and	directed	 into	the	objective	with	dichroic	 filter	cubes.	Emitted	photons	are	 filtered	through	 a	 900	 nm	 long-bass	 filter	 and	 are	 relayed	 onto	 the	 sensor	 of	 a	 broadband	 InGaAs	 camera	 that	 is	sensitive	 to	 both	 visible	 and	 near-infrared	wavelengths.	 (c)	 Dorsomedial	 striatum	 from	mouse	 acute	 slice	imaged	in	brightfield	(top)	and	near-infrared	(bottom)	after	tissue	nanosensor	loading.	Scale	bars	=	10	µm.					
95 
	
	
Figure	5.S4	nIRCat	imaging	in	Mus	spicilegus	brain	tissue	(a)	nIRCat	∆F/F	average	trace	in	response	to	single	electrical	pulse	(3	ms,	0.3	mA)	 in	the	dorsolateral	striatum.	Pre-stimulation	(“Pre”)	nIRCat	∆F/F	 image	and	nIRCat	∆F/F	response	after	stimulation	(“Stim”)	show	nIRCat	fluorescence	modulation.	Scale	bars	=	10	µm.	(b)	∆F/F	time	trace	from	triplicate	stimulation	run.	Mean	trace	and	standard	deviation	bands	around	the	mean	are	shown.	 	
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Figure	 5.S5	 Intensity	 of	 nIRCat	 labeling	 at	 baseline	 does	 not	 predict	 site	 of	 ∆F/F	 hotspots.	 (a)	 ROI	 size	distribution	from	three	different	fields	of	view	(representing	n	=	3	biological	replicates)	in	the	dorsal	striatum,	each	stimulated	separately	by	0.3	mA	stimulation.	In	each	of	these	fields	of	view,	ROIs	showed	similar	median	size	and	size	distribution	even	when	compared	across	biological	 replicates.	Box	plot	definitions:	 red-line	=	median,	edges	of	box:	25th	and	75th	percentiles,	top	and	bottom	lines:	minimum	and	maximum	values	of	non-outlier	data,	red	points:	outlier	data.	 	(b)	Mean	intensity	projection	at	a	region	of	interest	and	its	maximum	∆F/F	projection	shown	in	(c)	show	labeling	intensity	does	not	predict	∆F/F	hot	spots.	Scale	bars	in	(b)	and	(c)	=	5	µm.	(d)	Bulk	loading	of	nIRCats	into	striatal	tissue	yields	heterogeneous	nanosensor	distribution	in	tissue	at	baseline.	Mean	intensity	projection	of	nIRCat	tissue	labeling	in	a	representative	dorsal	striatal	section	after	bulk	loading	and	during	baseline	imaging.	(e)	∆F/F	in	nIRCat	signal	in	the	same	field	of	view	as	(D),	0.5	sec	after	0.3	mA	single	pulse	electrical	stimulation.	(f)	Overlay	of	mean	intensity	projection	of	nIRCat	labeling	at	baseline	
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and	evoked	change	in	∆F/F	reveals	that	areas	with	higher	nIRCat	labeling	at	baseline	do	not	predict	hotspots	in	evoked	∆F/F.	Scale	bars	in	(d-f)	=	10	µm.	(g)	Representative	voltammogram	of	FSCV	measurements	made	in	this	study	confirms	evoked	signal	is	dopamine.			
		
Figure	5.S6	Variability	in	effect	of	quinpirole	and	sulpiride	on	nIRCat	response	on	spatially	segregated	ROIs	within	a	field	of	view.	(a)	∆F/F	of	ROIs	in	ACSF	and	in	ACSF	with	1	µM	of	quinpirole.	Each	∆F/F	data	point	corresponding	to	an	ROI	is	an	average	from	n=3	repeat	stimulations.	(b)	Distribution	of	post-to-pre	drug	ratio	for	data	in	(a)	with	mean	=	0.67	±	0.24	(n=120	ROIs	identified	within	the	field	of	view)	(c)	Scatter	plot	of	ROIs	in	(a)	shows	a	negative	correlation	between	the	pre-drug	∆F/F	amplitude	of	an	ROI	and	its	post-to-pre	drug	∆F/F	amplitude	ratio	(r	=	-0.57,	p	<	0.0001).	(d)	∆F/F	of	ROIs	in	ACSF	and	in	ACSF	with	1	µM	of	sulpiride.	Each	∆F/F	data	point	corresponding	to	an	ROI	is	an	average	from	n=3	repeat	stimulations.	(e)	Distribution	of	post-to-pre	drug	ratio	for	data	in	(d)	with	mean	=	1.38	±	0.49	(n=165	ROIs	identified	within	the	field	of	view).	(f)	Scatter	plot	for	ROIs	in	(d)	shows	a	negative	correlation	between	the	pre-drug	∆F/F	amplitude	of	an	ROI	and	its	post-to-pre	drug	∆F/F	amplitude	ratio	(r	=	-0.53,	p	<	0.0001).	All	ROIs	in	(A-F)	had	sizes	in	the	range	of	1	–	4	µm.			
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Figure	5.S7	Data	which	confirm	targeting	of	optogenetic	stimulation	of	dopaminergic	and	glutamatergic	inputs	to	 the	 striatum	 (a)	 Left:	 Schematic	 of	 AAV-CAG-ChR2-EYFP	 injection	 into	 dorsal	 medial	 prefrontal	 cortex	(dmPFC).	Right:	Fluorescence	image	collected	confirming	ChR2-EYFP	expression	at	injection	site.	Scale	bar		=	500	 µM.	 (b)	 Left:	 Schematic	 of	 imaging	 site	 of	 corticostriatal	 axon	 terminals	 in	 DS.	 Right:	 ChR2-EYFP+	corticostriatal	 terminals	present	 in	 the	DS	collected	 in	nIR/visible	 imaging	rig	prior	 to	 imaging	experiment	(nIRCat	imaging	data	in	Figure	5b).	Scale	bar	=	20	µM.	(c)	Top:	Fluorescence	image	of	tyrosine	hydroxylase	(TH)	positive	dopamine	neurons	in	the	substantia	nigra	pars	compact	(SNc)	and	dopamine	terminals	in	the	dorsal	striatum	(DS).	AAV-DIO-CHR2-EYFP	injection	into	SNc	of	DAT-Cre	mouse	shows	successful	viral	delivery	as	evidenced	by	colocalization	of	CHR2-EYFP	and	anti-TH	RFP.	Bottom:	Projections	from	the	SNc	into	the	DS	confirms	expression	of	ChR2	in	dopaminergic	terminals	and	TH	staining	confirms	dopaminergic	identity.	Scale	bars	=	1	mm.	 	(d)	Sample	trace	of	473	nm	light	pulse	(2	ms)	evoked	excitatory	postsynaptic	current	(EPSC)	recorded	in	medium	spiny	neuron	in	DS.	Application	of	10	µM	NBQX	abolishes	current,	confirming	that	it	is	AMPAR-mediated/glutamatergic.	 (e)	 Sample	 trace	 of	 473	 nm	 light	 pulse	 (2	ms)	 evoked	 EPSC	 recorded	 in	medium	 spiny	 neuron	 from	 striatal	 slice	 pre-incubated	 in	 2	mg/L	 nIRCat,	 indicating	 that	 nIRCat	 does	 not	interfere	with	opto-evoked	glutamate	release.					
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Figure	5.S8	Effect	of	quinpirole	on	ChR2	evoked	nIRCat	response	at	the	level	of	ROIs.	(a)	∆F/F	of	ROIs	in	ACSF	and	in	ACSF	with	1	µM	of	quinpirole.	Each	∆F/F	data	point	corresponding	to	an	ROI	is	an	average	from	n=3	repeat	stimulations	with	5	light	pulses	at	25	Hz.	(b)	Distribution	of	post-to-pre	drug	ratio	for	data	in	(a)	with	mean	=	0.59	±	0.22	(n=113	ROIs	identified	within	the	field	of	view).	(c)	Scatter	plot	for	ROIs	in	(A)	shows	a	negative	correlation	between	the	pre-drug	∆F/F	amplitude	of	an	ROI	and	its	post-to-pre	drug	∆F/F	amplitude	ratio	(r	=	-0.32,	p	<	0.001)	(blue	dots).	The	electrical	stimulation	data	from	figure	S5C	is	reproduced	here	for	comparison	(red	dots).	All	ROIs	in	(a-c)	had	sizes	in	the	range	of	1	–	4	µm.				
	
	
Figure	5.S9.	Nomifensine	extends	nIRCat	response	to	ChR2	stimulation	of	dopaminergic	terminals	in	the	dorsal	striatum.	 (a)	 Top:	 Representative	 “Pre”,	 “Stim”,	 and	 “Post”	 snapshots	 from	movie	 stack	 represent	 nIRCat	fluorescence	modulation	 before,	 during,	 and	 after	 blue	 light	 stimulation	 (5	 pulses,	 25	 Hz,	 1	mW/mm2)	 in	standard	ACSF.	Bottom:	After	10	min	incubation	in	10	µM	of	nomifensine,	the	ChR2	evoked	response	shows	brighter	and	broader	nIRCat	fluorescence	modulation.	(b)	Representative	traces	of	nIRCat	response	averaged	over	the	field	of	view	from	(a)	in	ACSF	and	ACSF	with	nomifensine	(+NOMF).	Decay	time	constants	are	tACSF	=	0.8	s	and	tNomifensine	=	11.7	s.		These	data	show	that	nomifensine	can	prolong	nIRCat	signal	decay.	Scale	bars	=	10	µm.	
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Chapter	6	
6.1	Summary		 This	 dissertation	 described	 a	 comprehensive	 computational	 and	 experimental	approach	 for	 developing	 and	 implementing	 an	 optical	 probe	 for	 the	 catecholamines	dopamine	 and	 norepinephrine,	 based	 on	 a	 synthetic	 fluorescent	 scaffold	 that	 possesses	favorable	photophysical	attributes	for	imaging	in	biological	specimens.		 In	 the	 first	 part	 of	 this	 dissertation,	 theoretical	 approaches	 were	 utilized	 to	 gain	insight	into	the	spatiotemporal	dynamics	of	dopamine	in	brain	tissue.	This	early	work	was	important	in	outlining	the	optimal	binding	kinetics	for	probes	targeted	to	dopamine,	which	had	hitherto	been	 insufficiently	understood.	Among	 the	 findings	 from	 this	 study	was	 the	counterintuitive	 conclusion	 that	 high	 affinity	 probes	 (with	Kd	 <	 10	 nM)	 are	 unfavorable	because	they	are	likely	to	saturate	at	basal	striatal	dopamine	levels,	which	arise	from	tonic	dopaminergic	activity	and	pervade	neural	tissue	at	rest.	Our	simulation	quantified	this	basal	dopamine	 level	 and	 showed	 that	 high	 affinity	 probes	 are	 likely	 to	 exhibit	 diminished	dynamic	range	upon	implementation	because	of	sensor	pre-saturation.	Furthermore,	high	affinity	 leads	 to	 delayed	 clearance	 profiles	 following	 transient	 events,	 which	 could	 be	detrimental	 to	probe’s	 temporal	 resolution.	We	 identified	probes	with	affinity	 (Kd)on	 the	order	 of	 1µM	 as	 optimal	 indicators	 for	 measuring	 dopaminergic	 dynamics	 in	 the	dorsomedial	 striatum,	 which	 accurately	 recapitulated	 the	 underlying	 biological	 signal.	Moreover,	with	this	simulation	work,	we	elucidated	the	spatial	extent	of	dopamine	spillover	from	 single	 release	 sites,	which	 enabled	 exploration	 of	 probe	 placement	with	 respect	 to	release	 sites.	 Learnings	 from	 this	 work	 provided	 critical	 guidance	 for	 subsequent	experimental	portions	of	this	dissertation,	which	encompassed	probe	synthesis,	validation	and	implementation.	Single	wall	 carbon	nanotubes	 (SWCNT)	were	 chosen	as	novel	 scaffolds	 for	optical	probe	synthesis	because	of	their	favorable	photophysics.	Previous	work	had	demonstrated	that	 supramolecular	complexes	 that	assemble	on	 the	surface	of	SWCNT	can	self-organize	into	structural	motifs	that	can	bind	small	molecule	analytes	and	modulate	the	fluorescence	of	the	underlying	SWCNT	scaffold.	However,	much	of	the	existing	literature	focused	on	 in	
vitro	solution	phase	experiments	and	applied	the	probes	in	simple	biological	systems	under	highly	 controlled	 conditions.	 In	 contrast,	 this	 dissertation	 introduced	 a	 comprehensive	approach	for	developing	and	implementing	SWCNT-based	optical	probes	for	use	in	realistic	biological	preparations.	Towards	this	goal,	several	concurrent	advances	were	made.		Using	our	computational	study,	we	showed	quantitatively	that	neurochemical	signals	are	highly	transient	 and	 occur	 in	 confined	 spatiotemporal	 domains.	 In	 other	 words,	 chemical	communication	 between	 neurons	 occurs	 in	 “temporal	 bursts”	 in	 “spatially	 localized”	domains.	 In	 order	 to	 capture	 these	 events	 for	 dopamine,	 we	 developed	 a	 probe	 with	 a	moderate	affinity	that	minimized	the	risk	of	sensor	saturation	(Kd	≈	10	µM)	but	nonetheless	underwent	 ultrastrong	 fluorescence	 modulation	 (up	 to	 20-fold	 increase	 for	 100	 µM	dopamine).	This	afforded	imaging	“temporally	confined”	signals	at	video	frame	rates	with	decent	signal-to-noise	ratio	(SNR	>	5	for	most	imaging	experiments).	To	ensure	that	we	can	capture	neurochemical	bursts	appropriately	in	the	spatial	domain,	we	developed	a	sensor	loading	 strategy	 that	 generated	 ex	 vivo	 mice	 brain	 slices	 with	 relatively	 uniform	 probe	
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labeling.	With	this	labeling	strategy,	we	recorded	dynamical	information	about	endogenous	dopamine	at	putative	release	sites	in	the	dorsomedial	striatum	of	ex	vivo	mice	brain	tissue.	The	SWCNT-based	technology	presented	in	this	dissertation	captured	electrically	and	optogenetically	 evoked	 releases	 of	 dopamine	 in	 the	 dorsomedial	 striatum,	 revealing	hotspots	of	activity	that	exhibited	a	log-normal	distribution	in	size,	ranging	from	2	–	10	µm	for	mice	brain	tissue.	Moreover,	the	synthetic	nature	of	the	molecular	recognition	platform	afforded	compatibility	with	dopamine-receptor	 targeting	antipsychotics	and	psychoactive	drugs	 and	 permitted	 studies	 of	 how	 such	 receptor-targeting	 drugs	 modulate	 evoked	dopamine	release.	This	assay	revealed	presynaptic	correlates	of	pharmacodynamics	at	the	level	of	putative	dopamine	release	sites,	which	had	heretofore	been	impossible	to	explore	with	existing	tools.	Our	results	suggest	that	this	technology	may	uniquely	support	similar	explorations	of	processes	that	regulate	dopamine	neuromodulation	at	the	level	of	individual	synapses,	 and	 exploration	 of	 the	 effects	 of	 receptor	 agonists	 and	 antagonists	 that	 are	commonly	used	as	psychiatric	drugs	as	well	as	those	that	lead	to	substance	use	disorder.	We	conclude	that	SWCNTs	can	serve	as	versatile	synthetic	optical	tools	to	monitor	interneuronal	chemical	signaling	in	the	brain	extracellular	space	at	spatial	and	temporal	scales	pertinent	with	the	encoded	information.																								
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